WO2002048115A2 - Quinazolinones and pyridinopyrimidinones for controlling invertebrate pests - Google Patents

Quinazolinones and pyridinopyrimidinones for controlling invertebrate pests Download PDF

Info

Publication number
WO2002048115A2
WO2002048115A2 PCT/US2001/046629 US0146629W WO0248115A2 WO 2002048115 A2 WO2002048115 A2 WO 2002048115A2 US 0146629 W US0146629 W US 0146629W WO 0248115 A2 WO0248115 A2 WO 0248115A2
Authority
WO
WIPO (PCT)
Prior art keywords
chloro
halogen
alkyl
ring
ffl
Prior art date
Application number
PCT/US2001/046629
Other languages
French (fr)
Other versions
WO2002048115A3 (en
Inventor
Gary David Annis
Brian James Myers
Thomas Paul Selby
Thomas Martin Stevenson
William Thomas Zimmerman
Original Assignee
E. I. Du Pont De Nemours And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E. I. Du Pont De Nemours And Company filed Critical E. I. Du Pont De Nemours And Company
Priority to US10/433,368 priority Critical patent/US20040110777A1/en
Priority to AU2002227243A priority patent/AU2002227243A1/en
Priority to JP2002549646A priority patent/JP2004515543A/en
Priority to EP01996125A priority patent/EP1341772A2/en
Publication of WO2002048115A2 publication Critical patent/WO2002048115A2/en
Publication of WO2002048115A3 publication Critical patent/WO2002048115A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/541,3-Diazines; Hydrogenated 1,3-diazines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/561,2-Diazoles; Hydrogenated 1,2-diazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dentistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

This invention provides methods for controlling invertebrate pests comprising contacting the pests or their environment with an arthropodicidally effective amount of a compound of Formula (I), its N-oxides or agriculturally suitable salts wherein B, J, K, R?3 and R4¿ and n are as defined in the disclosure.This invention also pertains to certain compounds of Formula (I) and compositions for controlling invertebrate pests comprising a biologically effective amount of a compound of Formula I and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.

Description

TITLE
QUINAZOLI ONES AND PYRJDINYLPYRIMIDINONES FOR CONTROLLING
INVERTEBRATE PESTS
BACKGROUND OF THE INVENTION This invention relates to certain quinazolinones and pyridinylpyrimidinones, their
N-oxides, agriculturally suitable salts and compositions, and a method of use for controlling invertebrate pests in both agronomic and nonagronomic environments.
The control of invertebrate pests is extremely important in achieving high crop efficiency. Damage by invertebrate pests to growing and stored agronomic crops can cause significant reduction in productivity and thereby result in increased costs to the consumer. The control of invertebrate pests in forestry, greenhouse crops, ornamentals, nursery crops, stored food and fiber products, livestock, household, and public and animal health is also important. Many products are commercially available for these purposes, but the need continues for new compounds that are more effective, less costly, less toxic, environmentally safer or have different modes of action.
WO 99/14202 discloses pyrimidin-4-one and pyrimidin-4-thiones of Formula i as fungicides
Figure imgf000002_0001
wherein, inter alia, X is O or S;
A is fused phenyl or pyridyl;
Rl and R2 are selected from H, halogen or trimethylsilyl;
R3 is -Cg alkyl, Cj-Cg alkenyl or Cj-Cg alkynyl, each optionally substituted; and
R4 is optionally substituted phenyl. SUMMARY OF THE INVENTION
This invention pertains to a method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula I, its N-oxide or an agriculturally suitable salt of the compound (e.g., as a composition described herein)
Figure imgf000003_0001
wherein
B is O or S;
J is a phenyl ring substituted with 1 to 4 R5, or a naphthyl ring system, a 5- or
6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R5; K is, together with the two contiguous linking carbon atoms, a fused phenyl or a fused pyridinyl ring selected from the group consisting of K-l, K-2, K-3, K-4 and K-5, each optionally substituted with 1 to 4 R4
Figure imgf000003_0002
R3 is G; Ci-C6 alkyl, C2-Cg alkenyl, C2-Cg alkynyl, C3-C6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of halogen, G, CN, NO2, hydroxy, Cj- alkoxy, Cj-C4 haloalkoxy, CrC4 alkylthio, CrC4 alkylsulfinyl, C,-C4 alkylsulfonyl, C2-C6 alkoxycarbonyl, C2-Cg alkylcarbonyl, C3-C6 trialkylsilyl, or a phenoxy ring optionally substituted with one to three substituents independently selected from R6; hydroxy; CrC4 alkoxy; Cj-C4 alkylamino; C2-C8 dialkylamino; C3-C6 cycloalkylamino; C2-C6 alkoxycarbonyl or C2-C6 alkylcarbonyl;
G is a phenyl ring or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6; a 5- or 6-membered nonaromatic carbocyclic or heterocyclic ring, optionally including one or two ring members selected from the group consisting of C(=O), SO or S(O)2 and optionally substituted with 1 to 4 substituents selected from R12; each R4 is independently H, Cj-C6 alkyl, C2-C6 alkenyl, C2-Cβ alkynyl, C3-C6 cycloalkyl, C C6 haloalkyl, C2-C6 haloalkenyl, C2-C6 haloalkynyl, C3-Cg halocycloalkyl, halogen, CN, NO , hydroxy, Cι-C alkoxy, Cj-C4 haloalkoxy,
Cj-C4 alkylthio, Cj-C4 alkylsulfinyl, C]-C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C C4 haloalkylsulfonyl, Cι-C4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, Cj-C4 alkoxyalkyl, Cj-C4 hydroxyalkyl, C(O)R10, CO2R10, C^NR^R1 !, NR10R! K N(R! ^COR10, N(R! ^CO^R^ or C3-C6 trialkylsilyl; or each R4 is independently a phenyl, benzyl, phenoxy or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6; each R5 is independently H,
Figure imgf000004_0001
alkyl, C2-C6 alkenyl, C2-CG alkynyl, C3-C6 cycloalkyl, C Cg haloalkyl, C -Cg haloalkenyl, C2-C6 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, CO2H, CONH2, NO2, hydroxy, CrC4 alkoxy, C C4 haloalkoxy, C1-C4 alkylthio, Cj-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C C4 haloalkylthio, C]-C4 haloalkylsulfinyl, Cj- . haloalkylsulfonyl, C C4 alkylamino, C -Cg dialkylamino, C3-C6 cycloalkylamino, C2-C5 alkylcarbonyl, C2-Cg alkoxycarbonyl, C -Cg alkylaminocarbonyl, C3~C dialkylaminocarbonyl,
C3-C6 trialkylsilyl; or each R5 is independently a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic S-, 9- or 10-membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from R6; or
(R5)2 when attached to adjacent carbon atoms can be taken together as -OCF2O-, -CF2CF2O-, or -OCF2CF2O-; each R6 is independently C C4 alkyl, C2-C4 alkenyl, C -C4 alkynyl, C3-C6 cycloalkyl, Cj-C4 haloalkyl, C2-C4 haloalkenyl, C2-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, -C4 alkoxy, Cj-C haloalkoxy, CrC alkylthio, C alkylsulfinyl, C C4 alkylsulfonyl, -C4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C2-Cg alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-Cg dialkylaminocarbonyl or C3-C6 trialkylsilyl; RlO is H or C C4 alkyl or -C4 haloalkyl;
RU is H or - alkyl; each R12 is independently Cj-C2 alkyl, halogen, CN, NO2 and C!-C2 alkoxy; and n is 1 to 4. This invention also relates to such a method wherein the invertebrate pest or its environment is contacted with a biologically effective amount of a compound of Formula I or a composition comprising a compound of Formula I and a biologically effective amount of at least one additional compound or agent for controlling invertebrate pests.
This invention also pertains to a compound of Formula la, its N-oxide or an agriculturally suitable salt of the compound
Figure imgf000005_0001
la
wherein
K is, together with the two contiguous linking carbon atoms, a fused phenyl or a fused pyridinyl ring selected from the group consisting of K-l, K-2, K-3, K-4 and K-5, each optionally substituted with 1 to 4 R4
Figure imgf000005_0002
J substituted with 1 to 3 R5 is selected from the group consisting of J-6, J-7, J-8, J-9, J-10, J-l l, J-12 and J-13
Figure imgf000005_0003
Figure imgf000006_0001
R3 is Cj-Cg alkyl, C2-Cg alkenyl, C2-C6 alkynyl or C3-C6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, CrC2 alkoxy, Cj-C2 alkylthio, Cj-C2 alkylsulfinyl and C1-C2 alkylsulfonyl; one R4 group is attached to the K-ring at the 2-position or 5-position, and said R4 is CrC4 alkyl, CrC4 haloalkyl, halogen, CN, NO2, CrC4 alkoxy, CrC4 haloalkoxy, Cι-C4 alkylthio, Cι-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, or C1-C4 haloalkylsulfonyl; and an optional second R4 is H, C\-C(_ alkyl, C2-C alkenyl, C2-C(_ alkynyl, C3-C6 cycloalkyl, C1-C6 haloalkyl, C2-C6 haloalkenyl, C2-Cg haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, hydroxy, C1-C4 alkoxy, Cj-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C]-C4 haloalkylsulfonyl, Cι-C4 alkylamino, C2-C8 dialkylamino, C -C6 cycloalkylamino, Cj- alkoxyalkyl, C1-C4 hydroxyalkyl,
C(O)R10, CO2R10, C(O)NR10Rn, NR10Rn, N(Rn)COR10,
Figure imgf000006_0002
or C3-C6 trialkylsilyl;
R5 is
Figure imgf000006_0003
V is N, CH, CF, CC1, CBr or CI; each R6 is independently C1-C4 alkyl, C2-C alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, C1-C4 haloalkyl, C2-C4 haloalkenyl, C2-C haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, C!-C alkoxy, C C4 haloalkoxy, C1-C4 alkylthio, CrC4 alkylsulfinyl, CrC4 alkylsulfonyl, C1-C4 alkylamino, C2-Cg dialkylamino, C3- C6 cycloalkylamino, C_t,-C6 (alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C2-C6 alkoxycarbonyl, C -C6 alkylaminocarbonyl, C3-Cg dialkylaminocarbonyl or C3- C6 trialkylsilyl; each R7 is independently H, Cj- alkyl, Cj-Cg haloalkyl, halogen, CN, CrC4 alkoxy,
C1-C4 haloalkoxy or C1-C4 haloalkylthio; R9 is H, C2-C6 alkyl, CrC6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl or C3-C6 haloalkynyl, provided that R7 and R9 are not both H; R10 is H or C !-C4 alkyl or C ι-C4 haloalkyl;
R11 is H or C1-C4 alkyl; and n is 0, 1 or 2.
This invention also pertains to a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula la and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents. This invention also pertains to a composition comprising a biologically effective amount of a compound of Formula la and an effective amount of at least one additional biologically active compound or agent.
DETAILS OF THE INVENTION In the above recitations, the term "alkyl", used either alone or in compound words such as "alkylthio" or "haloalkyl" includes straight-chain or branched alkyl, such as methyl, ethyl, 72-propyl, t-propyl, or the different butyl, pentyl or hexyl isomers. "Alkenyl" includes straight-chain or branched alkenes such as 1-propenyl, 2-propenyl, and the different butenyl, pentenyl and hexenyl isomers. "Alkenyl" can also include polyenes such as 1 ,2-propadienyl and 2,4-hexadienyl. "Alkynyl" includes straight-chain or branched alkynes such as
1-propynyl, 2-propynyl and the different butynyl, pentynyl and hexynyl isomers. "Alkynyl" can also include moieties comprised of multiple triple bonds such as 2,5-hexadiynyl. "Alkoxy" includes, for example, methoxy, ethoxy, 77-propyloxy, isopropyloxy and the different butoxy, pentoxy and hexyloxy isomers. "Alkoxyalkyl" denotes alkoxy substitution on alkyl. Examples of "alkoxyalkyl" include CH3OCH9, CH3OCH2CH2, CH3CH2OCH2, CH3CH2CH2CH2OCH2 and CH3CH2OCH2CH2. "Alkylthio" includes branched or straight-chain alkylthio moieties such as methylthio, ethylthio, and the different propylthio, butylthio, pentylthio and hexylthio isomers. "Cycloalkyl" includes, for example, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. The term "heteroaromatic ring" denotes fully aromatic rings in which at least one ring atom is not carbon and can contain 1 to 4 heteroatoms independently selected from the group consisting of nitrogen, oxygen and sulfur, provided that each heteroaromatic ring contains no more than 4 nitrogens, no more than 2 oxygens and no more than 2 sulfurs (where aromatic indicates that the Hiickel rule is satisfied). The heteroaromatic ring can be attached through any available carbon or nitrogen by replacement of hydrogen on said carbon or nitrogen.
The term "halogen", either alone or in compound words such as "haloalkyl", includes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as "haloalkyl", said alkyl may be partially or fully substituted with halogen atoms which may be the same or different. Examples of "haloalkyl" include F3C, C1CH2, CF3CH2 and CF3CC12. The teπns "haloalkenyl", "haloalkynyl", "haloalkoxy", and the like, are defined analogously to the tenn "haloalkyl". Examples of "haloalkenyl" include (C1)2C=CHCH2 and CF3CH2CH=CHCH2. Examples of "haloalkynyl" include HC≡CCHCl, CF3C≡C, CC13C≡C and FCH2C≡CCH2. Examples of "haloalkoxy" include CF3O, CCl3CH2O, HCF2CH2CH2O and CF3CH2O.
The total number of carbon atoms in a substituent group is indicated by the "C;-C," prefix where i and j are numbers from 1 to 6. For example, C1-C3 alkylsulfonyl designates methylsulfonyl through propylsulfonyl; C2 alkoxyalkyl designates CH3OCH2; C3 alkoxyalkyl designates, for example, CH3CH(OCH3), CH3OCH2CH2 or CH3CH2OCH2; and C4 alkoxyalkyl designates the various isomers of an alkyl group substituted with an alkoxy group containing a total of four carbon atoms, examples including CH3CH2CH2OCH2 and CH3CH2OCH2CH2. In the above recitations, when a compound of Formula 1 contains a heteroaromatic ring, all substituents are attached to this ring through any available carbon or nitrogen by replacement of a hydrogen on said carbon or nitrogen. When a group contains a substituent which can be hydrogen, for example R3, then, when this substituent is taken as hydrogen, it is recognized that this is equivalent to said group being unsubstituted.
Compounds of this invention can exist as one or more stereoisomers. The various stereoisomers include enantiomers, diastereomers, atropisomers and geometric isomers. One skilled in the art will appreciate that one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other stereoisomer(s) or when separated from the other stereoisomer(s). Additionally, the skilled artisan knows how to separate, enrich, and/or to selectively prepare said stereoisomers. Accordingly, the compounds of the invention may be present as a mixture of stereoisomers, individual stereoisomers, or as an optically active form.
The present invention comprises compounds selected from Formula I, N-oxides and agriculturally suitable salts thereof, compositions thereof and methods of their use for invertebrate pest control. One skilled in the art will appreciate that not all nitrogen containing heterocycles can form N-oxides since the nitrogen requires an available lone pair for oxidation to the oxide; one skilled in the art will recognize those nitrogen containing heterocycles which can form N-oxides. One skilled in the art will also recognize that tertiary amines can form N-oxides. Synthetic methods for the preparation of N-oxides of heterocycles and tertiary amines are very well known by one skilled in the art including the oxidation of heterocycles and tertiary amines with peroxy acids such as peracetic and ??.-chloroperbenzoic acid (MCPBA), hydrogen peroxide, alkyl hydroperoxides such as t-butyl hydroperoxide, sodium perborate, and dioxiranes such as dimethydioxirane. These methods for the preparation of N-oxides have been extensively described and reviewed in the literature, see for example: T. L. Gilchrist in Comprehensive Orgamc Synthesis, vol. 7, pp 748-750, S. V. Ley, Ed., Pergamon Press; M. Tisler and B. Stanovnik in Comprehensive Heterocyclic Chemistiγ, vol. 3, pp 18-19, A. J. Boulton and A. McKillop, Eds., Pergamon Press; M. R. Grimmett and B. R. T. Keene in Advances in Heterocyclic Chemistiγ, vol. 43, pp 139-151, A. R. Katritzky, Ed., Academic Press; M. Tisler and B. Stanovnik in Advances in Heterocyclic Chemistry, vol. 9, pp 285-291, A. R. Katritzky and A. J. Boulton, Eds., Academic Press; and G. W. H. Cheeseman and E. S. G. Werstiuk in Advances in Heterocyclic Chemistry, vol. 22, pp 390-392, A. R. Katritzky and A. J. Boulton, Eds., Academic Press. The salts of the compounds of the invention include acid-addition salts with inorganic or organic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, fumaric, lactic, maleic, malonic, oxalic, propionic, salicylic, tartaric, 4-toluenesulfonic or valeric acids.
Preferred methods for reasons of better activity, cost and/or ease of synthesis are: Preferred 1. Methods wherein for the compounds of Formula I B is O and R3 is
C Cg alkyl, C2-Cg alkenyl, C2-C6 alkynyl or C3-C6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, C C2 alkoxy, C C? alkylthio, Cι-C2 alkylsulfinyl and C C2 alkylsulfonyl. Preferred 2. Methods of Preferred 1 wherein J is a phenyl group substituted with 1 to
4 R5. Preferred 3. Methods of Preferred 2 wherein n is 1 to 2; one R4 group is attached to the K-ring at the 2-position or 5-position, and said R4 is C 1 -C4 alkyl, C ! -C4 haloalkyl, halogen, CN, NO2, C _ -C4 alkoxy,
C]-C4 haloalkoxy, Cp alkylthio, C C4 alkylsulfinyl, CrC4 alkylsulfonyl, C]-C4 haloalkylthio, Cj-C4 haloalkylsulfinyl or Cj- haloalkylsulfonyl; and each R5 is independently H, halogen, CrC4 alkyl, Cι-C2 alkoxy, C C4 haloalkyl, CN, NO2, CrC4 haloalkoxy, CrC4 alkylthio, CrC4 alkylsulfinyl, C1-C4 alkylsulfonyl, -C4 haloalkylthio, CrC4 haloalkylsulfinyl, Cι-C4 haloalkylsulfonyl or C2-C alkoxycarbonyl; or each R5 is independently a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with R6; or (R5)2 when attached to adjacent carbon atoms can be taken together as
-OCF2O-, -CF2CF2O- or -OCF2CF2O-. Preferred 4. Methods of Preferred 3 wherein R3 is C1-C4 alkyl optionally substituted with halogen, CN, OCH3 or
S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; each R5 is independently H, halogen, methyl, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, OCH2CF3, OCF2CHF2, S(O)pCH2CF3 or S(O)pCF2CHF2; or a phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine ring, each ring optionally substituted with C]-C4 alkyl, Cj-C4 haloalkyl, halogen or CN; and p is 0, 1 or 2. Preferred 5. Methods of Preferred 4 wherein R3 is t-propyl or t-butyl. Preferred 6. Methods of Preferred 1 wherein J is a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 4 R5. Preferred 7. Methods of Preferred 6 wherein
J is a 5- or 6-membered heteroaromatic ring selected from the group consisting of J-l, J-2, J-3, J-4 and J-5, each J optionally substituted with 1 to 3 R5
Figure imgf000010_0001
J-l -2 J-3 j_4 J-5
Q is O, S or NR5; and
W, X, Y and Z are independently N or CR5, provided that in J-4 and J-5 at least one of W, X, Y or Z is N. Preferred 8. Methods of Preferred 7 wherein n is 1 to 2; one R4 group is attached to the K-ring at the 2-position or 5-position, and said
R4 is CrC4 alkyl, CrC4 haloalkyl, halogen, CN, NO2, CrC4 alkoxy, CrC4 haloalkoxy, CrC4 alkylthio, CrC4 alkylsulfinyl, CrC4 alkylsulfonyl, 0^4 haloalkylthio, C1-C4 haloalkylsulfinyl, or C1-C4 haloalkylsulfonyl; and each R5 is independently H, CrC4 alkyl, CrC4 haloalkyl, halogen, CN, NO2,
CrC4 haloalkoxy, CrC4 alkylthio, CrC4 alkylsulfinyl, CrC4 alkylsulfonyl, CrC4 haloalkylthio, C C haloalkylsulfinyl, C]-C haloalkylsulfonyl or C2-C4 alkoxycarbonyl; or a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with R6. Preferred 9. Methods of Preferred 8 wherein
J substituted with 1 to 3 R5 is selected from the group consisting of J-6, J-7, J-S, J-9, J-10, J-l l, J-12 and J-13
Figure imgf000011_0001
Figure imgf000011_0002
R5 IS
Figure imgf000011_0003
V is N, CH, CF, CC1, CBr or CI; each R7 is independently H, C Cg alkyl, Cj-Cg haloalkyl, halogen, CN,
C1-C4 alkoxy, C1-C4 haloalkoxy or C1-C4 haloalkylthio; R9 is H, C2-C6 alkyl, CrC6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl or C3-C6 haloalkynyl, provided that R7 and R9 are not both H; and n is 0, 1 or 2. Preferred 10. Methods of Preferred 9 wherein J substituted with 1 to 3 R5 is J-6;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is C1-C4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is CH3, CF3, OCHF2 or halogen; and p is 0, 1 or 2. Preferred 11. Methods of Preferred 10 wherein
R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and
R7 is halogen or CF3. Preferred 12. Methods of Preferred 9 wherein J substituted with 1 to 3 R5 is J-7;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, lor 2.
Preferred 13. Methods of Preferred 12 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and
R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2. Preferred 14. Methods of Preferred 9 wherein J substituted with 1 to 3 R5 is J-S; R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3) OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN R6 is CH3, CF3 or halogen;
R7 is CH3, CF3 or halogen; and p is 0, 1 or 2. Preferred 15. Methods of Preferred 14 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and
R7 is halogen or CF3. Preferred 16. Methods of Preferred 9 wherein J substituted with 1 to 3 R5 is J-9;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is CH3, CF3 or halogen; and p is 0, 1 or 2.
Preferred 17. Methods of Preferred 18 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and R7 is CF3. Preferred 18. Methods of Preferred 9 wherein J substituted with 1 to 3 R5 is J-10; R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is O, lor 2. Preferred 19. Methods of Preferred IS wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and
R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2. Preferred 20. Methods of Preferred 9 wherein J substituted with 1 to 3 R5 is J-l 1;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, C C4 haloalkyl, halogen or CN; R7 is CH3, CF3, OCHF2 or halogen; and p is 0, 1 or 2. Preferred 21. Methods of Preferred 20 wherein
R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and
R7 is halogen or CF3. Preferred 22. Methods of Preferred 9 wherein J substituted with 1 to 3 R5 is J-l 2;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, Cj-C haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, lor 2.
Preferred 23. Methods of Preferred 22 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and
R9 is CF3. CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2. Preferred 24. Methods of Preferred 9 wherein J substituted with 1 to 3 R5 is J-l 3; R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, lor 2. Preferred 25. Methods of Preferred 24 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2.
Most preferred is the method wherein the compound of Formula I is selected from the group consisting of: 8-methyl-3-(l-methylethyl)-2-[2-methyl-6-(trifluoromethyl)-3-pyridinyl]-4(3H)- quinazolinone, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3,8-dimethyl-
4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3-ethyl-S-methyl- 4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-8-methyl-3- (l-methylethyl)-4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3- (1,1 -dimethylethyl)-8-methyl-4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3,8-dimethyl- 4(3H)-quinazoline, 6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-ethyl-S-methyl-
4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-8-methyl-3- ( 1 -methylethyl)-4(3H)-quinazoline,
6-chloro-2-[3 -chloro- 1 -(3 -chloro-2-pyridinyl)- 1 H-pyrazol-5 -yl] -3 - (l,l-dimethylethyl)-8-methyl-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3,S- dimethyl-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-ethyl- 8-methyl-4(3H)-quinazoline, 6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-8- methyl-3 -( 1 -methylethyl)-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- (1,1 -dimethylethyl)-8-methyl-4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-8-methyl-3-(l-methylethyl)- 4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-(l,l-dimethylethyl)-8- methyl-4(3H)-quinazoline, 2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-8-methyl-3-
( 1 -methyl ethyl)-4(3H)-quinazoline,
2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- (1 ,1 -dimethylethyl)-8-methyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- methyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- ethyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-(l- methylethyl)-4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3-methyl-
4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3-ethyl-4(3H)- quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3- (1 -methylethyl)-4(3H)-quinazoline,
6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyι-idinyl)-lH-pyrazol-5-yl]-3-methyl- 4(3H)-quinazoline,
6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-ρyrazol-5-yl]-3-ethyl-4(3H)- quinazoline, and 6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-ρyrazol-5-yl]-3-
( 1 -methylethyl)-4(3H)-quinazoline. Preferred compounds for reasons of better activity, cost and/or ease of synthesis are: Preferred A. Compounds of Formula la wherein J substituted with 1 to 3 R5 is J-6; R3 is CrC4 alkyl optionally substituted with halogen, CN, OCΗ3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is CH3, CF3, OCHF2 or halogen; and p is 0, 1 or 2. Preferred B. Compounds of Preferred A wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R7 is halogen or CF3.
Preferred C. Compounds of Formula la wherein J substituted with 1 to 3 R5 is J-7;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, lor 2. Preferred D. Compounds of Preferred C wherein
R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and
R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2. Preferred E. Compounds of Formula la wherein J substituted with 1 to 3 R5 is J-8;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN R6 is CH3, CF3 or halogen; R7 is CH3, CF3 or halogen; and p is 0, 1 or 2. Preferred F. Methods of Preferred E wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R7 is halogen or CF3. Preferred G. Compounds of Formula la wherein J substituted with 1 to 3 R5 is J-9;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is CH3, CF3 or halogen; and p is 0, 1 or 2. Preferred H. Compounds of Preferred G wherein
R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and
R7 is CF3. Preferred I. Compounds of Formula la wherein J substituted with 1 to 3 R5 is J-10;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, lor 2.
Preferred J. Compounds of Preferred I wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and
R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2. Preferred K. Compounds of Formula la wherein J substituted with 1 to 3 R5 is J-l 1; R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is C1-C4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is CH3, CF3, OCHF2 or halogen; and p is 0, 1 or 2. Preferred L. Compounds of Preferred K wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R7 is halogen or CF3.
Preferred M. Compounds of Foπnula la wherein J substituted with 1 to 3 R5 is J-l 2;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is O, lor 2. Preferred N. Methods of Preferred M wherein
R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and
R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2. Preferred O. Compounds of Formula la wherein J substituted with 1 to 3 R5 is J-l 3;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, lor 2.
Preferred P. Methods of Preferred O wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2.
Most preferred is the compound of Formula I selected from the group consisting of:
8-methyl-3-(l-methylethyl)-2-[2-methyl-6-(trifluoromethyl)-3-pyridinyl]-4(3H)- quinazolinone,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3,8-dimethyl- 4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3-ethyl-8-methyl-
4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-8-methyl-3-
( 1 -methylethyl)-4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3-
(1,1 -dimethyl ethyl)-8-methyl-4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3,8-dimethyl-
4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-ethyl-8-methyl- 4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-8-methyl-3-
( 1 -methyl ethyl)-4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-
(1,1 -dimethylethyl)-8-methyl-4(3H)-quinazoline, 6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazoI-5-yl]-3,8- dimethyl-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-ethyl-
8-methyl-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-8- methyl-3 -( 1 -methyl ethyl)-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-
(1,1 -dimethylethyl)-8-methyl-4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-p)τidinyl)-lH-pyrazol-5-yl]-S-methyl-3-(l-methylethyl)-
4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-(l,l-dimethylethyl)-8- methyl-4(3H)-quinazoline,
2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-8-methyl-3-
( 1 -methyl ethyl)-4(3H)-quinazoline, 2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- (1,1 -dimethylethyl)-8-methyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- methyl-4(3H)-quinazoline, 6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- ethyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyι-azol-5-yl]-3-(l- methylethyl)-4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3-methyl- 4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3-ethyl-4(3H)- quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,S-dichloro-3- ( 1 -methyl ethyl)-4(3H)-quinazoline, 6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-methyl-
4(3H)-quinazoIine,
6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-ethyl-4(3H)- quinazoline, and
6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3- (1 -methylethyl)-4(3H)-quinazoline.
This invention also pertains to a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula la and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents. Preferred compositions are those comprising the above preferred compounds.
Of note is a method for controlling arthropods comprising contacting the arthropods or their environment with an arthropodicidally effective amount of a compound of Formula 1 , its N-oxides or agriculturally suitable salts thereof
Figure imgf000021_0001
wherein
B is O or S; J is a phenyl group substituted with 1 to 2 R5 and optionally substituted with 1 to 3 R6, or a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 4 R7; n is 1 to 4;
R3 is C Cg alkyl, C2-Cg alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, NO2, hydroxy, C1-C4 alkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl and C1-C4 alkylsulfonyl; C1-C4 alkoxy; C1-C4 alkylamino; C2-Cg dialkylamino; C3-C6 cycloalkylamino; C2-Cg alkoxycarbonyl or C2-Cg alkylcarbonyl; each R4 is independently H, Cj-Cg alkyl, C2-Cg alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, Cj-Cg haloalkyl, C2-C6 haloalkenyl, C2-Cg haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, CO2H, CONH2, NO2, hydroxy, CrC alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C1-C4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, C2-Cg alkylcarbonyl, C2-Cg alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-C dialkylaminocarbonyl,
C3-C6 trialkylsilyl; or each R4 is independently phenyl, benzyl or phenoxy, each optionally substituted with C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, C1-C4 haloalkyl, C2-C4 haloalkenyl, C2-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, CrC4 alkoxy, CrC4 haloalkoxy, CrC4 alkylthio, CrC4 alkylsulfinyl,
C C4 alkylsulfonyl, C1-C4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C -C4 alkylcarbonyl, C2-Cg alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-C dialkylaminocarbonyl or C3-C6 trialkylsilyl; each R5 is independently Cj-Cg alkyl, C2-Cg alkenyl, C2-Cg alkynyl, C3-C6 cycloalkyl, C Cg haloalkyl, C2-C haloalkenyl, C -Cg haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, CO2H, CONH2, NO2, hydroxy, CrC4 alkoxy, Cj-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, Cj-C4 haloalkylthio, C C4 haloalkylsulfinyl, C!-C4 haloalkylsulfonyl, C]-C4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, C2-Cg alkylcarbonyl,
C2-Cg alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3~Cg dialkylaminocarbonyl, C3-C6 trialkylsilyl; or (R5)2 when attached to adjacent carbon atoms can be taken together as -OCF2O-, -CF2CF2O-, or -OCF2CF2O-; each R6 is independently H, halogen, CrCg alkyl, C2-C6 alkenyl, C2-C6 alkynyl,
C3-C6 cycloalkyl, CpC alkoxy or C2-C4 alkoxy carbonyl; or each R6 is independently a phenyl, benzyl, phenoxy or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with - alkyl, C -C4 alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, C1-C4 haloalkyl, C -C4 haloalkenyl, C2-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, Cj-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, Cj-C alkylamino, C?-Cg dialkylamino, C3- cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C2-Cg alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-Cg dialkylaminocarbonyl or C3-C6 trialkylsilyl; each R7 is independently H, Cj-Cg alkyl, C2-Cg alkenyl, C2-Cg alkynyl, C3-C6 cycloalkyl, C Cg haloalkyl, C -Cg haloalkenyl, C2-Cg haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, CO2H, CONH2, NO2, hydroxy, CrC4 alkoxy, C]-C4 haloalkoxy, Cι-C alkylthio, C2-C4 alkylsulfinyl, C]-C4 alkylsulfonyl,
C!-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, C C alkoxycarbonyl, C1-C4 alkylamino, C -Cg dialkylamino, C3-C6 cycloalkylamino, C2-Cg alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-C dialkylaminocarbonyl, C3-C6 trialkylsilyl; or each R7 is independently a phenyl, benzyl, benzoyl, phenoxy or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with C1-C4 alkyl, -C4 alkenyl, C -C4 alkynyl, C3-C6 cycloalkyl, C1-C4 haloalkyl, -C4 haloalkenyl, C -C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO , C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, Cj-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C1 -C4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, C3-C6
(alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C2-Cg alkoxycarbonyl, C2-C6 alkylaminocarbonyl, C3-Cg dialkylaminocarbonyl or C3-C6 trialkylsilyl. Of note are compounds of Formula 1 wherein
Figure imgf000023_0001
B is O;
J is a phenyl group substituted with 1 to 2 R5 and optionally substituted with 1 to 3 R6; or J is selected from the group consisting of pyridine, pyrimidine, pyrazole, thiophene and thiazole, each optionally substituted with 1 to 3 R7; R3 is C2-C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; each R4 is independently CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2 or halogen; each R5 is independently CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, OCH2CF3,
OCF2CHF2, S(O)pCH2CF3 or S(O)pCF2CHF2; each R6 is independently halogen or methyl; or phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C1-C4 alkyl, C1-C4 haloalkyl, halogen or CN; each R7 is independently H, halogen, CH3, CF3, OCHF2, S(O)pCF3, S(O)pCHF2, OCH2CF3, OCF2CHF2, S(O)pCH2CF3, S(O)pCF2CHF2; or phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine, each ring optionally substituted with C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy, C C4 haloalkoxy, halogen, NO2 or CN; and p is 0, 1 or 2.
As noted above, J is a phenyl ring, a naphthyl ring system, a 5- or 6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R5. The term "optionally substituted" in connection with these J groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog. An example of phenyl optionally substituted with 1 to 4 R5 is the ring illustrated as U-l in Exhibit 1, wherein Rv is R5 and r is an integer from 1 to 4. An example of a naphthyl group optionally substituted with 1 to 3 R5 is illustrated as U-85 in Exhibit 1, wherein Rv is R5 and r is an integer from 1 to 4.
Examples of 5- or 6-membered heteroaromatic rings optionally substituted with 1 to 4 R5 include the rings U-2 through U-53 illustrated in Exhibit 1 wherein Rv is R5 and r is an integer from 1 to 4. Note that J-l through J-5 below also denote 5- or 6-membered heteroaromatic rings. Note that U-2 through U-20 are examples of J-l, U-21 through LI-35 and U-40 are examples of J-2, U-36 through U-39 are examples of J-3, U-41 through U-48 are examples of J-4 and LT-49 through U-53 are examples of J-5. Examples of aromatic 8-, 9- or 10-membered fused heterobicyclic ring systems optionally substituted with 1 to 4 R5 include U-54 through LT-84 illustrated in Exhibit 1 wherein Rv is R5 and r is an integer from 1 to 4. Although Rv groups are shown in the structures U-l through U-85, it is noted that they do not need to be present since they are optional substituents. Note that when Rv is H when attached to an atom, this is the same as if said atom is unsubstituted. The nitrogen atoms that require substitution to fill their valence are substituted with H or Rv. Note that some U groups can only be substituted with less than 4 Rv groups (e.g. U-14, LT-15, U-18 through U-21 and U-32 through U-34 can only be substituted with one Rv). Note that when the attachment point between (Rv)r and the U group is illustrated as floating, (Rv)r can be attached to any available carbon atom of the U group. Note that when the attachment point on the U group is illustrated as floating, the U group can be attached to the remainder of
Formula I through any available carbon of the U group by replacement of a hydrogen atom.
Exhibit 1
Figure imgf000025_0001
U-5 U-6 U-7
U-8
Figure imgf000025_0002
U-l l 3
U-9 U-10 U-12 U-1
Figure imgf000025_0003
U-16 U-17
Figure imgf000025_0004
Figure imgf000026_0001
U-27 U-28 U-29 U-30
Figure imgf000026_0002
U-40 U-41 U-42 U-43
Figure imgf000026_0003
-44 U-45 U-46 U-47 U-48
Figure imgf000026_0004
Figure imgf000027_0001
U-54 U-55 U-56 U-57
Figure imgf000027_0002
U-58 U-59 U-60 U-61
Figure imgf000027_0003
U-66 U-67 U-68 U-69
Figure imgf000027_0004
U-70 U-71 U-72 U-73
Figure imgf000027_0005
U-74 U-75 U-76 U-77
Figure imgf000028_0001
U-78 U-79 U-80 U-81
Figure imgf000028_0002
U-83 U-84
U-82 U-85
Figure imgf000028_0003
As noted above G can be a 5- or 6-membered nonaromatic carbocyclic or heterocyclic ring, optionally including one or two ring members selected from the group consisting of C(=O), SO or S(O)2 and optionally substituted with 1 to 4 substituents selected from R12. Examples of such G groups include those illustrated as G-l through G-41 in Exhibit 2 wherein m is an integer from 1 to 4. The term "optionally substituted" in connection with these G groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog. Although (R12)m are illustrated in the examples, they need not be present since they are optional substituents. Note that when the attachment point on these G groups is illustrated as floating, the G group can be attached to the remainder of Formula I through any available carbon or nitrogen of the G group by replacement of a hydrogen atom. The optional substituents can be attached to any available carbon or nitrogen by replacing a hydrogen atom. Note that when G comprises a ring selected from G-24 through G-29 and G-32 through G-35, A is selected from O, S, NH or NR12. Note that when G is G-3, G-5, G-7, G-9, G-16 through G-l 8, G-23, and G-24 through G-29, and G-32 through G-35 (when A is NR12), the nitrogen atoms that require substitution to fill their valence are substituted with H or R12. Exhibit 2
Figure imgf000029_0001
G-l G-3 G-4 G-5
Figure imgf000029_0002
G-6 G-7 G-8 G-9 G-10
Figure imgf000029_0003
(R12)nι
Figure imgf000029_0004
G-16 G-17
Figure imgf000029_0005
π(R.il2)m,
Figure imgf000029_0007
Figure imgf000029_0006
G-21 G-23 G-24 G-25
Figure imgf000029_0008
G-30 G.31
G-26 G-27 G"28 G-29
Figure imgf000029_0009
Figure imgf000030_0001
G-37 G-38 G-39 G-40 G-41
As noted above, R3 can be (among others) Cj-Cg alkyl, C2-C6 alkenyl, C2-Cg alkynyl, C3-C6 cycloalkyl, each optionally substituted with one or more substituents selected from (among others) a phenyl, phenoxy or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6. The tem "optionally substituted" in connection with these groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog. Examples of such substituents include the rings illustrated as U-l through U-53 and U-8S illustrated in Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents independently selected from R6 rather than (Rv)r Note that R6 substituents do not need to be present since they are optional substituents.
As noted above, each R4 is independently (among others) a phenyl, benzyl, phenoxy or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6. The term "optionally substituted" in connection with these R4 groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog. Examples of such R4 groups include the rings illustrated as U-l through U-53, U-86 and U-88 illustrated in Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents independently selected from R6 rather than (Rv)r. Note that R6 substituents do not need to be present since they are optional substituents.
As noted above, each R5 is independently (among others) a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic S-, 9- or 10-membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from R6. Examples of such R5 groups include the rings illustrated as U-l through U-88 illustrated in Exhibit 1, except that such rings are optionally substituted with 1 to 3 substituents independently selected from R6 rather than (Rv)r. Note that R6 substituents do not need to be present since they are optional substituents. Note that in J-6 through J-l 3, R7 and R9 are subsets of R5. As noted above K is, together with the two contiguous linking carbon atoms, a fused phenyl or a fused pyridinyl ring optionally substituted with 1 to 4 R4. The tenn "optionally substituted" in connection with these K groups refers to groups which are unsubstituted or have at least one non-hydrogen substituent that does not extinguish the biological activity possessed by the unsubstituted analog. Examples of such K groups include the rings illustrated as K-l through K-5 in Exhibit 3. Note that K-2 through K-5 can be optionally substituted with one to three 3 R4 groups. In the exemplified K groups, the upper right bond is attached through the available linking carbon atom to the nitrogen atom of the N=C-J portion of Formula I and the lower right bond is attached through the available linking carbon atom to the carbon atom of the C(=B)NR3 portion of Foπnula I. The wavy line indicates that the K-ring is attached to the remainder of Formula I as illustrated below.
Exhibit 3
Figure imgf000031_0001
Figure imgf000031_0002
Preferred K-rings are K-l , K-2 and K-5. Most preferred is K-l .
The compounds of Formula I can be prepared by one or more of the following methods and variations as described in Schemes 1-13. The definitions of B, J, K, R3, R4, R5 and n in the compounds of Formulae I and 2-24 below are as defined above in the Summary of the Invention. Of note are compounds wherein K is K-l . Compounds of Formula lb (Formula I wherein B is O) can be prepared by procedures outlined in Schemes 1-13. A typical procedure is detailed in Scheme 1 and involves dehydration of an o-amido amide of Formula 2 with sodium hydride and ethyl chloro fomiate in a suitable solvent (See e.g. Example 1). Other methods for preparing compounds of Formula I include treating a compound of Formula 2 with acetic anhydride and sodium acetate, heating at greater than 70 °C neat or optionally in an appropriate solvent such as tetrahydrofuran, and treating 2 with a suitable acid scavenger and trimethylsilyl chloride in a suitable solvent. Further useful methods include heating o-amido amides of Formula 2 adsorbed on surface-active materials such as zeolites or clay, generally in the range of 50-150 °C. A specific example of this type is described in Example 2 and involves heating the anthranilic amide on Montmorillonite clay. Compounds of Formula Ic (Formula I wherein B is S) can be prepared by conventional methods for conversion of amides to thioamides such as by treatment with phosphorus pentasulfide or Lawesson's reagent. (See (Bull. Soc. Chim. Belg.), 1978, 87, 229; and (Tetrahedron Lett.), 1983, 24, 3815 for general procedures).
Scheme 1
Figure imgf000032_0001
Compounds of Formula 2 can be prepared by procedures outlined in Scheme 2. A typical procedure involves coupling of an o-amino amide of Formula 3 with an acid chloride of Formula 4 in the presence of an acid scavenger to provide the compound of Formula 2. Typical acid scavengers include amine bases such as triethylamine, diisopropylethylamine and pyridine; other scavengers include hydroxides such as sodium and potassium hydroxide and carbonates such as sodium carbonate and potassium carbonate. In certain instances it is useful to use polymer-supported acid scavengers such as polymer-bound diisopropylethylamine and polymer-bound dimethylaminopyridine.
Scheme 2
Figure imgf000032_0002
An alternate procedure for the preparation of compounds of Formula 2 involves coupling of an o-amino amide of Formula 3 with an acid of Formula 5 in the presence of a dehydrating agent such as dicyclohexylcarbodiimide (DCC). Polymer supported reagents can be useful here, such as polymer-bound cyclohexylcarbodiimide. Synthetic procedures of Schemes 2 and 3 are only representative examples of useful methods for the preparation of Formula 2 compounds as the synthetic literature is extensive for this type of reaction.
Scheme 3
Figure imgf000033_0001
One skilled in the art will also realize that acid chlorides of Formula 4 may be prepared from acids of Formula 5 by numerous well-known methods.
Formula 3 o- Amino amides are typically available from the corresponding o-nitro amides of Formula 6 via catalytic hydrogenation of the nitro group. Typical procedures involve reduction with hydrogen in the presence of a metal catalyst such as palladium on carbon or platinum oxide and in hydroxylic solvents such as ethanol and isopropanol. These procedures are well documented in the chemical literature.
Scheme 4
Figure imgf000033_0002
The intermediate amides of Formula 6 are readily prepared from commercially available o-nitro acids of Formula 7. Typical methods for amide formation can be applied here. These include direct dehydrative coupling of acids of Foπnula 7 with amines of Formula 8 using for example DCC, and conversion of the acids to an activated form such as the'acid chlorides or anhydrides and subsequent coupling with amines to form amides of Formula 6. Ethylchloro formate is an especially useful reagent for this type of reaction. Scheme 5
Figure imgf000034_0001
hitermediate o-amino amides of Formula 3 may also be prepared from anhydrides of Fomiula 9 (Scheme 6). Typical procedures involve combination of equimolar amounts of the amine 8 with the anhydride of Fomiula 9 in polar aprotic solvents such as pyridine and dimethylformamide at temperatures ranging from room temperature to 100 °C.
Scheme 6
Figure imgf000034_0002
An alternate procedure for the preparation of compounds of Formula 2 involves reaction of an amine 8 with a compound of Formula 10. Typical procedures involve combination of the amine with the compound of Formula 10 in solvents such as tetrahydrofuran or pyridine at temperatures ranging from room temperature to the reflux temperature of the solvent. Benzoxazinones (compounds of Formula 10 wherein K is K-l) are well documented in the chemical literature and are available via known methods that involve the coupling of either an anthranilic acid or an isatoic anhydride with an acid chloride. Scheme 7
Figure imgf000035_0001
10
Compounds of Foπnula I may also be prepared by modification of known procedures (J. Med. Chem. 1985, 28, 568). Usually this involves condensation of an aryl aldehyde of Formula 11 with a compound of Formula 3 in an alcoholic solvent and with a catalytic amount of base to produce intem ediate 12, which is then further oxidized to the Formula I compound by known methods. This reaction is shown in Scheme 8.
Scheme 8
oxidation
Figure imgf000035_0002
12
An alternate procedure for the preparation of specific quinazolinones of Fomiula I
(Formula Id) is depicted in Scheme 9. This procedure may be specifically suitable for pyrazole-substituted quinazolinones which may prove difficult to prepare by alternate procedures. The cross coupling reaction of quinazolines of Formula 13 (wherein X is a leaving group such as halogen, triflate or fluorosulfonate) with pyrazoles of Formula 14 (where Met is Sn, Zn, B(OH)2, Mg, Li or Cu and additional counterions as necessary) in the presence of a palladium or nickel catalyst produces compounds of Formula Id. Quinazolines of Fomiula 13 wherein X is halogen are known in the art (PCT patent application publication WO98/26664 and references cited therein). Preferred catalysts for the synthesis of compounds of Formula Id include but are not limited to Pd(PPh3) , PdCl2(PPh3)2, PdCl2(diphenylρhosphinoferrocene), NiCl (PPh3)2, and Tetrakis(tri-2- furylphosphino)palladium. The exact conditions for each reaction depend upon the catalyst used and the metal attached to the pyrazole. The additional presence of an external base (such as an alkali carbonate, tertiary amine or alkali fluoride) is necessary for reactions involving pyrazoles of Formula 14 where Met is B(OH)2. Similar procedures also can be used for other K-rings and J-groups.
Scheme 9
Figure imgf000036_0001
Pyrazoles of Formula 14 can be made by lithiation of the pyrazole 17 followed by transmetallation with the appropriate metal as described in Scheme 10. Pyridylpyrazoles 17 are prepared by the reaction of pyrazoles 15 with a 2,3-dihalopyridine of Formula 16 to afford the 1 -pyridylpyrazole 17 with good specificity for the desired regiochemistry. Metallation of 17 with lithium diisopropylamide (LDA) followed by transmetallation with the appropriate metal affords the metal pyrazole of Formula 14. For conditions and catalysts used in transmetallation and cross coupling reactions see Metal-catalyzed Cross-coupling Reactions. Diederich, Francois; Stang, Peter J.; Editors. 1998, p. 517, (Wiley-VCH, Weinheim, Germany) and references cited therein.
Scheme 10
Figure imgf000037_0001
15 16 17 IS
Figure imgf000037_0002
14
The starting pyrazoles 15 are known compounds. Pyrazole 15 wherein R5 is CF3 is commercially available. Pyrazoles 15 wherein R5 is Cl or Br can be prepared by literature procedures (Chem. Ber. 1966, 99(10), 3350-7). A useful alternative method for the preparation of 15 wherein R5 is Cl or Br is depicted in Scheme 11. Metallation of the sulfamoyl pyrazole 19 with π-butyllithium followed by direct halogenation of the anion with either hexachloroethane (for R5 being Cl) or 1,2-dibromotetrachloroethane (for R5 being Br) affords the halogenated derivatives 20. Removal of the sulfamoyl group with tri fluoro acetic acid (TFA) at room temperature proceeds cleanly and in good yield to afford the pyrazoles 15 wherein R5 is Cl or Br respectively. One skilled in the art will recognize that Formula 15c is a tautomer of Fomiula 15b.
Scheme 11
Figure imgf000037_0003
An alternate procedure for the preparation of quinazolinones of Formula Id involves prolonged heating of a benzoxazinone of Formula 21 with an amine of Formula 22 as shown in Scheme 12. Reactions times as long as 1-7 days may be required. An example of this type is detailed in Example 3. Similar procedures also can be used for other K-rings and
J-groups.
Scheme 12
Figure imgf000038_0001
The benzoxazinones of Formula 21 are available by the method of Scheme 13. Coupling of a pyrazole acid of Fomiula 23 with an anthranilic acid of Formula 24 via sequential addition of methanesulfonyl chloride and triethylamine affords the benzoxazinone of Fomiula 21. The intermediate acid of Formula 23 is available from the lithiated pyrazole 18 by quenching with carbon dioxide. Similar procedures also can be used for other K-rings and J-groups.
Scheme 13
Figure imgf000038_0002
It is recognized that some reagents and reaction conditions described above for preparing compounds of Formula I may not be compatible with certain functionalities present in the intermediates. In these instances, the incoiporation of protection/deprotection sequences or functional group interconversions into the synthesis will aid in obtaining the desired products. The use and choice of the protecting groups will be apparent to one skilled in chemical synthesis (see, for example, Greene, T. W.; Wuts, P. G. M. Protective Groups in Organic Synthesis, 2nd ed.; Wiley: New York, 1991). One skilled in the art will recognize that, in some cases, after the introduction of a given reagent as it is depicted in any individual scheme, it may be necessary to perform additional routine synthetic steps not described in detail to complete the synthesis of compounds of Fomiula I. One skilled in the art will also recognize that it may be necessary to perform a combination of the steps illustrated in the above schemes in an order other than that implied by the particular sequence presented to prepare the compounds of Fomiula I.
One skilled in the art will also recognize that compounds of Formula I and the intermediates described herein can be subjected to various electrophilic, nucleophilic, radical, organometallic, oxidation, and reduction reactions to add substituents or modify existing substituents. Without further elaboration, it is believed that one skilled in the art using the preceding description can utilize the present invention to its fullest extent. The following Examples are, therefore, to be construed as merely illustrative, and not limiting of the disclosure in any way whatsoever. Percentages are by weight except for cliromatographic solvent mixtures or where otherwise indicated. Parts and percentages for chromatographic solvent mixtures are by volume unless otherwise indicated. !H NMR spectra are reported in ppm downfield from tetramethylsilane; s is singlet, d is doublet, t is triplet, q is quartet, m is multiple., dd is doublet of doublets, dt is doublet of triplets, br s is broad singlet.
EXAMPLE 1
Preparation of 8-methyl-3-(l -methylethyl)-2-[2-methyl-4-(trifluoromethyl)phenyl]-4(3H)- quinazolinone
Step A: Preparation of 3-methyl-N-( 1 -methylethyl)-2-nitrobenzamide
A solution of 3-methyl-2-nitrobenzoic acid (2.00 g, 11.0 mmol) and triethylamine (1.22 g, 12.1 mmol) in 25 mL of methylene chloride was cooled to 10°C. Ethyl chloroformate was carefully added and a solid precipitate formed. After stirring for 30 minutes isopropylamine (0.94 g, 16.0 mmol) was added and a homogeneous solution resulted. The reaction was stirred for an additional hour, poured into water and extracted with ethyl acetate. The organic extracts were washed with water, dried over magnesium sulfate and evaporated under reduced pressure to afford 1.96 g of the desired intermediate as a white solid melting at 126-128 °C. !H ΝMR (CDC13) δ 1.24 (d,6H), 2.38 (s,3H), 4.22 (m,lH), 5.80 (br s,lH), 7.4 (m,3H). Step B: Preparation of 2-amino-3-methyl-N-( 1 -methylethyDbenzamide
The 2-nitrobenzamide of Step A (1.70 g, 7.6 mmol) was hydrogenated over 5% Pd/C in 40 mL of ethanol at 3.45 X 105 Pa. When the uptake of hydrogen ceased the reaction was filtered through celite and the celite was washed with ether. The filtrate was evaporated under reduced pressure to afford 1.41 g of the title compound as a solid melting at
149-151 °C.
*H ΝMR (CDC13) δ 1.24 (dd,6H), 2.16 (s,3H), 4.25 (m,lH), 5.54 (br s,2H), 5.85 (br s,lH),
6.59 (t,lH), 7.13 (d,lH), 7.17 (d,lH).
Step C: Preparation of S,S-dimethyl-N-[4-(trifluoromethyl)phenyllsulfilimine A solution of N-chlorosuccinimide (12.43 g, 93.1 mmol) in -170 mL of dichloromethane was added to a mixture of 4-(trifluoromethyl) aniline (15 g, 93.1 mmol) and dimethyl sulphide (6.35 g, 102 mmol) in 230 mL of dichloromethane at -5 to 0 °C.
After the addition was complete, the mixture was stirred at 0-5 °C for 1 hour, and
N-chlorosuccinimide (0.02 g, 4.64 mmol) was added. After a further 30 minutes, the mixture was washed with 500 mL of IN sodium hydroxide.
The organic phase was dried and evaporated to give the product as a solid 19.72 g melting at 101-103 °C (after crystallization from ethyl acetate/hexanes).
IR (Νujol®) 1603, 1562, 1532, 1502, 1428, 1402, 1335, 1300, 1270, 1185, 1150,
1103, 1067, 1000, 972, 940, 906, 837, 817 cm \ !H NMR (CDCI3) δ 7.35 (d,2H), 6.84 (d,2H), 2.67 (s,3H).
Step D: 2-[(methylthio)methyl]-4-(trifluoromethyl)benzenamine
Sodium methoxide in methanol (1.95 g, 9.02 mmol, 25%) was added to
S,S-dimethyl-N-[4-(trifluoromethyl)phenyl]sulfilimine from Step C (2 g, 9.04 mmol) in
15 mL of toluene. The mixture was warmed to ~80°C for ~1 h. The mixture was allowed to cool to 25 °C and was poured into 100 mL of water. The mixture was extracted with
2x100 mL of ethyl acetate and the combined extracts were dried and evaporated to give the product 1.8 g as a solid melting at 65.5-67.5 °C (after crystallization from hexanes).
IR (Νujol®) 3419, 3333, 1629, 1584, 1512, 1440, 1334, 1302, 1235, 1193, 1139,
1098, 1078, 979, 904, 832 cm"'. JH NMR (CDCI3) δ 7.35 (dd,lH), 7.26 (s,lH), 6.72 (d,lH) 4.39 (br s,2H), 3.69 (s,2H), 1.99
(s,3H).
Step E: Preparation of 2-methyl-4-(trifluoromethyl)benzenamine
Activated Raney nickel (500 g wet paste, ~50μ) was added portionwise to a solution of 2-[(methylthio)methyl]-4-(trifluoromethyl)benzenamine (55.3 g, 0.25 mole) in 1 L of ethanol over 30 minutes at 25-30 °C. The heterogeneous mixture was stirred vigorously for
30 minutes after the addition. The stirring was stopped, and the solids were allowed to settle over one hour. The liquid was decanted from the solids and poured through filter paper.
The filtrate was evaporated under reduced pressure, and the residue was taken up in dichloromethane. The organic phase was separated from a small volume of water, dried over magnesium sulfate and evaporated under reduced pressure to afford 37.6 g of the title compound as an amber oil.
IH NMR (CDC13) δ 7.28 (m,2H), 6.68 (d,lH), 3.87 (br s,2H), 2.19 (s,3H). Step F: Preparation of 2-methyl-4-(trifluoromethyl)benzonitrile
Concentrated hydrochloric acid (16 mL) was added dropwise at a moderate rate to a heterogeneous mixture of 2-methyl-4-(trifluoromethyl)benzenamine (14 g, SO mmol) and 120 mL of water while stirring vigorously. A thick suspension resulted which was stirred for 20 minutes, diluted with 280 mL of water and cooled to 5 °C. A solution of sodium nitrite (5.5 g, SO mmol) in 25 mL of water was added slowly to the reaction suspension. After stirring for 30 minutes at 5 °C a solution resulted which was stirred cold for 30 more minutes and then neutralized with potassium carbonate. This diazonium salt solution was then added portionwise via cannula to a stirred, 95 °C mixture of potassium cyanide (22 g, 0.34 mole), copper sulfate pentahydrate (20 g, 80 mmol) and 140 mL of water. After the addition the mixture was stirred for 30 minutes at 95 °C and then allowed to cool to room temperature. Ether was added and the heterogeneous mixture was filtered through celite. The solids were washed with ether, and the filtrate was partitioned. The aqueous phase was extracted with ether, and the combined organic extracts were dried over magnesium sulfate and concentrated under reduced pressure to afford 13.1 g of the title compound as a brown oil. *H NMR (CDCI3) δ 7.74 (d,lH), 7.60 (s,lH), 7.55 (d,lH), 2.64 (s,3H).
Step G: Preparation of 2-methyl-4-trifluoromethyl benzoic acid
Potassium hydroxide (15.7 g, 0.28 mole) and 15 mL of water were added as a solution to a stirred, heterogeneous mixture of 2-methyl-4-(trifluoromethyl)benzonitrile (13 g, 70 mmol) and 135 mL of ethylene glycol. The reaction mixture was heated at 120-130 °C for 20 hours and allowed to cool to room temperature. The dark solution was poured into 800 mL of water and filtered through celite. The filtrate was washed with ether and then the aqueous was acidified with concentrated hydrochloric acid. This aqueous phase was extracted three times with ethyl acetate, the organic extracts were combined, dried over magnesium sulfate and evaporated under reduced pressure to afford the title compound as a tan solid.
IH NMR (CDCI3) δ 7.98 (d,lH), 7.70 (s,lH), 7.65 (d,lH), 2.60 (s,3H). Step H: Preparation of 2-methyl-4-(trifluoromethoxy)benzoyl chloride
Thionyl chloride (0.42 g, 3.5 mmol) was added to a solution of the benzoic acid from Step G (0.50 g, 2.4 mmol) in 10 mL of toluene at room temperature. The reaction was reflux ed for three hours then cooled to room temperature. The solvent was evaporated under reduced pressure and excess thionyl chloride was removed by azeotroping with toluene. The benzoyl chloride obtained was used directly in Step I. Step I: Preparation of 2-methyl-N-[2-methyl-6-[ ( l-methylethyl)amino]- carbonyl1phenyl1-4-(trifluoromethyl)benzamide The benzoyl chloride of Step H (0.29 g, 1.3 mmol) was added to a mixture of the aniline from Step B (0.36 g, 1.9 mmol) and diisopropylethylamine (0.26 g, 2.0 mmol) in 10 mL of chloro foπn at room temperature. The reaction was allowed to stir overnight. The solid precipitate was filtered and dried to afford 0.38 g of the title compound, as a solid melting at 247-248 °C.
»H ΝMR (CDC13) δ 1.24 (d,6H), 2.41 (s,3H), 2.58 (s,3H), 4.20 (m.lH), 5.94 (br d,lH), 7.2-7.3 (m,2H), 7.40 (d,lH), 7.52 (s,lH), 7.53 (d,lH), 7.70 (d,lH), 9.36 (br s,lH). Step J: Preparation of 8-methyl-3-( l-methylethyl -2-r2-methyl-4-
(trifluoromethyl)phenyl~|-4(3H)-quinazolinone A slurry of the benzamide of Step I (0.25 g, 0.6 mmol) in N N-dimethylformamide (4 mL) was added cautiously to a slurry of ΝaH (0.03 g, 0.7 mmol, 60%) in NN-dimethylformamide (2 mL). Gas evolution was seen and the mixture became a light yellow solution. After stirring for approximately 5 min, methylchloro formate (0.11 g,
1.2 mmol) was added and a solid precipitate formed. The reaction was stirred for 30 min, then poured into water (50 mL) and extracted with ethyl acetate (2x50 mL). The combined extracts were washed with water (2x50 mL) then dried and evaporated to give 0.16 g of the title compound, a compound of the invention, as a solid melting at 100-103 °C. ]H ΝMR (CDCI3) δ 1.25 (d,6H), 2.52 (s,3H), 2.81 (s,3H), 4.28 (m,lH), 7.26 (t,lH), 7.43 (d,lH), 7.57-7.61 (br s,2H), 7.98 (d,lH), 8.07 (d,lH).
EXAMPLE 2
Preparation of 6-chloro-2- [" 1 -(3 -chloro-2-p yridinyl)-3 -(trifluoromethyl)- 1 H-pyrazol-5-yl] -
3,S-dimethyl-4(3H)-quinazoline Step A: Preparation of 2-amino-3-methyl-5-chlorobenzoic acid
To a solution of 2-amino-3-methylbenzoic acid (Aldrich, 15.0 g, 99.2 mmol) in NN-dimethylformamide (50 mL) was added N-chlorosuccinimide (13.3 g, 99.2 mmol) and the reaction mixture was heated to 100 °C for 30 minutes. The heat was removed, the reaction was cooled to room temperature and let stand overnight. The reaction mixture was then slowly poured into ice-water (250 mL) to precipitate a white solid. The solid was filtered and washed four times with water and then taken up in ethyl acetate (900 mL). The ethyl acetate solution was dried over magnesium sulfate, evaporated under reduced pressure and the residual solid was washed with ether to afford the desired intermediate as a white solid (13.9 g). *Η ΝMR (DMSOA5) δ 2.11 (s, 3Η), 7.22 (s, IH), 7.55 (s, IH). Step B: Preparation of 3-chloro-2-|"3-(trifluoromethyl)-lH-pyrazol-l-yl1pyridine
To a mixture of 2,3-dichloropyridine (99.0 g, 0.67 mol) and 3-trifluoromethyl pyrazole (83 g, 0.61 mol) in dry N,N-dimethylformamide (300 mL) was added potassium carbonate (166.0 g, 1.2 mol) and the reaction was then heated to 110-125 °C over 48 hours. The reaction was cooled to 100 °C and filtered through Celite® diatomaceous filter aid to remove solids. NN-Dimethylformamide and excess dichloropyridine were removed by distillation at atmospheric pressure. Distillation of the product at reduced pressure (b.p. 139-141 °C, 7 mm) afforded the desired intermediate as a clear yellow oil (113.4 g). Η ΝMR (CDC13) δ 6.78 (s, 1Η), 7.36 (t, 1Η), 7.93 (d, 1Η), 8.15 (s, 1Η), 8.45 (d, 1Η). Step C: Preparation of l-(3-chloro-2-pyridinyl')-3-(trifluoromethyl -lH-pyrazole-5- carboxylic acid To a solution of the pyrazole product from Step B (105.0 g, 425 mmol) in dry tetrahydrofuran (700 mL) at -75 °C was added via cannula a -30 °C solution of lithium diisopropylamide (425 mmol) in dry tetrahydrofuran (300 mL). The deep red solution was stirred for 15 minutes, after which time carbon dioxide was bubbled through at -63 °C until the solution became pale yellow and the exothermicity ceased. The reaction was stirred for an additional 20 minutes and then quenched with water (20 mL). The solvent was removed under reduced pressure, and the reaction mixture partitioned between ether and 0.5 Ν aqueous sodium hydroxide solution. The aqueous extracts were washed with ether (3x), filtered through Celite® diatomaceous filter aid to remove residual solids, and then acidified to a pΗ of approximately 4, at which point an orange oil formed. The aqueous mixture was stirred vigorously and additional acid was added to lower the pΗ to 2.5-3. The orange oil congealed into a granular solid, which was filtered, washed successively with water and IN hydrochloric acid, and dried under vacuum at 50 °C to afford the title product as an off-white solid (130 g). (Product from another run following similar procedure melted at 175-176 °C.) !Η ΝMR (DMSOA;) δ 7.61 (s, IH), 7.76 (dd, IH), 8.31 (d, IH), 8.60 (d, IH). Step D: Preparation of 6-chloro-2-[T -(3-chloro-2-pyridinyl)-3-(trifluoiOmethyl)-lH- pyrazol-5-yl"|-8-methyl-4H-3,l-benzoxazin-4-one To a solution of methanesulfonyl chloride (2.2 mL, 28.3 mmol) in acetonitrile (75 mL) was added dropwise a mixture of the carboxylic acid product from Step C (7.5 g, 27.0 mmol) and triethylamine (3.75 mL, 27.0 mmol) in acetonitrile (75 mL) at 0-5 °C. The reaction temperature was then maintained at 0 °C throughout successive addition of reagents. After stirring for 20 minutes, 2-amino-3-methyl-5-chlorobenzoic acid from Step A (5.1 g, 27.0 mmol) was added and stirring was continued for an additional 5 minutes. A solution of triethylamine (7.5 mL, 54.0 mmol) in acetonitrile (15 mL) was then added dropwise, and the reaction mixture was stirred 45 minutes, followed by the addition of methanesulfonyl chloride (2.2 mL, 28.3 mmol). The reaction mixture was then warmed to room temperature and stirred overnight. Approximately 75 mL of water was then added to precipitate 5.8 g of a yellow solid. An additional 1 g of product was isolated by extraction from the filtrate to provide a total of 6.8 g of the title compound as a yellow solid.
*H NMR (CDC13) δ 1.83 (s, 3H), 7.50 (s, IH), 7.53 (m, 2H), 7.99 (m, 2H), 8.58 (d, IH).
Step E: Preparation of N-[4-chloro-2-methyl-6-[(methylamino)carbonyl]phenyl"j-l-(3- chloro-2-pyridinyl)-3-(trifluoromethyl -lH-pyrazole-5-carboxamide
To a solution of the benzoxazinone product of Step D (6.6 g, 15 mmol) in tetrahydrofuran (50 mL) was added methylamine (2.0 M solution in TΗF, 38 mL,
77.38 mmol), and the reaction mixture was heated to 60 °C, stirred for 1 hour and then cooled to room temperature. The tetrahydrofuran solvent was evaporated under reduced pressure, and the residual solid was purified by chromatography on silica gel to afford the title compound, as a white solid' melting at 225-226 °C.
!Η ΝMR (CDCI3) δ 2.17 (s,3Η), 2.95 (m,3H), 6.2 (m,lH), 7.2 (m,2H), 7.4 (m,2H), 7.85
(md,lH), 8.45 (md,lH), 10.2 (br s, IH).
Step F: Preparation of 6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH- pyrazol-5-vH-3,8-dimethyl-4(3H)-quinazoline
A solution of the title compound from Step E (50 mg, 0.11 mmol) in dichloromethane
(20 mL) was mixed with 2 g of montmorillonite K10 clay (Aldrich, preactivated by heating under vacuum) and evaporated to dryness in vacuo. The dry residue was heated using a steam bath (ca. 90-95 °C) for a total of 24 hours. The solids were then extracted twice by mixing with dichloromethane and ethyl acetate (1 :1) and filtering. The combined filtrates were evaporated to leave a film. This material was chromatographed on silica gel using 5% ethyl acetate in dichloromethane as the eluant. Pure fractions were combined, evaporated and the residue crystallized from dichloromethane/hexanes to afford 15 mg of the title compound, a compound of the invention, as a white solid. IR (KBr) 1674, 1598, 1462, 1241, 1194, 1169, 1140 cm"1.
!Η ΝMR (CDCI3) δ 2.10 (s,3Η), 3.78 (s,3H), 7.06 (s, IH), 7.37 (dd,lH), 7.42 (d,lH), 7.87
(dd,lH).
EXAMPLE 3
Preparation of 8-chloro-2-π-(3-chloro-2-p\;ridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yll-3- methyl-4(3H)-quinazolinone
Step A: Preparation of 8-chloro-2-[ l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH- p yrazol-5-yll -4H-3 , 1 -benzoxazin-4-one Application of the procedure of Example 2, Step D with 2.91 g of the carboxylic acid of Example 2, Step C and 1.71 g of 2-amino-3-chlorobenzoic acid affords 2.5 g of the title benzoxazinone.
1Η ΝMR (CDCI3) δ 7.46 (t,lΗ), 7.50 (m,lH), 7.52 (s,lH), 7.76 (d,lH), 8.00 (d,lH), 8.11 (d,lH), 8.58 (d, IH). Step B: Preparation of 8-chloro-2-[T -(3-chloro-2-pyridinyl)-3-(trifluoromethylV 1H- pyrazol-5-yll-3-methyl-4(3H -quinazolinone A solution of the title compound of Step A (300 mg) in 2 mL of tetrahydrofuran was treated with methylamine (2.0 M solution in TΗF, 10 mL), sealed in a capped bottle and stirred for four days at room temperature. The solvent was removed under reduced pressure and the solid residue was washed with ether. The ether soluble material was purified by chromatography on silica gel using hexanes/ethyl acetate (1 : 1) as eluant. The title compound, a compound of the invention, was isolated as a solid, m.p. 155-157 °C. !Η NMR (CDC13) δ 3.8 (s,3Η), 7.1 (s,lH), 7.4 (m,2H). 7.7 (d,lH), 7.9 (d,lH), 8.15 (d,lH), 8.35 (m,lH).
By the procedures described herein together with methods known in the art, the following compounds of Tables 1 to 33 can be prepared. The following abbreviations are used in the Tables: t is tertiary, s is secondary, n is normal, / is iso, c is cyclo. Me is methyl, Et is ethyl, Pr is propyl, z'-Pr is isopropyl, t-Bu is tert butyl, Ph is phenyl, OMe is methoxy, OEt is ethoxy, SMe is methylthio, SEt is ethylthio, CN is cyano, NO2 is nitro, TMS is trimethylsilyl, S(O)Me is methylsulfinyl, and S(O)2Me is methylsulfonyl.
Table 1
Figure imgf000045_0001
R5b is Cl R5b is CF3 R5b is OCF3 R5b is CF(CF3ϊ-
R3 R4a R4b R3 R4a R4b R3 R4a R4b R3 R4a R4b
.-Pr Me H /-Pr Me H /-Pr Me H /-Pr Me H -Pr Cl H /-Pr Cl H /-Pr Cl H /-Pr Cl H
/-Pr Me Cl /-Pr Me Cl /-Pr Me Cl /-Pr Me Cl
/-Pr Cl Cl /-Pr Cl Cl /-Pr Cl Cl /-Pr Cl Cl -Pr Me Br /-Pr Me Br /-Pr Me Br -Pr Me Br
/-Pr Cl Br /-Pr Cl Br /-Pr Cl Br /-Pr Cl Br t-Bu Me H t-Bu Me H t-Bu Me H t-Bu Me H t-Bu Cl H t-Bu Cl H t-Bu Cl H t-Bu Cl H t-Bu Me Cl t-Bu Me Cl t-Bu Me Cl /-Bu Me Cl t-Bu Cl Cl t-Bu Cl Cl t-Bu Cl Cl t-Bu Cl Cl t-Bu Me Br t-Bu Me Br t-Bu Me Br t-Bu
Figure imgf000045_0002
Me Br
Figure imgf000045_0004
Figure imgf000045_0003
Figure imgf000046_0001
Table 2
Figure imgf000046_0002
R5b is Cl R5b is CF3 R5b is OCF3 R5b is CF(CF3 τ
R3 R4a R4b R3 R4a R4b R3 R4a R4b R3 R4a R4b
/-Pr Me H /-Pr Me H /-Pr Me H /-Pr Me H
/-Pr Cl H /-Pr Cl H /-Pr Cl H /-Pr Cl H
/-Pr Me Cl /-Pr Me Cl /-Pr Me Cl /-Pr Me Cl
/-Pr Cl Cl /-Pr Cl Cl /-Pr Cl Cl /-Pr Cl Cl
/-Pr Me Br /-Pr Me Br /-Pr Me Br /-Pr Me Br
/-Pr Cl Br /-Pr Cl Br /-Pr Cl Br /-Pr Cl Br t-Bu Me H t-Bu Me H t-Bu Me H t-Bu Me H t-Bu Cl H t-Bu Cl H t-Bu Cl H t-Bu Cl H t-Bu Me Cl t-Bu Me Cl t-Bu Me Cl /-Bu Me Cl t-Bu Cl Cl t-Bu Cl Cl t-Bu Cl Cl t-Bu Cl Cl t-Bu Me Br t-Bu Me Br t-Bu Me Br t-Bu Me Br t-Bu Cl Br t-Bu Cl Br t-Bu Cl Br
Figure imgf000046_0003
t-Bu Cl Br
Figure imgf000047_0001
Table 3
Figure imgf000047_0002
Figure imgf000048_0001
Table 4
Figure imgf000048_0002
Figure imgf000049_0001
R3 R4a R4b R5 R6 R3 R4a R4b R5 Rδ R3 R4a R4b R5 R6
Me CH3 H Br Cl Me Cl H CF3 Br Me Cl CF3 Br
Et CH3 H Br Cl Et Cl H CF3 Br Et Cl CF3 Br
/-Pr CH3 H Br Cl /-Pr Cl H CF3 Br /-Pr Cl CF3 Br t-Bu CH3 H Br Cl t-Bu Cl H CF3 Br t-Bu Cl CF3 Br
Me CH3 H Br Br Me Cl H Cl Cl Me Cl Cl Cl
Et CH3 H Br Br Et Cl H Cl Cl Et Cl Cl Cl
/-Pr CH3 H Br Br /-Pr Cl H Cl Cl /-Pr Cl Cl Cl t-Bu CH3 H Br Br /-Pr Cl H Cl Cl t-Bu Cl Cl Cl
Me CH3 F CF3 Cl Me CH3 Cl CF3 Cl Me Cl Cl Br
Et CH3 F CF3 Cl Et CH3 Cl CF3 Cl Et Cl CI Br
/-Pr CH3 F CF3 Cl /-Pr CH3 Cl CF3 Cl /-Pr Cl Cl Br t-Bu CH3 F CF3 Cl t-Bu CH3 Cl CF3 Cl t-Bu Cl Cl Br
Me CH3 F CF3 Br Me CH3 Cl CF3 Br Me Cl Br Cl
Et CH3 F CF3 Br Et CH3 Cl CF3 Br Et Cl Br Cl
/-Pr CH3 F CF3 Br /-Pr CH3 Cl CF3 Br /-Pr Cl Br Cl t-Bu CH3 F CF3 Br t-Bu CH3 Cl CF3 Br t-Bu Cl Br Cl
Me CH3 F Cl Cl Me CH3 Cl Cl Cl Me Cl Br Br
Et CH3 F Cl Cl Et CH3 Cl Cl Cl Et Cl Br Br
/-Pr CH3 F Cl Cl /-Pr CH3 Cl Cl Cl /-Pr Cl Br Br t-Bu CH3 F Cl Cl t-Bu CH3 Cl Cl Cl t-Bu Cl Br Br
Me CH3 F Cl Br Me CH3 Cl Cl Br Me Cl CF3 CF3 Cl
Et CH3 F Cl Br Et CH3 Cl Cl Br Et Cl CF3 CF3 Cl
/-Pr CH3 F Cl Br /-Pr CH3 Cl Cl Br .-Pr Cl CF3 CF3 Cl t-Bu CH3 F Cl Br t-Bu CH3 Cl l Br t-Bu Cl CF3 CF3 Cl
Me CH3 F Br Cl Me CH3 Cl Br Cl Me Cl CF3 CF3 Br
Et CH3 F Br Cl Et CH3 Cl Br Cl Et Cl CF3 CF3 Br
/-Pr CH3 F Br Cl /-Pr CH3 Cl Br Cl /-Pr Cl CF3 CF3 Br t-Bu CH3 F Br Cl t-Bu CH3 Cl Br Cl t-Bu Cl CF3 CF3 Br
Me CH3 F Br Br Me CH3 Cl Br Br Me Cl CF3 Cl Cl
Et CH3 F Br Br Et CH3 Cl Br Br Et Cl CF3 Cl Cl
/-Pr CH3 F Br Br /-Pr CH3 Cl Br Br /-Pr Cl CF3 Cl Cl t-Bu CH3 F Br Br t-Bu CH3 Cl Br Br t-Bu Cl CF3 Cl Cl
Me CH3 Br CF3 Cl Me Cl F CF3 Cl Me Cl CF3 Cl Br
Et CH3 Br CF3 Cl Et Cl F CF3 Cl Et Cl CF3 Cl Br
/-Pr CH3 Br CF3 Cl /-Pr Cl F CF3 Cl /-Pr Cl CF3 Cl Br t-Bu CH3 Br CF3 Cl t-Bu Cl F CF3 Cl t-Bu Cl CF3 Cl Br
Me CH3 Br CF3 Br Me Cl F CF3 Br Me Cl CF3 Br Cl
Figure imgf000051_0001
d CJ CJ CJ CJ CJ CJ CJ CJ CJ CJ CJ CQ CQ CQ CQ CQ CQ CQ CQ CQ Q CQ oa DQ CQ eQ OQ CQ e CQ CQ m eQ oa CQ CQ ι- 3 c I 3 3 3 3 oil « ϊ 3 s W ^ ffl CQ CQ CQ w ^ in ffl ffl CQ ς UI CQ 5 W Pi CQ 3
il CQ CQ CQ u o υ u CQ CQ CQ CQ O U J u m CQ CQ CQ U CJ U CJ CQ CQ CQ eQ CJ U O CJ CQ CQ CQ CQ CJ ro co co co ro ro co ro ro ro ro ro il Ui Ui Ui J CJ J CJ CJ CJ u cq m ff CQ CQ CQ CQ CQ U PL U U U U U PL U,
CJ J J J l υ cj cj cj u u υ cj cj cj cj υ cj cj υ υ U o m •° I ro d U U PL U U PL U U PL U U PL PL PL U PL PL U PL J CJ CJ CJ CJ CJ CJ CJ CJ CJ CJ CJ CJ CJ O CJ U υ id o ϋ o u υ υ u υ u u υ u o u o o υ u υ υ υ u υ cj cj cj c c o υ cj cj cj cj cj CQ
Figure imgf000051_0002
oil CQ CQ CQ CJ u υ cj CQ CQ CQ o cj o U CQ CQ CQ CQ U U U U CQ CQ CQ eQ U O U U eQ CQ Cq CQ U co co ro co co co co co co co co , , -_- __ . , , , ,
Oil PL PL PL r ) U PL U PL U PL PL PL r , r _ r . r ) r _ r _ r _ υ o CJ CJ ^ u υ υ cj o CJ u CQ CQ CQ CQ CQ CQ CQ CQ J CJ O C CJ CJ U U ^ ^ ^ ^ ^ CQ
-0 I id CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ CQ αo a I co co co ro ro o co co c eo co co co co co co co co co co co co co co
X X X X K 33 33 X X X X 33 HI ffi 33 33 33 33 33 S Ε -, 33 MH H pH 3H Ε H -l ?H M-l -l -,
CJ cj υ u u u u J u u υ J U J CJ J CJ CJ U O CJ CJ CJ U CJ U CJ CJ CJ CJ CJ CJ CJ CJ CJ CJ o O n 3 3 n 3 it co I il s ξ ω «? ά? CQ 2 « £ 2 ω w CQ ___ i ^ ∞ ___ m ^ & '___ m p? '___ m CQ S
Figure imgf000052_0002
Figure imgf000052_0001
H ωH Hω, ω H „o _o o--- o_. roHH ro H, -ω, ω HroH ro HH ω ►, ro HH o „ o„ o,--. o^ o„ o„ o„ o„ Q. Q. JQ. JQ. (jQl JQ. Ql JQ. w^ d HH HωH ro HH ro H, ω HH l?α
o o o o o o o ω ro ro ω o o o o tjo ω ω w o o o o ω w w ro o o o o w ro ω w o o
Figure imgf000052_0003
3 M 3ϊ tro >^ !-? |ϊ ro ^ £ |ϊ rø 'fl £ 2 ro >fl M 2 V9. ro ro ro ro ro ro ro w ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro co ro
I s» o o o o o o o o o o o o o o o o o o o o o o o o o o o o o Q Q Q Q Q Q Q Q ro ro ro ro ro ω ro ro o o o o o o o o Q Q Q Q Q Q I ~Λ ro ω ro o o o o ω ω ω ω o o o o ro ro ro ω o o o o ω ro w cd o o o o w ω ω ω o o I CΛ
■HH w S ώ ^ ^ S t ^H w ^ ro ^ w S ώ iHH w S ώ ^ M S ro I j ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro w ro ro w ro ro w ro ro ro ro w 1^ ω ro ω ro ω ω w ω ω w ω ro ro ω w o o o o o o o o o o o o o o o o o o o o o o I cr π o " o o o^ o^ o i-Q '-Q oQj i-Q oQ- i-Q i-Q Q. ro *• ω "• ro ^ rø ro ^ ro ^ ω ,_1 ro ^ o ~ o ~ o o ~ o ~ o ~ o ~ o ~ ιQj i-Q Q Q t-ζj Q I ro ω ω o o o o ω ω ro ω o o o o ro ω ro ω o o o o ω ω ro ω o o o o c w ro ω o o I o
R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 t-Bu Cl Cl Br Cl t-Bu Br Cl Br t-Bu Br Br Cl Br
Me Cl Cl Br Br Me Br Br Cl Me Br Br Br Cl
Et Cl Cl Br Br Et Br Br Cl Et Br Br Br Cl
/-Pr Cl Cl Br Br /-Pr Br Br Cl /-Pr Br Br Br Cl t-Bu Cl l Br Br t-Bu Br Br Cl t-Bu Br Br Br Cl
Me Cl Br CF3 Cl Me Br Br Br Me Br Br Br Br
Et Cl Br CF3 Cl Et Br Br Br Et Br Br Br Br
/-Pr Cl Br CF3 Cl /-Pr Br Br Br /-Pr Br Br Br Br t-Bu Cl Br CF3 Cl t-Bu Br Br Br t-Bu Br Br Br Br
Me Cl Br CF3 Br Me Cl Br Cl Cl t-Bu Cl Br CF3 Br
Et Cl Br CF3 Br Et Cl Br Cl Cl t-Bu Cl Br Cl Cl
/-Pr Cl Br CF3 Br /-Pr Cl Br Cl Cl
Table 6
Figure imgf000053_0001
R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 R3 R4a R4b R5 R6
Me CH3 H CF3 Cl Me Cl H Cl Br Me Cl Br Cl Br
Et CH3 H CF3 Cl Et Cl H Cl Br Et Cl Br Cl Br
/-Pr CH3 H CF3 Cl /-Pr Cl H Cl Br /-Pr Cl Br Cl Br t-Bu CH3 H CF3 Cl t-Bu Cl H Cl Br t-Bu Cl Br Cl Br
Me CH3 H CF3 Br Me Cl H Br Cl Me Cl Br Br Cl
Et CH3 H CF3 Br Et Cl H Br Cl Et Cl Br Br Cl -Pr CH3 H CF3 Br /-Pr Cl H Br Cl /-Pr Cl Br Br Cl t-Bu CH3 H CF3 Br t-Bu Cl H Br Cl t-Bu Cl Br Br Cl
Me CH3 H Cl Cl Me Cl H Br Br Me Cl Br Br Br
Et CH3 H Cl Cl Et Cl H Br Br Et Cl Br Br Br
/-Pr CH3 H Cl Cl /-Pr Cl H Br Br /-Pr Cl Br Br Br t-Bu CH3 H Cl Cl t-Bu Cl H Br Br t-Bu Cl Br Br Br
Me CH3 H Cl Br Me Cl H CF3 Cl Me Cl I CF3 Cl
Et CH3 H Cl Br Et Cl H CF3 Cl Et Cl I CF3 Cl
/-Pr CH3 H Cl Br /-Pr Cl H CF3 Cl /-Pr Cl I CF3 Cl t-Bu CH3 H Cl Br t-Bu Cl H CF3 Cl t-Bu Cl I CF3 Cl
Figure imgf000054_0001
o o o o o o o o o o o o o
HH 3-! 33 33 3. 33 33 33 33 33
Figure imgf000054_0002
ro ro ro ro ro Ti n J Tj Tj Tj Tj Tj TJ TI p It c
O O O O
TJ TJ TJ TJ TJ ro ro ro ro ro ro ro ro O O O O O O O O
Q TI Tj TJ TJ O TJ O TJ TJ TJ ^ roJ. w ro co or w w ro i-o to ω ι-o i-o l-O ) l-O i- to i-o ω i-o ^ I fi ro o o o o ro w ro ro o o o o ro ro ro ro o o o o ro ro ω ro o o o o ω ω w ro o o o o I Λ w 5 m £
Figure imgf000054_0003
O O O O o o o o o o o o o o o o o o o o o o o O O O O O -
3J 33 33 3! 33 Q O O O O O O '1 j T TJ 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 33 33 33 33 33 33 33 33 f It cr i-
Figure imgf000054_0004
ω o o o o w ro ro w o o o o ro ω ro ω o o o o ro ro ro ω o o o o o o o o ro ro ro ro I O
Figure imgf000054_0005
o o o o o o o o o o o o o o O o o o o o o o o o o o o o o o o o o o o o o I -εfe>-
0 Tj 0 Tj 0 , 0 Tj 0 T 0 "ri 01τj 0 Tj 0 Tj 0 Tj 0 Tj 0 Tj 0 Tj 0 Tj 0 Tj 0 Tj o W i ^ UJ i UJ U-> t^ ) UJ OJ > lJ l > -i > tno p I cr ro ^ o o o o o o o o toQ toQ toQ tQo toQ toQ toQ n W rø ro w ro ω ro ro o o o o o o o o ζ. Q Q Q I sj, o w ro ro ro o o o o ro ro ro ro o o o o ro ro ro ro o o o o ro ro ro ro o o o o w ro ro ro
Figure imgf000054_0006
tn n. ω 5 tn W TJ t mn ro TJ tn tn z ___•> 5? or J tn ω TJ t mn r TJ t ra tnn
3 3 3 K H? S ro o r TJ t tni
3 3 ct o
3 I to
O O O O O o o o o o o o o o o o o o o o o o o o o o o o o o
HH X HH WH ffi uC HH HH HH HH HH HH HH H HH HH HH HH H HH HH HH oHH i-H oHH oHH o3-J 33 33 33 to o P ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ω p 1 <r ω ro o o o o o .-. .-. - O O O O O O O
Q O O iTj Tj Tj Tj Tj Tj Tj Q ro ro r Lis °TJ °TJ OTJ |5«.
' ' ' ' to to to to to to to ω ω ro ro ω ω o o o o o o o to o to o o w ω ω ro o o o o ro ro ro ro o o o o ω ro ro w o o o o ro ro ro ro o o o o w ω ro I ON
« ? w ϊ S ώ w S ro w S ro ζ m S ro ζ m S ro ζ w S ro I t w ω o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o pi
Q Q n o
Figure imgf000055_0001
ro ro w ro ro ro ro o o o o o o o o Q Q Q
Figure imgf000055_0003
Figure imgf000055_0002
o o w ro ro ro o o o o rø w ro ω o o o o ro ω ω ω o o o o ro ω ro ro o o o o ro ro ω I Os
£ j|' ώ ζ w S ώ ζ w 2 ώ τj W ^ ώ w 2 ώ j w S p to rt ct 3 ι- rt t c ι-1 ^ ι-1 " '- ^ C ^ n C ^ n e •? S '- <1> S ,-' ' w w w ro ro ro ro w ro ro w ro ro ro w ro ro w ro ro ro w ro ro ro ro o o o o o o o o o o o
Figure imgf000055_0004
O O TJ TJ TJ Tj TJ n n n n n n n n n n n n n n n n n n n θ O O O ^ »τj τj τj Tj τj τj to to to o i-o t o I cr
Ω Q ro ro ro ro ω H H Q o ι-o -1 ~* -1 *' -1 -?H l-?l HHHI3 Q H- QH- QH- Q_ QH- QH- 0H- °H- LQ(J υnJ Q) ) n) Q) n) Q) π H- oH- oH- oH- roH, ro I"! ro -1 ro »H ro -1 ro >1 ro "H I I -*
o o w ro ro ro o n o o w ω w w o o o n ro ω ro ijϋ o o n o o n o n t' ro ω t' o o o I I O*N
τj W i- ro ro ώ τj ro τj W
Figure imgf000056_0001
Figure imgf000056_0002
^. ^-. - - ^ - ^-. O O O O O O O O O O O O O O O O O O O O O O O O o π o o π π π iτj > τj n n n n j j n n n n τj τj τj τ] τj τj τj τj τj τj τj |-H ι-H |ι ι1 >— ■ i-1
— — — — — — ' ' to to ι-o t-o t-o t-o t-o ι-o to to to to ι-o to ι-o ι-o t-o ι-o (.- t-o t-o ι-o ι-o to I - cfe- ro ro ro o o o o ro w ro ro ro ro ro ro o o o o o o o o Q Q Q Q Q Q Q Q ro ro ro ro ro ro I m o o o o o o o ro ro ω ω o o o o ro ro ro ro o o o o ro ω ω ro o o o o w ro ro ω o o
Figure imgf000056_0003
τj W , crj ζ w ; t30 j W S ro τj W S « ζ w ^ tB j W ^ I I t3o ro w w ro ro w ro ro ro ro ro ro ro w ro ro ro ro ro ro ro w ro w ro ro ro ro ro ro ro ro w ro ro ro w PI o o o o o o o o o o o o o o o o o o o o o o p Ii cr o o o o o o o Q Q Q Q Q Q Q Q ro ro w w ω ro ro ro o o o o o o o o Q Q Q Q Q Q I J, ro ro ro o o o o ro ro ro ro o o o o ro ro ro ro o o o o w ro ro ro o o o o ω ro ro ω o o
Figure imgf000056_0004
^ S ^ ro Tj w S ro j w S to ^ w S ro iHj ro S t ^ ro S ro P rt n S Hr ^ ft C Hy '-* m C HH " f C H ^ ft C Hy rt Q C Hr r* C 3 HH '+ ft C h^ Cl C '^ I ti l-1 o w ro ro w ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro w ro ro ro ro w
Figure imgf000056_0005
ro ω ro ro ro ro ω ω ω ω ω ω ro ro ro o o o o o o o o o o o o o o o o o o o o o o I - cfer-
Figure imgf000056_0006
w or ro o o o o ro ro ro ro o o o o ro ro ro ro o o o o ro ro ro ro o o o o ro ro ro ro o o 150 I a
R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 R3 R4a R4b R5 Rδ t-Bu Cl Cl Br Cl t-Bu Br Cl Br t-Bu Br Br Cl Br
Me Cl Cl Br Br Me Br Br Cl Me Br Br Br Cl
Et Cl Cl Br Br Et Br Br Cl Et Br Br Br Cl
/-Pr Cl Cl Br Br /-Pr Br Br Cl /-Pr Br Br Br Cl t-Bu Cl Cl Br Br t-Bu Br Br Cl t-Bu Br Br Br Cl
Me Cl Br CF3 Cl Me Br Br Br Me Br Br Br Br
Et Cl Br CF3 Cl Et Br Br Br Et Br Br Br Br
/-Pr Cl Br CF3 Cl /-Pr Br Br Br /-Pr Br Br Br Br t-Bu Cl Br CF3 Cl t-Bu Br Br Br t-Bu Br Br Br Br
Me Cl Br CF3 Br Me Cl Br Cl Cl t-Bu Cl Br CF3 Br
Et Cl Br CF3 Br Et Cl Br Cl Cl t-Bu Cl Br Cl Cl
/-Pr Cl Br CF3 Br /-Pr Cl Br Cl Cl
Table 7
Figure imgf000057_0001
R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 R3 R4a R4b R5 R6
Me CH3 H CF3 Cl Me Cl H Cl Br Me Cl Br Cl Br
Et CH3 H CF3 Cl Et Cl H Cl Br Et Cl Br Cl Br
/-Pr CH3 H CF3 Cl /-Pr Cl H Cl Br /-Pr Cl Br Cl Br t-Bu CH3 H CF3 Cl t-Bu Cl H Cl Br t-Bu Cl Br Cl Br
Me CH3 H CF3 Br Me Cl H Br Cl Me Cl Br Br Cl
Et CH3 H CF3 Br Et Cl H Br Cl Et Cl Br Br Cl
/-Pr CH3 H CF3 Br /-Pr Cl H Br Cl /-Pr Cl Br Br Cl t-Bu CH3 H CF3 Br t-Bu Cl H Br Cl t-Bu Cl Br Br Cl
Me CH3 H Cl Cl Me Cl H Br Br Me Cl Br Br Br
Et CH3 H Cl Cl Et Cl H Br Br Et Cl Br Br Br
/-Pr CH3 H Cl Cl /-Pr Cl H Br Br /-Pr Cl Br Br Br t-Bu CH3 H Cl Cl t-Bu Cl H Br Br t-Bu Cl Br Br Br
Me CH3 H Cl Br Me Cl H CF3 Cl Me Cl I CF3 Cl
Et CH3 H Cl Br Et Cl H CF3 Cl Et Cl I CF3 Cl
/-Pr CH H Cl Br -Pr Cl H CF3 Cl /-Pr Cl I CF3 Cl t-Bu CH3 H Cl Br t-Bu Cl H CF3 Cl t-Bu Cl I CF3 Cl
Figure imgf000058_0001
o o o o O o o o O o o o o o o o o o o o o o O o O o o o o o o o o o o O O
33 33 33 33 33 33 33 33 33 33 33 33 3! 33 33 33 3! 33 33 33 33 33 33 3! 33 33 33 X 33 33 33 33 3! 33 33 33 33 pi
Figure imgf000058_0002
o o O o o ro or ro ro ro ro ro ro O O O O O O O O O o o O O O O O ro ro ω ω ω ro ω ro
ro o O or ro ro ro O O O O ro ro ω W O O O O ro ro ro ro O O O o ro ro >-- ω ro o o o o
Figure imgf000058_0003
*.
2 ro tn ro ω m ro tn 2 ro tn ro tn 2 ro m 2 tn ro w |?3
3 3 3 c 3 3 3 o o o o O o O O
O o o o o o o o o O O o O o o o O o O
33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 3! 3! 33 33 33 33 o o o o o o o o
o O O O O O O O O O O O O O O O o O O O O O O 33 33 33 33 33 33 3! 33 •fe- o O ω w W W ro ro ro ω o O O o O O O O O o O O O O O O O O O O O O Pi
W O O O O ro ro ro o o o o ro ro w w o o o O ro ro ro ro O O O O O O O O ro W W ro Pi
ro tn 2 ro 2 ro or 2 or ro m 2 ro tfl ro ro ω w ro ro
3 3 3 3 3 3 3 3 o o o o o o O o o o O o o o o O o o o o o o O o o o O o o o o o O o O o o Pi -fe- o o o o o o o o o o O o o o o o o
1 σ*
Figure imgf000058_0004
o ω ro ro ω o o o o ro w ro ω O O O O ro ro ω w o o o o ro ro ω ω o o o O ω ω ro w Pi
m TJ £? ω tn m z ro TJ £? o TJ m t tnn ro TJ g ini ω TJ ro ro ro TJ ra tn ro TJ 2?
3 -I ω TJ 2? r
3 -i 3 -i c 3 I to o o o o o o o o o o o o o
33 33 o H-H H-π o3l oK oE oK o3. oK o3H offi oK offi oW oK o3l oK oK oHL oH oW oH-H oH oH-H oH-H o 3 H-H t 3o3 to3 t 3o3 to to i-o to to i-o i-o i-o i-o i-o to to i-o i-o i-o to to i-J to i-o to to to to i-o to to 33 3! 33 33 33 3 33 Pi fe- w ro ro ro ro ro w ro ro ro ro ro ro w ro ro ro w ro
Figure imgf000059_0001
ω ro o o o O O c Oj c Oj c Oj Tj o TJ o Tj o TJ o τι T oJ o Tj w ro ro ro w w ro o o o o o o o r Q. o TJ o TJ o TJ Pi to to to to to ro to to l-O I tn o o ro ro ro ro o o o o ro ro ro ro o o o o ro ω ω ro o o o o ro ro ro ro o o o o w ro ro I σs
Figure imgf000059_0002
w w o o o o o o o o o o o o o o o o o o o o o o o o o o O O O O PI
Figure imgf000059_0003
O O
TJ Tj -J o to o o o o o o o tQo tQo tQo tQo tQo toQ tQo tQo ro ^ ro ^ ω ^ ω ω ^ ro ro ^ ω ^ o " o'-^ o~ o" o" o'-^ o~ ol-^ tQo tQ ι-Q I tn o o ro ro w ro o o o o ω ω ro w o o o o ro ro ro ro o o o o ro w ro ro o o o o ro ω ro I C\ m ct ro
3 § w S rø ζ w ώ ς w ; ώ ζ w 2 ώ ς ro ώ J ro _ά_, ro - roό τj 3J τj Wra ? B i. fj I
3 3 3 i-i e ° C i-l I L5O ro ro ω ro ro ω ω w w ro ro ro w ro ro ω ro ro ro ω ro ro ro ro ro ro o o o o o o o o o o o fl
Q o TJ τj n n n n n n n n n n n ro n n n τj n n n τj n n θ O O θ Q ζ >τi >τ| τj n ι f Il cr
Figure imgf000059_0004
o o ro ro ω ro o o o o ro ω ω ro o o o o ω ro ro ro o o o o o o o o ω ω ro ro o o o l°
Figure imgf000060_0001
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O Q O O O i_i —1 H^ H^ H-3 S H H 3l H-H H^ H-H HH 3-, Ε S S S H H-H M H-H H-H H-H H-H h-H S H H-H t-O LO O LO tO l-O l-O l-O LO t-O t-O L LO l-O L t-O t- LO l-O tO l-O LO l-O l-O l-O L^ f Il co
^ -, ^-, ^, ^^ - -. 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Pi --- Q Q ϋ -2 --. ϋ n n τj n n j n n n n n n τj ι-tj j n τj n n τι n τj n n ^ w M " w ι-1 -fe- ro HH roHH roHH oH- oH- oH- o— ωH, ro-, Hro, Hω, HroH Hro, Hro, roH, o- o- -o o- o- o- o- Ho- ^QJΩI JQI ^Q GI JQ JQJQI Hro ro-1 -ω, roH, ωH, ωHH Ifo
I tn o o o o o o o ro w ro ro o o o o or ro ro ro o o o o ro ro ro w o o o o ro ro ro ro o o |?3
ζ ? l* rø τj , l' ro τj W ^ ώ τ 2) ϊ ro τj ? l" rø H M
-ι ^ f 3 ιrt ft c ,-< n S '-' 0 3 '-^ 0 3 '- 0 ,0 3 ,-< Λ C >^ <1> 3 ,- I '-o w w ro w ro w ro ro ro w ro ro ro w ro ro w ro ro w ro ro ro w w ro w
Figure imgf000060_0002
o o o o o o o o o o o o o o o o o o o o o o f Il cr L o o o o o o o Q Q Q Q Q Q Q Q ω ro ro ω ro ω ro ro o o o o o o o o Q Q Q Q Q Q Pi
I LΛ ro ro ro o o o o ro ro ω ω o o o o ro ro ro ro o o o o ro ω ω ω o o o o w ro ω ω o o I Os
>- S c. ^ S S ro fl W S ώ ^ !J td ifl W w >. w 2 td ^ w ^
H " » C ^ n S ,ι <, C '' ', C 'i (, i: >ι ,, C ,ι ', C H '> C H - C Hi I i-o
Figure imgf000060_0003
ω ω w rø rø w ω ω ro w ω ro w tG ω o o o o o o o o o o o o o o o o o o o o o o f Il cr
Figure imgf000060_0004
ro ω ro o o o o ω ro w ro o o o o ro ω ro ro o o o o ω ro ω ro o o o o ro ro w ω o o I p*
R3 R4a R4b R5 Rδ R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 t-Bu Cl Cl Br Cl t-Bu Br Cl Br t-Bu Br Br Cl Br
Me Cl Cl Br Br Me Br Br Cl Me Br Br Br Cl
Et Cl Cl Br Br Et Br Br Cl Et Br Br Br Cl
/-Pr Cl Cl Br Br /-Pr Br Br Cl /-Pr Br Br Br Cl t-Bu Cl Cl Br Br t-Bu Br Br Cl t-Bu Br Br Br Cl
Me Cl Br CF3 Cl Me Br Br Br Me Br Br Br Br
Et Cl Br CF3 Cl Et Br Br Br Et Br Br Br Br
/-Pr Cl Br CF3 Cl /-Pr Br Br Br /-Pr Br Br Br Br t-Bu Cl Br CF3 Cl t-Bu Br Br Br t-Bu Br Br Br Br
Me Cl Br CF3 Br Me Cl Br Cl Cl t-Bu Cl Br CF3 Br
Et Cl Br CF3 Br Et Cl Br Cl Cl t-Bu Cl Br Cl Cl
/-Pr Cl Br CF3 Br /-Pr Cl Br Cl Cl
Table 8
Figure imgf000061_0001
R3 R4a R4b R5 ≠ R3 R4a R4b R5 R6 R3 R4a R4b R5 Rδ
Me CH3 H CF3 Cl Me Cl H Cl Br Me Cl Br Cl Br
Et CH3 H CF3 Cl Et Cl H Cl Br Et Cl Br Cl Br
/-Pr CH3 H CF3 Cl /-Pr Cl H Cl Br /-Pr Cl Br Cl Br t-Bu CH3 H CF3 Cl t-Bu Cl H Cl Br t-Bu Cl Br Cl Br
Me CH3 H CF3 Br Me Cl H Br Cl Me Cl Br Br Cl
Et CH3 H CF3 Br Et Cl H Br Cl Et Cl Br Br Cl
/-Pr CH3 H CF3 Br /-Pr Cl H Br Cl /-Pr Cl Br Br Cl t-Bu CH3 H CF3 Br t-Bu Cl H Br Cl t-Bu Cl Br Br Cl
Me CH3 H Cl Cl Me Cl H Br Br Me Cl Br Br Br
Et CH3 H Cl Cl Et Cl H Br Br Et Cl Br Br Br
/-Pr CH3 H Cl Cl /-Pr Cl H Br Br /-Pr Cl Br Br Br t-Bu CH3 H Cl Cl t-Bu l H Br Br t-Bu Cl Br Br Br
Me CH3 H Cl Br Me Cl H CF3 Cl Me Cl I CF3 Cl
Et CH3 H Cl Br Et Cl H CF3 Cl Et Cl I CF3 Cl
/-Pr CH3 H Cl Br /-Pr Cl H CF3 Cl /-Pr Cl I CF3 Cl t-Bu CH3 H Cl Br t-Bu Cl H CF3 Cl t-Bu Cl I CF3 Cl
Figure imgf000062_0001
O o o o O o O o o o o o o o o o o o o o o o o o o o o O o O O O O O O O
33 33 33 33 33 33 33 3! 33 33 33 33 33 33 to PI
W ro ω ro ro TJ TJ Tj TJ Tj TJ TJ Tj Tj TJ 33 ft
O o O
TJ o TJ o ω ro ω ro ro ro ro ro o o o o o o _-- o o i- o TJ o o o o o O O TJ TJ ro ro w w ro ro w ro I LΛ ro o o o o ro ro ro ro o o o o ro ro ω ro o o o o ω ro ro ro o o o o ω ro ro ω o o o o I O
2 ro J in m t ro T ,J tn S ro Tj W ^ T- Tj W ^ ro TJ ? TJ in
3 r W
3 2? ω TJ w ro T 2 3 r? S I to
O o o O O o o o O O O O O O O O O o o o o O O O O O
33 33 33 O O O O O O to t to 33 33 33 33 t So Q f Il co
T] TJ τj O O O O O O O O O O Q O O O O O O O O O O θ 33 33 3 3, 33 3; 3; jιj 3 I cr Ov o τι O
TI o τι o Tj O ro w ro ro ro ro ro ro o o o o o Q Q o n o Tj oTJ T oJ T o] T oJ oTJ TJ π J t to to LO LO to to to Q Q Q TJ TJ J t to to to I tn ω o o o ro ro ro w o o o o ro ro ro ro o o o o ro ω ro ro o o o O O o o o ro ro w ω Pi l OS
Figure imgf000062_0002
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o f Ilco oj o Tj oj oj o Tj oj oj oj o T oj o Tj o Tj oj o Tj oj o Tj o Tj fl ω Q Q Q Q Q Q Q Q n o n o y o n o n o n o y o M ro ro ro ro ro w ro ro o o
Figure imgf000062_0003
o ω ro ro ω o o o o ro ro w ω o o o o ro ro ω ro o o o o w w ro ro o o o o ω ω ω ro |! O
Figure imgf000063_0001
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O
33 33 33 33 33 33
Figure imgf000063_0002
ro ro ro ro ro w ro ro ro ro ro ro ro ro ro ro ro ro ro
I cr ro ω o o o o O O O o O O O O
TJ o Tj Tj TJ j TJ Tj ro ro ro ro ω ro ro ro o o o o o o o r. o TJ o TJ o τι Pi
I tn o o ro ro ro ro o o o o ro w ro ro o o o o ro ro ro ro o o o o ro ro w ro o o o o ro ω ω I PS Ch. tn m ro -_-rJ 21 ro tn ro J 21 ro TJ tn ro J u in ro TJ ra tn 2 ω ro 21 ro tn ro l" 3 3 y 21 V I t3o ω w o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o P
P n O O O O O O O O O O O O O O O O n ro ro n Tj Tj Tj Tj Tj Tj Tj Tj Tj Tj Tj Tj Tj Tj Tj fl Os tO
Q Q o o O O O O Tj Tj T Tj Tj Tj Tj Tj o t o w w w co c- w td do o o o ri o o n o Tj Tj j OJ ) I 1^ tn o o ro ro ro ro o o o o ro ro ro ro o o o o ro ro ro ro o o o o w ro ro ro o o o o w ro ω V I C3Λ
21 ro ro 21 S ro τj W : ro 21 : ro 2ϊ : ro τj 21 : ro τj W : ro ro ro τ ro j W ^ ro j 21 l!:S- ro ro ro ro ro w ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro w ro o o o o o o o o o o o f Il co
O O Tj TJ Tj n n n n ro n τj n ro ro n n ro τι n n n ro τj τj τj O O O θ Q Q Q y y y Q
I cr
Figure imgf000063_0003
o o ro ro ro ro o o o o ro w ro ro o o o o ro ro w ro o o o o o o o o ro ro ro w o o o PI
HH rt t e c ^ ^ c; ι-t '* ft C HH ^ Ct c; ι-t ™ fD c; '-' <" '-' 0) β ,-l rD S ,-1 <" S ,-< 1 LO
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O fl
- -. -
Figure imgf000064_0001
ω HH roH, ωH, o o o o Mro ωHH ωHt roH, roH, roH, roH, roH, o .-. o^ o^ o — o→ o^. o^ o^ JQj ^Q ^Q Jj JQj ^Q ^Ω JQj ro*. ωH, ωH, ωH, Hω, wH, Pi
1 i-n o o o o o o o ro w ro ro o o o o ro ro ro ro o o o o ro ro ro ro o o o o ro ro ω ω o o
Figure imgf000064_0002
s 21 §» ro τH 21 l rø ro 21 l ώ ro 2? l* ro τ3 2? l* ro ro 2? l* ro ro |?3
^ ^ > c X n G X a' G X n G X a' G X r'' G X n G X c[' G X a' G X 1 i-
Figure imgf000064_0003
,~ --1 l— ' l~ l— '
Figure imgf000064_0004
o o o o o o o Q Q Q Q Q Q Q Q ω ro w ro ω w ro ro o o o o o o o o Q Q Q Q Q Q
ω ω ro o o o o ro ro ro ω o o o o ro ro ω ro o o o o ro ro ro ro o o o o w ro w ro o o P)
I Ch ro 2? ^ ro ^ 2, ^ ro ^ 2? - ro τH 2? ^ ro ro 2? ^ ro >n 2, ^ ro 'n 21 i> ro Ϊ 2ϊ ^ ro ^ w ^ ro τ I t ro ro w ro w ro w w w w ro ro w ro ro ro ro ro ro ro ro ro ro ro w ro ro w ro ro ro ro ro ro ro w w
Figure imgf000064_0005
ro ω ro ω ω ω ro ro ω ω ro ro w ω ro o o o o o o o o o o o o o o o o o o o o o o f Il cr
Figure imgf000064_0006
ω ω ω o o o o ω ro ro ω o o o o ro w ro ω o o o o ro w rø ω o o o o ro ro ω ω o o I Ch
R3 R4a R4b R5 R6 R3 R4a R4b R5 Rδ R3 R4a R4b R5 R6 t-Bu Cl Cl Br Cl t-Bu Br Cl Br t-Bu Br Br Cl Br
Me Cl Cl Br Br Me Br Br Cl Me Br Br Br Cl
Et Cl Cl Br Br Et Br Br Cl Et Br Br Br Cl
/-Pr Cl Cl Br Br /-Pr Br Br Cl /-Pr Br Br Br Cl t-Bu Cl Cl Br Br t-Bu Br Br Cl t-Bu Br Br Br Cl
Me Cl Br CF3 Cl Me Br Br Br Me Br Br Br Br
Et Cl Br CF3 Cl Et Br Br Br Et Br Br Br Br
/-Pr Cl Br CF3 Cl /-Pr Br Br Br /-Pr Br Br Br Br t-Bu Cl Br CF3 Cl t-Bu Br Br Br t-Bu Br Br Br Br
Me Cl Br CF3 Br Me Cl Br Cl Cl t-Bu Cl Br CF3 Br
Et Cl Br CF3 Br Et Cl Br Cl Cl t-Bu Cl Br Cl Cl
/-Pr Cl Br CF3 Br /-Pr Cl Br Cl Cl
Figure imgf000065_0001
R-i R4a R4b R! E-ϊ R-1 R4a R4b R-1 Rδ R-- P R4b R! R-ϊ
Me CH3 H CF3 Cl Me Cl F CF3 Cl Me Cl H Cl Br
Et CH3 H CF3 Cl Et Cl F CF3 Cl Et Cl H Cl Br
/-Pr CH3 H CF3 Cl /-Pr Cl F CF3 Cl /Pr Cl H Cl Br t-Bu CH3 H CF3 Cl t-Bu Cl F CF3 Cl t-Bu Cl H Cl Br
Me CH3 H CF3 Br Me Cl F CF3 Br Me Cl H Br Cl
Et CH3 H CF3 Br Et Cl F CF3 Br Et Cl H Br Cl
/-Pr CH3 H CF3 Br /-Pr Cl F CF3 Br /-Pr Cl H Br Cl t-Bu CH3 H CF3 Br t-Bu Cl F CF3 Br t-Bu Cl H Br Cl
Me CH3 H Cl Cl Me Cl F Cl Cl Me Cl H Br Br
Et CH3 H Cl Cl Et Cl F Cl Cl Et Cl H Br Br
/-Pr CH3 H Cl Cl /-Pr Cl F Cl Cl /-Pr Cl H Br Br t-Bu CH3 H Cl Cl t-Bu Cl F Cl Cl t-Bu Cl H Br Br
Me CH3 H Cl Br Me Cl F Cl Br Me Cl H CF3 Cl
Et CH3 H Cl Br Et Cl F Cl Br Et Cl H CF3 Cl
/-Pr CH3 H Cl Br -Pr Cl F Cl Br /-Pr Cl H CF3 Cl
Figure imgf000066_0001
o o o o O O O O O O O o o o π o o o o o o o o o o o o o o o o o o o o o o
33 33 33 33 H^ H^ HH HH HH HM H HH HH f Ilco
Q Q Q Q hn hn τj τj TJ Tj TJ TJ TJ TJ TJ Tj Tj Tj τj τj τj τj 3 jr; a a 3 3; 33 3; 33 I cr o o ω ro ro ro ro ro ro ro o o O O O O
TJ oTJ Tj oTj o TJ o n T TJ TJ Tj Tj Tj ro ro ro ro ro ro ro w o Pi to to LO to o o o o o o oJ to to LO to to t to to I tn o o o o ω ro ω ro o o o o ω ro ro ω o o o o ro ω ω ro o o o o ω ro ro ω o o o o ro
Figure imgf000066_0002
rø TJ m? S ro ω J m s ro TJ . or _3 n m z ro 2? W TJ 2 m? £ ω ro 2 ω TJ t 2n1 ro TJ tt 2n1 ro TJ 2 tn1 fe fe r roo I t O O O o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o f Ilco
H^ H^ Hf H Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q ro Tj Tj Tj Tj Tj Tj Tj Tj fl ro) OnJ τJj Q-ϊ ro ro ro ω ω ro ω ω o o o o o o o o Q Q Q Q Q Q Q Q ro w ω ω ro ro ω ro o I tn o o o o ω w ro ro o o o o w ro ro w o o o o ro ro ω ro o o o o ro ω ro ro o o o o ω P I C3h
I o
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O
Figure imgf000066_0003
ro ro w ω ω ro ro ω ω ω ro ro 3i H T| τι τi 33 33 3; 33
Ω Ω Ω Ω Ω Ω Ω Ω n Q Q Q n Q Q Q ro ro ro ro ro ro ro ro o o o o o o o o Q Q Q Q Q
Figure imgf000066_0004
ω ω ω ω o o o o ro ω w ω o o o o ro ro ro ω o o o o ro ro ro ro o o o o ro ω ω ro o I Ch
c ro TJ tn ro TJ ro ro TJ w 2 ro TJ
3 3 3 3 W fe' ro j 2] £ ro τj 2? ro τj 2? S ώ τ ffl 2 ro τj S &' I P Li c O o o o o o o o o o o o O o o O o o o o o o o o o o o o o o o o o o o o o o
33 33 33 33 33 33 33 33 33 33 X 33 33 33 HH HL H ffi E K E HH H» H-H HH HH HH HH HH HH 3< HU HH HH HH HH O LO t to to to to to to to LO to to to LO 31 l- tO l-O I-O l-O tO l-O L l-O LO tO tO I-O l-O l-O LO tO I-O t tO t LO I cfeo- ro ro ω ro ro ro W ω ω ω ro ro ro ro ro ro ro o o o o o o o o o o o o o o o o o o o o Pi I • cfer- ro o o O O o o o o o Tj o Tj O Tj Oj O
Tj o TJ LO LO to to to LO L Ω tQo ro ^ ro "• ro ^ ^ro ro *< ro -1 ro "• ro ^ o — o H- oH- o H- oH- o - o H. -o jQ Q1 j11 I*. o ro ro ro ro o o o o ro ro ro ro o o o o ro ro ro ro o o o o ro ro ro ro o o o o ro ro ro ro I Ch
Figure imgf000067_0001
ro ro ro ro ro ro ro w ro w ro ω ro ro ro ω ro ro ro ro w Od co C ro ro ro ro w o o o o o o o o fl ro ro ro ro ro w ro ro ro ro w w w ro ro ro f Il cr 0 w ro ω ω ro o o o o o o o o oy oy oy oy oy oy oy oy ω ω ro w rø ro ω ro o o o o Q Q Q Q P I tin ro o o o o ω ro ω ω o o o o ω w ro ro o o o o ro ω ω ω o o o o o o o o ω ro ω ω I Ch
Figure imgf000067_0002
β Hr " ft 3 Hr " ft C H-r " ft C Hr " ft I ii-o ro o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o f Il t
^ ^ -. ^ - O O O O O O O O O O O O O O O O O O O O O O O O ^ ϋ ϋ ϋ ϋ ro ro n n n ro n n ro ro ro ro n ro ro n Tj Tj Tj Tj Tj Tj Tj Tj fl n Ω Ω Ω Ω H? H? H? H? H? H? H? H? Ω Ω Ω Ω Ω Ω Ω Ω n ro Q Q Q Q Q Q ro ro ω w ro ro ω ω P I <i-n o o o o o ω ω ω ro o o o o ro ro ω ro o o o o ro ω ro w o o o o ro ro w ro o o o o I Ch
tn ro TJ ra tn ro TJ 2> ro TJ 2 m1 it r ro t m ooo TJ 1 m-V w
3 3 3 « o n ro m ro 2 2 e 3 ~1 ft ^ ώ r
O O O O O O O O O O O O O O o o O O O O O O O O O O O o o O O O O O O 1*
33 33 33 33 33 33
Figure imgf000068_0001
o TI ToJ TJ TJ Tj TJ ro ro ro ro ro ro ro ro o O O O O O O T oJ o TJ T oj o T o O J Tj TJ O TJ o TJ ro ro ro ro ro ro w 1*3 O LO LO to to LO to to to to to I tn w ω o o o Ω H? ro ω w o o o o w ro w ro o o o o ro ro ro ro o o o o w ro ro ro o o o 1*3 I Ch w rø TJ 2 m1 ro TJ tn
Figure imgf000068_0002
ro ro w ro ro w ω ro ro ω w ro ro w ro ro ro ro ro ro ro w ro ro ro ro w ro ro w ro w ro w ro w ro P w ro ro ro ro ro w ro ro ro o TJ o o 0 0 0 0 0 0 O O
TJ TJ o O 0 0 0 1*3 j o Tj j TJ J 0 Tj 0 Tj 0 Tj O TJ TJ TJ Tj Tj Tj Tj O TJ o TJ o TJ T Tj Tj to to 1-0 t to to to LO LO to t to to to to to to LO > to I • cfer- CJ
, ---,- ,Q-, 0j 0Tj 0Tj 0j 0Tj 0Tj 0j TJ υ ro- ω ro ω ro ro w ro O O O O O O r tO LO to Q. X> 0 TI O TJ 0J O TJ TJ 0J 0 TI O TJ ro ro ro 1*3 tO LO LO LO to ~> to to to to l-O to o. o I tn o o w ro ro ro o o o o ro ω ro ω o 0 0 0 ro w ro ro o o o o ω w ro ro o o o o w ro ω 1*3
I Ch w ω TJ ro ro ro TJ 21 TJ 21 ro J ϋ roJ o ra m m 2 ro TJ 21 a ro 3
3 3 ω r ΪΓ ro ro 2?
3 3 -> ft s ft- ro G ro HI w " § ct* G 1- V 1* I to ro ro ro ro ro ro ro ro w ro ro ro ro ω ro 0d Cd Cd oo C oo Dd dd CO CO Od oo oo cd oo 00 Cd 00 co Cd oo dd P
Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω ro" τj τj τj τj ro n n n n ro n n n n n n n n n n τι τι 1*3
I T Ω Ω Ω Ω Ω Ω ro ro Q Q Q Q Q Q ω ro ω ro ro ro ro ro o o o o o o o o Q Q Q Q Q Q Q Pi
I tn ro ro o o o o ro ro ro ro o o o o w ro ro ro o o o o ro ro ω ro o o o o ro ro ro ro o o o 1*3 I Ch
R3 R4a R4b R5 R6 R3 R4a R4b R5 Rδ R3 R4a R4b R5 R6
/-Pr CH3 CF3 CF3 Br /-Pr Br Br Cl Cl /-Pr Br Cl Cl Br t-Bu CH3 CF3 CF3 Br t-Bu Br Br Cl Cl t-Bu Br Cl Cl Br
Me CH3 CF3 Cl Cl Me Br Br Cl Br Me Br Cl Br Cl
Et CH3 CF3 Cl Cl Et Br Br Cl Br Et Br Cl Br CI
/-Pr CH3 CF3 Cl Cl /-Pr Br Br Cl Br /-Pr Br Cl Br Cl t-Bu CH3 CF3 Cl Cl t-Bu Br Br Cl Br t-Bu Br Cl Br Cl
Me CH3 CF3 Cl Br Me CH3 CF3 Br Cl Me Br Cl Br Br
Et CH3 CF3 Cl Br Et CH3 CF3 Br Cl Et Br Cl Br Br
/-Pr CH3 CF3 Cl Br /-Pr CH3 CF3 Br Cl /-Pr Br Cl Br Br t-Bu CH3 CF3 Cl Br t-Bu CH3 CF3 Br Cl t-Bu Br Cl Br Br
Me CH3 CF3 Br Br «-Pr CH3 Cl Cl Cl t-Bu CH3 CF3 Br Br
Et CH3 CF3 Br Br H-Bu CH3 Cl Cl Cl i-Bu CH3 Cl Cl Cl
/-Pr CH3 CF3 Br Br 5-Bu CH3 Cl Cl Cl
Table 10
Figure imgf000069_0001
R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 R3 R4a R4b R5 R6
Me CH3 H CF3 Cl Me Cl F CF3 Cl Me Cl H Cl Br
Et CH3 H CF3 Cl Et Cl F CF3 Cl Et Cl H Cl Br
/-Pr CH3 H CF3 Cl /-Pr Cl F CF3 Cl /-Pr Cl H Cl Br t-Bu CH3 H CF3 Cl t-Bu Cl F CF3 Cl t-Bu Cl H Cl Br
Me CH3 H CF3 Br Me Cl F CF3 Br Me Cl H Br Cl
Et CH3 H CF3 Br Et Cl F CF3 Br Et Cl H Br Cl
/-Pr CH3 H CF3 Br /-Pr Cl F CF3 Br /-Pr Cl H Br Cl t-Bu CH3 H CF3 Br t-Bu Cl F CF3 Br t-Bu Cl H Br Cl
Me CH3 H Cl Cl Me Cl F Cl Cl Me Cl H Br Br
Et CH3 H Cl Cl Et Cl F Cl Cl Et Cl H Br Br
/-Pr CH3 H Cl Cl /-Pr Cl F Cl Cl /-Pr Cl H Br Br t-Bu CH3 H Cl Cl t-Bu Cl F Cl Cl t-Bu Cl H Br Br
Me CH3 H Cl Br Me Cl F Cl Br Me Cl H CF3 Cl
Et CH3 H Cl Br Et Cl F Cl Br Et Cl H CF3 Cl
/-Pr CH3 H Cl Br /-Pr Cl F Cl Br /-Pr Cl H CF3 Cl ro TJ ? ω TJ S m-J TJ ϋ WJ ro r 21 ro TJ i roi-1 ω w r TJ ϋ tn r ro 1*3
3 3 ω 3 o 3 3 i? ω TJ o
3 21 J o J
3 3 21 3 I LO o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
Figure imgf000070_0001
o o o o Tj j Tj Tj j ►rj Tj Tj j Tj Tj Tj j Tj 1*3
-fe- I cr n Q Q Q rø ro ro ω ro w ro ro o o o o o o o o Q Q Q Q Q Q Q Q ro ro ω ro ro ro ro ro o 1*3
I tn o o o o ro ro w ro o o o o w ro ro ro o o o o ω ro ω ω o o o o rø ω ro w o o o o ω 1*3 I Ch ro ^ ro & rø ro 2? & ω ro ro ^ rø ro ro & ro ro ro & ω τj 2i ^ W ro 2? !' W ro 2ϊ ^ W ω TJ -? fe' ώ τ- W fe' ώ HH m fe' ώ HH t 2 ώ - ro 2 ώ τ- W fe'
3 -i
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 1*3
I co
1*3
H^ H^ H^ HH^ Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω ^ ^ ro Tj Tj Tj Tj Ti Ti I cr
wy tyo yT Ly w^ ro^ ω-• ro-< ro^ ω-• ro-< ro"• oH- oH- oH- oH- oH- oH- o- o1- wy' wy y, y? u? Jy tuo LyO ro'1 ro ro-• ro^ ro-• ω ω 1*3 -■ ro^ o— I tn o o o o ro ro ω ro o o o o ro ro ω ro o o o o ro ro w ro o o o o ω ro ro ω o o o o ω
Figure imgf000070_0002
W ro ? |? ro ro 1 i' W ro W l^ W ro 21 2 w ro ? S ro 1*3 I t o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o 1*3
I co ω ro ro ro ro ω ω ro ro ω ro ro i 3; ; 3i 33 3; H 33 33 f Il cr
Ω Ω Ω Ω Ω Ω Ω Ω ro y Q Q Q y Q y ro ro ro ro ro ro ω ro o o o o o o o o Q Q Q Q Q 1*3 I tn ro ω ω ro o o o o ω ω ro ro o o o o ro ω ro ro o o o o ro ω ω ro o o o o ro ω ro ro o 1*3 I Ch
ro TJ ro ω TJ w 2 ro TJ t tn ω TJ t ron ro TJ t Sn ω ω TJ m w TJ t ra tnn W ro ro 2? P t r TJ rt tio
3 3 3 f o
3 3 3 -< C '"i 3 c
O o o o o o o o O o o O o o o o o O O O O O O O O O o o o o o o o o o o o
33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 to to to to to 33 33 33 33
I co ro ω ro ro ro ω ro ro ro ro ro ro ro ro ro w ro o o o o o o o o o o o o o o o o o o o o f Il cr w O o o O o o o O o O O
Tj T oj Tj o O
TJ Tj Tj o Tj o TJ ro ro ro ro ro ω o TJ o TJ o TJ TJ 1*3 LO to to to LO to ro rø o o o o o o o o to to to to I SJ, o W ro ro ro o o o O ro ro ω w O O o o ro ω ro ro o o o o ro ro ro ro o o o o ro ro ro ro Pi
ω m 1*3
Figure imgf000071_0001
ro ω W w ro ω W ro ω ω ro ro ro ω ro ro ro ro ro ro ro w w ro w ro ro ro ro o o o o o o o o p I co ro ro w ro ro ro w ro ro ro ro ro ro w ro ro f Il cr ro rø ro rø ro o o o o o o o o Oy Oy Oy
Figure imgf000071_0002
ω o o o o ω w ro ω o o o o ω ro ro ω o o o o ro ro ro w o o o o o o o o ro w ω ω I
H-. v- <? a a fe ω ϋ ro ro >rj ro τj mro fe =_, ro τj ro m 2 ro TJ w S ω TJ 2 w § ό ro TJ ro ro S ro TJ ro m 2 ro TJ w S ά
3 3 3 - C ^ CD C - ro ro w 2 1*3
3 I ω o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o f It P
^ - - - - O O O O O O O O O O O O O O O O O O O O O O O O ro y 2 _J ro ro ro ro ro ro ro ro ro ro ro ro ro ro ro τj τj τj τj τj τj Tj τj τj
I cr ro Q Q O o ro ro ro ro ro ro ω ro o o o o o o o o Q Q Q Q Q Q Q Q ro ro ro ro ro ro w ro o o o o o ro ro ω ro o o o o ro ro ro ro o o o o ro ro ω ω o o o o ro ω ro ro o o o o 1*3
I ON
m S ω ro t Sin1 ro m o ϋ tnJ ct o TJ ro ro TJ tn ø TJ ffl 2 ro o 21 ro TJ TJ ra tn 1*3
3 3 t r c TJ r
3 ft r
3 3 3 r 3 - 21 ro 1 3 1 to o o o o o o o o O O O O O O O O o O o o o O o o O o 1*3
33 33 33 HH HH HH 33 33 33 33 33 33 33 33 3! 33 o o o o o o o o o o o
HH 3H HH HH HH HH HH HH HH HH 3H
LO LO LO LO LO LO LO t Xo to to t to to to to to LO to to to to to to to to LO LO
Figure imgf000072_0001
ro ω o o o o ro ro ro ro o o o o ro ro ro ro o o o o ro ro w w o o o o ro ro ro ro o o o 1*3 I Ch m ω tn ro TJ 21 ro TJ i ro-V ro ^ tnJ tn ω
3 ro 2 ro TJ r TJ 2? Pi
3 -i 3 3 3 ro 2? ro w
3 o G -> I to ro w ro ro ro rø ro ro w ω w w ro rø rø rø ro w ro ω rø rø rø rø rø ω ro ro w ro ro rø rø w rø ro ro
I co ro ro ro ro ro ro rø ro ro ω o o O O O O O O O O
Tj Tj o Tj o Tj o Tj o Tj o TJ o n o Tj o TJ o Tj o TJ o TJ o TJ o TJ oj Tj Tj Tj Tj j Tj Tj Tj tO tO tO LO LO LO tO LO LO LO LO LO I-O tO LO tO LO L LO LO LO LO LO LO I σ- ~~
Ω Ω o ro ro o O O r w ω ω o O O O O O O O O HH HH H-,
T J Tj J Tj ro w ro rø ø O O O O O O
L r J o T o O LO LO LO LO to LO LO n τj τj τj τj τι τj τj _? ;? EP
LO LO LO LO LO LO LO LO o o w ro rø W O O O rø rø rø ro o o o o ro rø rø ω o o o o rø rø rø ro o o o o w ro ω 1*3 I Ch w ω ro 2? ro m r TJ 2 tn ro m 1*3
3 3 o ? ro ro 2 ro1 S ό ft ro TJ
3 rt C -ι I1 C 1 c 1 " I t rø rø w ro w ro ro ro ω ro ro w ro ro ro ro ro ro w ro ω ro w ro ro w ro ro ro ro ro ro ro ro ro ro ro
I co o o o o o o o o o o o o o o ro Tj Tj Tj Tj Tj j j j Tj Tj Tj Tj 1*3 I σ -fe*
Figure imgf000072_0003
Figure imgf000072_0002
ro rø o o o o rø rø ro ω o o o o ω ro ro ro o o o o rø rø ω ω o o o o ω w ro rø o o o
Figure imgf000072_0004
R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 R3 R4a R4b R5 Rθ
/-Pr CH3 CF3 CF3 Br /-Pr Br Br Cl Cl -Pr Br Cl Cl Br t-Bu CH3 CF3 CF3 Br t-Bu Br Br Cl Cl t-Bu Br Cl Cl Br
Me CH3 CF3 Cl Cl Me Br Br Cl Br Me Br Cl Br Cl
Et CH3 CF3 Cl Cl Et Br Br Cl Br Et Br Cl Br Cl
/-Pr CH3 CF3 Cl Cl /-Pr Br Br Cl Br /-Pr Br Cl Br Cl t-Bu CH3 CF3 Cl Cl t-Bu Br Br Cl Br t-Bu Br Cl Br Cl
Me CH3 CF3 Cl Br Me CH3 CF3 Br Cl Me Br Cl Br Br
Et CH3 CF3 Cl Br Et CH3 CF3 Br Cl Et Br Cl Br Br
/-Pr CH3 CF3 Cl Br /-Pr CH3 CF3 Br Cl /-Pr Br Cl Br Br t-Bu CH3 CF3 Cl Br t-Bu CH3 CF3 Br Cl t-Bu Br Cl Br Br
Me CH3 CF3 Br Br «-Pr CH3 Cl Cl Cl t-Bu CH3 CF3 Br Br
Et CH3 CF3 Br Br H-Bu CH3 Cl Cl Cl /-Bu CH3 Cl Cl Cl
/-Pr CH3 CF3 Br Br 5-Bu CH3 Cl Cl Cl
Table 11
Figure imgf000073_0001
Ri PA R4b R Ei R. R4a R4b R5 Ei R! R4a R4b Ri -i
Me CH3 H CF3 Cl Me Cl F CF3 Cl Me Cl H Cl Br
Et CH3 H CF3 Cl Et Cl F CF3 Cl Et Cl H Cl Br
/-Pr CH3 H CF3 Cl /-Pr Cl F CF3 Cl /-Pr Cl H Cl Br t-Bu CH3 H CF3 Cl t-Bu Cl F CF3 Cl t-Bu Cl H Cl Br
Me CH3 H CF3 Br Me Cl F CF3 Br Me Cl H Br Cl
Et CH3 H CF3 Br Et Cl F CF3 Br Et Cl H Br Cl
/-Pr CH3 H CF3 Br /-Pr Cl F CF3 Br /-Pr Cl H Br Cl t-Bu CH3 H CF3 Br t-Bu Cl F CF3 Br t-Bu Cl H Br Cl
Me CH3 H Cl Cl Me Cl F Cl Cl Me Cl H Br Br
Et CH3 H Cl Cl Et Cl F Cl Cl Et Cl H Br Br
/-Pr CH3 H Cl Cl /-Pr Cl F Cl Cl /-Pr Cl H Br Br t-Bu CH3 H Cl Cl t-Bu Cl F Cl Cl t-Bu Cl H Br Br
Me CH3 H Cl Br Me Cl F Cl Br Me Cl H CF3 Cl
Et CH3 H Cl Br Et Cl F Cl Br Et Cl H CF3 Cl -Pr CH3 H Cl Br /-Pr Cl F Cl Br /-Pr Cl H CF3 Cl
Figure imgf000074_0001
*3
O O o O TJ Tj ro TJ TJ Tj Tj Tj TJ j Tj TJ TJ Tj TJ TJ TJ Tj TJ Tj Tj TJ Tj 33 3! 33 33 33 33 33 33 33 4-. cr o o O
TJ J ω ro or ro ro ω ro ω O O
O O O O O
Tj TJ o TJ o O
Tj j ro ro ω ro ro rø ro ro *3 to to to to t to tn o O o O rø or ω t o o O o rø ro ro ro O O O o ro rø w rø o O O O rø rø ro w O o o O rø *3 Ch
ro J w rø J m o TJ W £ rø ro m £ w TJ ro rø J tn m n to
3 3 t r
3 3 r £ rø J ro £ rø TJ
3 3 3 G t rø ro i *3
3 ct ω
o o o o o o o o o o O o O O o o O o o o O o o o o O O o O o o o o o o 1 ω rø rø ω o O o o o o o o o o o o o o o o o O o O o o O TJ TJ TJ TJ Tj J Tj j j
Ci o o ω ro ω ro ω r ro ω o o o o o o O O O
TJ oJ o o o o TJ TJ o TJ J o Tj o Tj o Tj TJ ro rø ω ro rø rø ω rø O *3 to to to to to to tn
O o o o rø ω Cd O o O o rø ro w rø o o o o rø ro ro ro o O O O ro rø ro w o o o o ω *3 Ch
Figure imgf000074_0002
o o o o o O o o o o o o O o o o O o o o O O o o o O o o O o o o o o o 1 rø w rø ω w rø rø rø w ro rø rø *3
33 X 33 X 33 EC 33 33 X -fe. cr o o o o o o O o TJ o Tj o o TJ o TJ o TJ J o rø Cd rø rø ro Cd ro o O o o o o O o o Tj o Tj oj T oJ o Tj *3 to to to to to tn rø ør ω rø o o o o ro ω ω W o O O o Cd W Cd W o o o O rø w rø rø o o o o rø rø rø rø o *3 Ch
ώ TJ ro £ ro ro m £ ro r 2 -1 £ ω τ 1*3
3 3 3 o j 21 £ ω τ- 2l ω ro in r in
3 ro 2? ø
3 rø i £
3 - ro n I 2? ώ TJ rø 1 to
O o o o O o o o O o o o o o o o o o o o o o o o o o o o o o o o o o o o o 1*3
33 33 33 33 33 33 33 33 33 31 HH HH HH Έ K K Έ Έ Έ Έ Έ Έ K Έ S S HH HH H HH HH HH HH HH HH HH HH
-o 1 co ro rø rø ro ro ro rø rø ro ro ro cd cd ro t-d cd cd o o π n π o n o n π o π o o o o o o o o 1*3
1 cfer- rø o o o o o o o o T oJ Q Q Q Q Q Q Q rø rø rø rø ro rø ro ro o o o o o o o o Q ro Q τj 1*3
1 <-n o ω ro rø td o o o o rø ω rø rø o o o o ω rø rø ffl Ω Ω Ω Ω H? H? S? H? Ω Ω Ω o ffl rø ro ro 1*3
1 Ch
£ rø ? w £ 1*3 t rø r m £ rø
3 f 3 o 3 ro - tniJ rø ro 2 m in1 rø ro 2 m w1 rø ro w rø ro 2 t tnn? rø w
C -• ro 2? rø
3 1 to
Figure imgf000075_0001
rø rø rø rø rø rø ro ro ro ro ro ro ro rø rø rø 1*3
1 cr ^4 4-- ω rø rø ro ro o o o o o o o r Q. oι-r| oTj oTj oTJ O O Oj mH? rø rø rø o Tj o J Oro T Tj o TJ T T 1*3. to to to LO rø w ro ro
LO LO LO LO ^ Ω Ω Ω Ω Tj o j LO LO LO LO ro o o o o ro ω w ω o o o o ro ro ro ro o o o o ro rø rø rø o o o o o o o o dd Cd Cd Cd 1*3 I Ch
^ rø rø ro τj rø ro w S ro ^ w 2 ro ^ ro £ ro τj rø 2 rø ro rø ^ rø ro tϊ rø TJ ra w £ ω TJ tn £ 1*3 3 -1 3 ". I '-o
W O O O O O O O O O O O O O O O O O O O O O O O O O o o o o o o o o o o o
^ - - - -. O O O O O O O O O O O O O O O O O O O O O ro Q Q Q ro ro or ro τj τj τj τj τj τj τj τj τj ro τj τj τj τι τj τ] τj o o o
F I+ cr ro Q Q O o w w ω ro ro rø rø rø o o o o o o o o Q Q Q Q
Figure imgf000075_0002
o o o o o rø ω w rø o o o o rø rø rø w o o o o rø ω rø w o o o o rø ro ro ro o o o o 1*3 I Ch
Figure imgf000076_0001
o o o o o o o o o o O O o o o o o o o o o o o o o o o o o o o o o o o 1*3
33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 to to to to to to to to to I - cfeo-
O O O O O O
Tj Tj Tj Tj Tj Tj cd cd td Cd Cd Cd d O LO LO LO LO LO rt> oJ o Tj oJ o TJ o O TJ J ro ro w ro ro ro ro ro o o o o o o o o o o o Tj o Tj o TJ o o £. S roJ. ro w w rø rø w 1*3 to LO LO to to ~> I tn
rø rø o o o rø ro ω rø o o o o w w w ω o o o o ω rø ω rø o o o o ω ω w ω o o o 1*3
ro rø ro ϋ mJ ro TJ ro £ ro ro ffl rø ffl rø m £ rø
3 -ι 3 3 3 3 3 ro ϋ mJ ro
3 ro 2 ø
3 ? r
3 ro 2> 1*3 I to ro rø rø rø rø rø w ro ro ω ro ro ro ro rø rø rø rø rø w rø rø ro ro rø rø rø rø rø rø rø rø rø ro w rø rø f Il co rø W rø rø rø rø rø rø W rø o o O O o O O O O O O O O O O O O O O O O O O Tj Tj Tj o TJ TJ Tj TJ Tj TJ Tj TJ ro TJ Tj Tj Tj Tj
Figure imgf000076_0002
O O O Hrj i-rj i-tj TJ Tj j o ro o TJ ω ω ω ω ω ω ω rø o o o o o o Tj o TJ to i-o to l-O o o Q o Tj o Tj o Q Q Q » ro ω 1*3
I tΛ o o ro rø ro rø o o o o ω rø ω rø o o o o rø rø rø rø o o o o rø ro ro rø o o o o w ro w
Figure imgf000076_0003
w ω ro ro 2? „ ω ro ffl m £ ω TJ ro f- 3 i-t rø ro rø ro m rø tn rø ffl rø ro ϋ wJ
3 -I 3 -I 3 3 ct ω
3 ro 2? 1*3
I t ro ro rø w rø rø rø rø ω ω ω ω rø w rø w W TO W W rø rø ω rø rø rø rø rø W W W W rø rø rø rø W 1*3 I o
Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω ro' j Tj Tj Tj Tj ffl Tj ffl ffl ffl 'n Tj Tj Tj ffl ffl Tj ffl ffl ffl 'TO Tj o o o o o o Q Q Q Q Q Q Q Q rø ω ω rø rø ro ro rø o o o o o o o o LOQ LOQ LOQ LOQ LQO LOQ LOQ
Figure imgf000076_0004
rø rø o o o o rø ro rø rø o o o o rø rø ω ω o o o o rø ω rø rø o o o o rø rø rø ω o o o
Figure imgf000076_0005
R3 R4a R4b R5 R6 R3 R4a R4b R5 Rδ R3 R4a R4b R5 R6
/-Pr CH3 CF3 CF3 Br /-Pr Br Br Cl Cl /-Pr Br Cl Cl Br t-Bu CH3 CF3 CF3 Br t-Bu Br Br Cl Cl t-Bu Br Cl Cl Br
Me CH3 CF3 Cl Cl Me Br Br Cl Br Me Br Cl Br Cl
Et CH3 CF3 Cl Cl Et Br Br Cl Br Et Br Cl Br Cl
/-Pr CH3 CF3 Cl Cl /-Pr Br Br Cl Br /-Pr Br Cl Br Cl t-Bu CH3 CF3 Cl Cl t-Bu Br Br Cl Br t-Bu Br Cl Br Cl
Me CH3 CF3 Cl Br Me CH3 CF3 Br Cl Me Br Cl Br Br
Et CH3 CF3 Cl Br Et CH3 CF3 Br Cl Et Br Cl Br Br
/-Pr CH3 CF3 Cl Br /-Pr CH3 CF3 Br Cl /-Pr Br Cl Br Br t-Bu CH3 CF3 Cl Br t-Bu CH3 CF3 Br Cl t-Bu Br Cl Br Br
Me CH3 CF3 Br Br ?z-Pr CH3 Cl Cl Cl t-Bu CH3 CF3 Br Br
Et CH3 CF3 Br Br n-Bu CH3 Cl Cl Cl /-Bu CH3 Cl Cl Cl
/-Pr CH3 CF3 Br Br --Bu CH3 Cl Cl Cl
Table 12
Figure imgf000077_0001
R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 R3 R4a R4b R5 R6
Me CH3 H CF3 Cl Me Cl F CF3 Cl Me Cl H Cl Br
Et CH3 H CF3 Cl Et Cl F CF3 Cl Et Cl H Cl Br
/-Pr CH3 H CF3 Cl /-Pr Cl F CF3 Cl /-Pr Cl H Cl Br t-Bu CH3 H CF3 Cl t-Bu Cl F CF3 Cl t-Bu Cl H Cl Br
Me CH3 H CF3 Br Me Cl F CF3 Br Me Cl H Br Cl
Et CH3 H CF3 Br Et Cl F CF3 Br Et Cl H Br Cl
/-Pr CH3 H CF3 Br /-Pr Cl F CF3 Br /-Pr Cl H Br Cl t-Bu CH3 H CF3 Br t-Bu Cl F CF3 Br t-Bu Cl H Br Cl
Me CH3 H Cl Cl Me Cl F Cl Cl Me Cl H Br Br
Et CH3 H Cl Cl Et Cl F Cl Cl Et Cl H Br Br
/-Pr CH3 H Cl Cl /-Pr Cl F Cl Cl /-Pr Cl H Br Br t-Bu CH3 H Cl Cl t-Bu Cl F Cl Cl t-Bu Cl H Br Br
Me CH3 H Cl Br Me Cl F Cl Br Me Cl H CF3 Cl
Et CH3 H Cl Br Et Cl F Cl Br Et Cl H CF3 Cl ro w ω ro 2> rø ro w ω ro E? rø ro w ro rø ro « ro in rø T) - ffliJ ω ro 21 rø r 1*3
3 -I 3 -I 3 M o
3 3 I to
Figure imgf000078_0001
o TJ o TJ o TJ ro ro ro ro ω ω ω ro o o o o o o o o o TJ o Tj oo o TJ o o o o r
-o LO LOr LO toro J Tj TJ rø rø ø ro rø rø rø o o LO H? Ω Ω 1*3 I t-h
O O O rø rø rø rø o o o o ro ro rø rø o o o o rø rø ω ω o o o o ro ro ro rø o o o o w » 1*3 I Ch
ro - ffliJ ro J 2 ffl? ro TJ ϋ- r w
3 3 5?1 ro ro 2? ro tn rø ro 2? ø rø 3 T -iJ 2? i? ro £ S ϊt _ rø? ro 1*3 I LO
3 "i o o o o o o o o o o o o o π o o o o o o o o o o o o o o o o o o o o o o o I co
-? W H? Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω ffl ro ro τ] τj τj τj τj τj τj 1*3 I cr
Q Tj Q TJ Q Tj rø - w ω ω ro ω ω ω o o o o o o o o Q Q Q Ω Ω Q Q Q ro rø w ω ω rø rø ro o o 1*3
I tn o o o rø w w w o o o o ω w rø ω o o o o rø w w rø o o o o w w ω ro o o o o rø rø 1*3 I Ch
Figure imgf000078_0002
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o f Il co rø rø ω ω rø ω ω ω ro rø rø rø 3 3 33 33 33 3| 3J H 33 3i
Figure imgf000078_0003
Figure imgf000078_0004
o o o o o o o Q Q Q Q Q Q Q Q rø rø rø rø rø rø w ro o o o o o o o o Q 1*3
LOQ LQO LOQ LQO tQo tO I tn ω rø w o o o o rø rø rø rø o o o o rø ω rø rø o o o o rø rø rø rø o o o o rø w rø rø o o 1*3 I Ch
ro ro ro rø r rø rø TJ ra W
3 ro w ø ro w rø TJ ffl ra rø
3 "• 3 ro -i w rt rø — T —J ro ω ro s £ A rø- 1*3 ft c I to
3 o o o O o o o o o o
33 33 33 33 33 o o o o o o o o o o n x o o o o o o o o o O O
33 33 33 X 33 33 3! o to 33 33 33 33 33 33 P ro ro ro ro ro ro rø ro ro rø w rø ro rø w rø o o o o o o o o o o o o o o o o o o o o o
Figure imgf000079_0001
Figure imgf000079_0002
rø rø rø rø o o o o rø ro rø ro o o o o ro rø rø rø o o o o rø rø w ro o o o o rø w w w o 1*3 I Ch
W ro ffl rø ffl rø ffl ω w £ r ro s ffl -£ r 3ø " ro S tn? u W ro ww £ rø ro ϋ ffl rø 1*3
3 -I 3 ø W £ rø ro S
3 3 " I to ro ω ro rø ro ro ro ro rø rø ro ω rø rø w rø rø rø rø ro rø ω rø rø rø rø ω w o o o o o o o o o f Il co rø rø rø rø ro rø w rø rø rø rø w rø rø rø rø rø f Il cr o
H? ω H? ω Ω Ω Ω Ω Ω Ω Ω Ω ro ro ro ro Q Q Q Q rø ω rø w rø rø rø rø Q Q θ o Q Q Q Q Q 1*3
I Ln o o o o ω ω rø rø o o o o ro w rø ω o o o o ω ω ω ω o o o o o o o o rø w rø w o 1*3 I Ch
-.. -. ώ ώ ro τj ro τj 21 ^ rø τj W 2 rø j ) S rø ro rø S ώ τj rø ^ rø ro 2) ^ rø ro W 1*3
I to
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O
Figure imgf000079_0003
Figure imgf000079_0004
o o o o w rø ro w ω ro ro ω o o o o o o o o Q Q Q Q Q Q Q Q rø rø ω rø rø rø
Figure imgf000079_0005
o o o o ro w ω rø o o o o ω rø w ro o o o o ω rø rø rø o o o o ω rø rø rø o o o o ω 1*3 I Ch
cd TJ S1 w ro 21 W ro ro £ o ffl £ TJ tn ff £ ω ro ra ffl ro ro ϋ fflJ l*λ
3 -1 2? j? ro 5 « ct r
3 ro ct rø
3 £ ct rø ro l
3 c 3 3
O O O O O O O O O O O O O o o o O o O O O o o O o O O O O O O O O
33 33 33 33 33 33 33 33 33 33 33 33 33 33 to to to fl
Figure imgf000080_0001
o o o o o ___ O
TJ TJ j TJ TJ St; o LO to LO LO ω ^ ro rø rø w w rø w o o o o o o r, ,-, O O O Q Q ffl Tj TJ Oj o Tj oTj o Tj O toj LO to to LO LO LO w rø w w w rø rø w I tn rø o o o o rø rø ω w o o o o rø rø ro ro o o o o ω ω ro rø o o o o rø ro ro rø o o o o
Figure imgf000080_0002
Figure imgf000080_0003
ro rø w rø rø rø rø W rø rø W W rø rø rø rø rø rø rø w ro rø w rø rø rø rø rø w rø rø w rø rø rø rø rø f Il ro rø rø w rø rø rø HH HH O O O O O O O ro rø ro τ] ro τj τj Tj τj O O o
Figure imgf000080_0004
H-j or ro oj Tj oj oro o O ro Tj O Tj Oj OTj OTJ LO LO LO LO LO LO LO to LO to to LO LO f 1lcr
Figure imgf000080_0005
Figure imgf000080_0006
o rø rø w w o o o o w rø ω rø o o o o rø ro rø rø o o o o rø rø ω rø o o o o rø rø ro w 1*3 I Ch
rø ro 2? rø roro W rø ro w S w Tj W S rø ro W ^ rø ro W ^ ό ro ro w ώ ΪJ w S ώ ζ -H ^ 1*3
3 -I I to rø rø ro w rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø W W rø rø rø rø w ro w rø w rø rø rø w rø w rø fl
Q Q Q Q Q Q Q Q Ω Ω Ω Ω rø rø ro' ro ro ro n ro ro n ro n ro ro ro ro ro ro ro ro n n rø ro l? cr Ω Ω Ω Ω Ω ro ro Q Q Q Q Q Q rø ffl ffl rø rø rø rø w o o o o o o o o Q Q Q Q Q Q Q Q 1*3 tn rø o o o o rø ω rø rø o o o o rø rø rø w o o o o w rø w rø o o o w rø rø rø o o o o 1*3 I Ch
R3 R4a R4b R5 R6 R R4a R4b R5 R6 R3 R4a R4b R5 R6
Et CH3 CF3 CF3 Br Et Br Br Cl Cl Et Br Cl Cl Br -Pr CH3 CF3 CF3 Br /-Pr Br Br Cl Cl /-Pr Br Cl Cl Br t-Bu CH3 CF3 CF3 Br t-Bu Br Br Cl Cl t-Bu Br Cl Cl Br
Me CH3 CF3 Cl Cl Me Br Br Cl Br Me Br Cl Br Cl
Et CH3 CF3 Cl Cl Et Br Br Cl Br Et Br Cl Br Cl
/-Pr CH3 CF3 Cl Cl /-Pr Br Br Cl Br /-Pr Br Cl Br Cl t-Bu CH3 CF3 Cl Cl t-Bu Br Br Cl Br t-Bu Br Cl Br Cl
Me CH3 CF3 Cl Br Me CH3 CF3 Br Cl Me Br Cl Br Br
Et CH3 CF3 Cl Br Et CH3 CF3 Br Cl Et Br Cl Br Br
/-Pr CH3 CF3 Cl Br /-Pr CH3 CF3 Br Cl /-Pr Br Cl Br Br t-Bu CH3 CF3 Cl Br t-Bu CH3 CF3 Br Cl t-Bu Br Cl Br Br
Me CH3 CF3 Br Br M-Pr CH3 Cl Cl Cl t-Bu CH3 CF3 Br Br
Et CH3 CF3 Br Br H-BU CH3 Cl Cl Cl /-Bu CH3 Cl Cl Cl
/-Pr CH3 CF3 Br Br s-Bu CH3 Cl Cl Cl
Figure imgf000081_0001
R5b is CHF-> R5b is CH2CF3 R5b is CFoCHFo
R-- R4a R4b R5a R3 R4a R4b~ R5a R R4a " R4b " R5a
/-Pr Me H Me /-Pr Me H Me /-Pr Me H Me
ffl w ro rø rø rø rø rø |*3 to £ £ £ £ £ £ ffl w w ffl ffl ffl |*3
3 3 3 3 3
Figure imgf000082_0001
Figure imgf000082_0002
£ CD £D £CD £CD £CD £CD £CD £CD £CD £CD £CD £CD £ *3 CD £CD I| ja £ CD C£D £CD £CD £CD £CD £CD £C £D £CD £CD £ 1 D C CD
ro - tnJ. ω ro ro ffl ω rø ro π ffliJ ro 3 ro t "- 2n1 |*3 I to £ £ £ £ £ ffl lff ffl ffl I*3,
°
Figure imgf000083_0001
o o o o o o o o o o o o o o o
Hfl Hj-| τj Tj Tj ro τj 33 33 33 33 33 33 33 S3
Figure imgf000083_0002
ro rø rø o o o o rø rø rø rø o o o o 1*3
£ £ £ £ £ £ £ £ £ £ I
— - — - rø J ώ ro ffl £ ct rø TJ ffl £ l £ TJ ffl £ rø TJ ro £ TJ ro 1*3
3 ør
3 3 ct rø ■ rø or m £ rø
3 rt ro ff
3 3 3 r ώ
3 3 ro ffl £ ct rø £
3 1 to
3 o o o o o o o o o o o o o o O o o o o o o o o o o o O o o o O o o O O o |*3
33 33 33 33 33 33 33 33 S3 33 S3 X 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 tn O to LO LO to to LO LO to to LO LO LO LO LO to to LO LO to LO to to LO to to LO LO LO to LO to -fe *3
-a'
O
Figure imgf000084_0001
p 1i5 Ito *
o o o rø rø M rø O O O O rø rø rø rø O O O o w •"H w ω rø O o o o rø rø rø rø O O O O rø
Figure imgf000084_0002
O o o o o O o o o o o o o o o o o O o o o O O o o o O O O O o o o O o *3
|*3 tn
33 33 33 S3 3! 33 33 S3 33 33 33 S3 33 33 33 33 33 33 S3 33 33 33 33 33 33 33 S3 33 33 33 33 33
LO LO LO LO to to to LO LO LO LO ι-o to to LO LO t 3o3 to to to to to to to LO LO to LO to to to LO •fe-
33 00 o O O O O O O O w r TJ Tj TJ Tj rø rø rø O O O O O O O O to to LO to to ffl t ro TJ n rø ω ω W rø to LO ro f Q
Figure imgf000084_0003
£ rø TJ £ rø ro ffl £ TJ m rø TJ ffl £ TJ ffl £t rø TJ ffl TJ ffl r |*3
3 3 ct rø £
3 3 rt ώ 3 r £ w £
3 t fl
3 3 ώ ro f Ct ø
3 1 to
Figure imgf000084_0004
ro 2- rø r 2- rø ro S £t rø ro roi' rø ro 2 ffl rø
3 o 3 3 3 ? £ rø r ro rø |*3
3 ro 2? rt rø 3 3 ro 2- W
3 o 3 I LO
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O
rø ro ω ro ro rø rø rø 3 | H 3ϊ 3; 33 θ O O O Tj
Figure imgf000085_0001
o o o rø rø rø rø o o o o w rø rø rø o o o o w rø rø rø o o o o ω rø rø rø o o o o o |*3
ro ro £ „ ro ro 21 ^ ro ro w ^ W ro 1 ^ W ro 2? ^ W ro ? ^ « ^ 21 S w ro 2? ^ W ro m S w |^
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o I*? ro
P
33 o o o Ito 4
Tj o T TJ l J ) W rø rø ω 33 33 S3 S3 33 S3 33 S3 Ω Ω Ω Ω Ω Ω Ω Ω flf ffl ffl rø ffl 1 f*A3 |Q
o o o ω w ω ω o o o o ω rø ω ω o o o o ω ω rø ω o o o o ω ω rø ω o o o o ω |*3
ro -? rø"- -c^t ro ro -? ~^ -^ rø ro ffl ^ ro ro ^ H c fw^ -5-?0 W --- o^.--. « ^.Λ- Hζ,u u «™--- ^c. — CD g' -o - ct ^ -? «■ rt fl ■ gro w- H -ϊ-u - _--..- 2c *—t - gw-'- - -ϊy u S^ _-- ■^r —t ■ 5 • .^ -, ■5. u" _"W--- ■^r — - ώ w g' |l ι^ ,
ro ω ro w ω ra rø o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
n n ro ro ro n n Q ro Q ro τj i-ri ro τj T] τj τj τι τj τj j Tj 33 33 33 3 33
Figure imgf000085_0002
ω rø ω o o o o o o o o rø w rø rø o o o o rø ω rø rø o o o o ω rø rø ω o o o o ω |*3
ro ffl ra £ rø ro tn £ rt ør ro w rø ro ^ fflJ m
3 3 ω 3 ro ϋJ ro
3 ro 3 w
3 ro w rø ø
3 ro 21 r ro 2- rø 1*3
ts ro rø rø w rø rø rø rø rø rø rø rø rø rø rø w ro rø rø rø rø rø ro rø rø rø o o o o o o o o o *3
I co i-n on o
33
HH HH HH rø ω ω rø rø rø rø rø o o o o o o o τι τι τ O O ro ro oflf o ffl o O ffl ffl Tj ffl TJ ffl Fl ffl
Ito
o o o w rø rø ω o o o o ω ω w rø o o o o ro rø rø w o o o o o o o o w w rø ω o |*3
? s π s ^ i ^ H ? s H ? ™ H ? - ^ ? - ? H H s » i ^
*3 rø ro rø w rø ro rø w rø w rø rø rø w rø rø rø rø rø rø rø rø rø rø rø rø rø o o o o o o o o o I*. tn
O
.33 0 Ito
» ro ^ ro^ ro ω ro ω ro Ω Ω Ω Ω Ω Ω H- ΩH- Ω ro τι τj ro τj τι τι τj θ o — o — o -* Q tQ tQ toQ tQ |il σ* ,'| iro
Ito o o o ω rø ω rø o o o o rø rø rø ω o o o o rø rø ω ω o o o o o o o o rø ω ω ω o |*3
ro w | rø ro w £ ώ ro w ! ώ ro « ! ώ 5 „ ! ώ $ 21 ^ ro ro w ! ro ro
Figure imgf000086_0001
w rø ro ro ro ro rø o o o o rø rø rø w o o o o ω ω rø rø o o o o rø rø rø w o o o o ro iro Oh
rø ro ør r ϋroJ rø tn | TJ tn |*3
3 -I £ *3 ct 3 or tn rø
3 ro 2- rø o
3 3 ro I to ώ £ rø
3 3 1 LO
Figure imgf000087_0001
rø o o o o rø ω w ω o o o o rø rø w rø o o o o |*3 o o o o ro I 1* C3h
^ H ™ I 7 ™ M » H s » H 5 « H ™ « H - ^ I 7 ™ i «
_ ,-, -, - ,_ 0 0 0 0
Q Q Q Q Q -3 -3 -3 -3
ro ffl ro ro ro Q _. θ — H- oH-
Figure imgf000088_0001
ω o o o o o o o o rø ω ro rø o o o o rø w ω rø o o o o rø ω rø rø o o o o ω rø ω |*3
S ώ ro -? 2 rø ro 21 l' rø ro 2? 5 ώ ro ffl rø ro 21 £ rø ro rø 2
Figure imgf000088_0002
rø o o o o rø ω rø ω ω rø rø rø o o o o w rø rø ω o o o o rø rø rø rø o o o o ω rø ω |*3
| rt* ro p. »ro. "2i l o* ro 3 ro -y 2, - c^t rø c πro-r ^1 'c^t W c ro -y m " ^ <t rø ro rø 2 ro c ro M £ g" -y c H-r ^ D £ -y Η" I t
- ^, ^ ^, - ^, -, - ^, 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 iro
Q Q Q Q Q Q Q Q Q -3 -3 -3 -3 -3 -3 -3 -3 -3 -3 -3 -3 -3 -3 K K lι: K K K K K a i-l -3 -3 -3 -
HH 3 33 33 33 33 S3 33 33 flf Q Q Q Q Q Q Q HH HH HH H- HH HH --, HH rø rø rø W ω rø rø rø O O θ |;
Figure imgf000088_0003
rø o o o o rø ω rø rø ω ω rø ω o o o o rø rø rø rø o o o o w rø rø w o o o o ω rø ω |*3
rø ro ffl rø ro w ra rø ro iwϊ rø
Figure imgf000089_0001
Figure imgf000089_0002
o w w w w o o o o rø w rø ω o o o o w rø ω rø o o o o w w rø rø o o o o w rø rø PS.
ro ω or ? £ ct ør o <? - H? -L. ffl £ r ro Ww £ rø ro ffl 21 £ rø
3 3 ro 2? £ rø r £ f £
3 ct ω fl
3 t rø r
3 ro 2 £ ø
3 ro 2? £ ø fl
3 3 -i ffl o 2f? I
3 r
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
*• -. o τι o TJ o TJ o TJ oJ o o o TJ ro -? -? ro --3 --3 33 S3 3J S3 S3 S! Q Q Ω Ω Ω Ω Ω
Figure imgf000089_0003
o rø ro rø ω o o o o rø rø rø ω o o o o rø rø w rø o o o o ω ω rø rø o o o o ω rø rø |*3
§- ro 3 - <-->3 £ §' ro --3 S £ ro ro 2, !| ro 3 ro-ι 3 -> 3 -I
Figure imgf000089_0004
rø o o o o w rø rø w o o o o o o o o rø rø ω rø o o o o rø w rø ω o o o o rø w ω |*3
ω ro 2? £t ω ro rø w w tn w ro 21 ω ro 5 rø
3 ro 2- rø ro m c £t 3 ω ro r fflV 3.
3 -i 3 ι
w rø rø rø rø rø rø ro rø rø rø rø w rø rø rø rø rø rø rø rø rø rø ro rø w rø rø w rø rø rø o o o -t
rø rø rø rø rø rø w ω o o o o o o o o ffl ro ro TJ
Figure imgf000090_0002
Figure imgf000090_0001
ro w rø rø o o o o rø rø w rø o o o o ω rø ω rø o o o o w w rø rø o o o o o o o |*3 I Ch
~. t. s rø r i røV £ ro ro ffl £ røώ oroA-? £ ώ ro 21 ^ rø ro 2- ^ rø ro 21 l» rø J ffl £ ra ro
3 o r
3 -! 3 -1 rø ro -? ct « » rø rto
ro ro ro ro ro ro w ro ro ro ro ro ro ro ro ro w ro ro ro ro ro ro ro ro ro ro ro ro
ω rø rø rø W rø rø rø O O O O O O O O τj τj τj τj ro τj τj τj O O O
Figure imgf000090_0003
rø ro ω ro o o o o ω rø rø rø o o o o rø ω rø rø o o o o w ω w ω o o o o o o o |*3
ώ 3 roH? 2rt1 §tt* rø^ τ-rj rø^ |r' Wc ro-, rø'^ SCD røc ro-? 2rt, ^c røc ro-^ ^1 ct' We ro- " c c -^ -* tf 3 H -ri rt- ft - -^ ','
o o o o o o o o w w rø ro rø ω rø rø w rø rø w rø w rø rø w rø rø
O O O O O O O θ H-j ι-rj Tj τj τj τj n τj
LO LO l-O LO LO LO LO LO ω rø ω
Figure imgf000090_0004
o o o o ω rø w w rø ω rø ω o o o o ω rø ω rø o o o o rø rø rø ω o o o o ω w ω i*3
rø ro rø ro tn
3 -I 2? f^ ff ro 2 in1 ro 3 ro -> 2? rø
3 ro 2- ra o 21 rø ro ϋ wJ £ I?,
3 r 3 o o o o o o o o o o o o o o o o o o o o o o o o o o o o iro
HH r^* ^ HH HH HH HH HH HH HH HH HH HH ffi HH 1-H HH r^ HH 1-H HH H-4 HH H HH HH HH HH * * *3 tn
ω rø ω ω o o o o o o o θ τj ro ro τj Tj ffl 33 33 33 33 33 3J S3 33 I c i"
Figure imgf000091_0001
O O O O rø W rø rø o o o o rø rø rø rø o o o o ω ω rø ω o o o o |*3
ω ro 2? £ ro ro 1 w4J ro or ro sij ω ts rø ro i roi? £ ts £ IS
3 3 rø ro £ to
3 3 3 3 21 fl
3 rø f
3 rø ro ffl
Figure imgf000092_0001
rø rø rø rø o o o o w rø w rø o o o o w rø rø ω o o o o ω rø ro rø o o o o w rø w rø |*3
I o Os
Figure imgf000092_0002
|ctAi?ϊt-
- - - - - - ^ - - - - ^ - - - - O O O O O O O O O O O O O O O O O O O O 'ro *3
O O O O O O O O O O O O O O O O ^ ji3 3j 33 K 33 33 33 33 S3 33 33 33 33 33 33 33 33 S3 33 t:- tn
P
Ω Ω Ω Ω Ω Ω Ω Ω S3 33 33 33 33 33 33 33 ffl ro Q Q Q Q Q Q o o o o 'iro
o o o o rø ω ω ω o o o o ω w ω ω rø rø ω rø o o o o rø ω ω rø o o o o rø ω rø rø |*3
rø ro S W £ rø ro M 2? £ !-? ffl rø i rofl W -, rø- row B ro -, ώ * 5 § ffl iτi S ? ffl ifl W S ffl w W l B rø w ro W ro S R,
3 -1 3 -• 3 -ι
Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 33 S3 S3 S! 33 S3 33 33 33 33 3; S3 S3 S3 33 S3 33 3; 3; 3! pl
Ω Ω Ω Ω Ω Ω Ω Ω ro ro τj τj τj τj τ] ro 33 3; 33 33 33 33 33 3; O θ 2.
Figure imgf000092_0003
o o o o w rø rø ω o o o o w rø rø rø rø rø rø rø o o o o rø ω rø rø o o o o rø rø w w |*3
Figure imgf000093_0001
ro rø ω rø o o o o o o o o o o o o
ω -i ro >-, rø H, rø -t ro ro ro ffl - o-- o-- o-- ro ffl ffl ro
Figure imgf000093_0002
o o o o o o o o o o o o rø rø M rø O o o o ro rø rø rø o o o o rø rø w rø O i — O — O — O , — 1 I*C3Λ
w ffl rø ω ω ro rø ffl ft Zr ro tn rø ro w £* ro ro S ffl ro ro 2? rø m £ ώ ζ rø § |*3.
3 "I C 3 3 -i C 3 -I
rø ω ør ro o o o o
— ro —ro f —fl —ro Q ,-, ,-, o,-, ,-,
Figure imgf000093_0003
o o o o o o o o rø rø rø rø o o o o rø w rø rø o o o o ω ω ω rø o o o o rø rø rø w |*3
W ro W : rø ro 21 |; rø ro l ^ rø ro w S rø ro - w? ^ £ ro ro 2? i' rø ^ 2? ^ rø ro S ^ rø ro w' s £ i P?L.
ω ω rø ra ω
Q O O O ro
Figure imgf000093_0004
o o o o rø ω rø rø o o o o o o o o rø rø ω w o o o o w rø w w o o o o rø rø ro ω |*3
rø ro m rø ro 2 m1 rø ro 21 ro ro 21 rø ro 2? rø ro w rø ro 2 m? 1*3
3 -i I tt-o
w ts w w ts rø w rø rø ro rø w rø ro rø rø rø rø rø rø w rø rø rø rø w rø w
Figure imgf000094_0001
O O O O O O O O ro TJ ro TJ ro rø rø rø rø
Il cr ito
W rø rø W O O O rø rø rø rø o o o o ro rø w rø o o o o rø rø w rø HI
Figure imgf000094_0002
rø ro ro ffl m ro z_τ ro 2- £ ft? rø r rø o t 2n - r rø ro ro 5 m? r ro 2 m- rø ro m rø ro 21 |*3
3 ø I t
w rø rø w rø rø rø rø rø ro rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø _ *3 Ln
IS rø ts ro rø w rø rø rø O — O — O — O — O — O — O — O — τj τj ffl ffl P Il σ*" itiτoj
rø rø ω ω o o o o w rø w rø o o o o rø rø rø rø o o o o rø rø ro w |*3
S ro 1 ; rø ro 21 w ro 21 S rø 3 ro -I ) ? ω 3 ro "i , ^ ω 3 ro -I 1 <? w 3 ro -Ϊ 21 | |?S
rø rø ro rø rø w rø rø rø rø rø w
Q Q Q Q
Figure imgf000094_0003
rø ts ro rø o o o o rø rø rø rø o o o o rø rø rø rø o o o o rø rø rø rø |*3
Figure imgf000095_0001
33 H -H -H H -H -H -H p-! o Q Q ϋ U υ U ffl ffl ffl m
ro ro ro ro ro r r ro r co ro ro co co co co ro ro ro ro ro H-l HH Hr -]H -lH HH HH --H HH -H -ζ -M --H HH -H -C --H -"H pH --H -lH αo
Figure imgf000095_0002
u u u u u o u u u o υ u υ υ u u u o u υ u o CQ g -q ro ffl
Figure imgf000095_0003
Figure imgf000096_0001
o o o o o o o o o o - - - Ω Ω Ω
Figure imgf000096_0002
o rø rø ω rø o o o o rø ω ω rø o o o o ro w rø rø o o o o rø rø rø W o o o o rø rø rø 1*3
I Ch
rø ro « rø ro rø £ ω r £ 2> rø ro tn rø r tn r w rø ro 2? |*3
3 -I m o
3 -i rø ro m LO
C -I 3 ro -i 21 ø ω o
3 ->
Q Q Q Q π o Q n Q o n n o n o o g S S a S 3 S S S S a S S S S S S S S P. ro tn
ffl Ω Ω Ω Ω Ω Ω Ω Ω S3 S3 S3 S3 33 33 53 33 ro ro ro ro ro ro ro ro '- '- '- " -H -H -H -- θ O θ - l-i r- itfflo
rø o o o o rø rø rø rø o o o o rø rø rø rø rø rø rø rø o o o o rø w rø rø o o o o rø w rø |*3
Figure imgf000096_0003
3 -I 3 -I 3 -I
o o o o o o o o i π π π
Ω — Ω —
Figure imgf000096_0004
H rø| -o— -o— —o o— HrøH røHt HrøI HwH o— o— oH-. oH- røHH Hrøf HrøH ωHt røHH Hωf ωH| røHt o— o— o— o-Hi Hrø| rø-H wH| røH| o— oH-l o-_i o-Hi ωH| rø-H ω-| ||*{3J,
ts ro t t 2nn? rø ro t ron ro rø ro ro m ø rø ro rø ø ffl £ r
3 3 W ro 2? r
3 ro 21 3 -ι t r rø
3 ro -5 3 ro w ø
3 ro 2 w? 1^
ω ω ro rø ts o o o o o o o o o o o
ω ω ts rø w ro ro ro o o o o ro
Figure imgf000097_0001
w o o o o o o o o o o o o ro w ω rø o o o o ω ω rø ω o o o o rø rø rø w o o o |-L
Sϊ ώ rø ^J Wrø ^ ^ όrø w ro jj rø ro « : rø ro 21 ^ rø 3 ro "-i 2? ; W ro 21 : rø 3 ro -i 2? : rø δ ^ ? ro 3 - "- 5 l;;S
Figure imgf000097_0002
rø o o o o o o o o rø w rø rø o o o o w rø ω ω o o o o ω rø rø rø o o o o rø rø rø |*3
- 3? rø -i ^ rø ro 21 ;? rø 3 ro -i 2? ϊ? ώ ro 21 : rø 3 ro -i 3 ΉJ
Figure imgf000097_0003
rø o o o o rø rø rø rø o o o o o o o o ω rø ω rø o o o o rø rø rø rø o o o o w ω rø |*3
w ro -3 rø ro ro tn rø tn ffl m rn rø z_ ro ___• 2 ro? rø ro 2 tn? rø ro 2 ffl- 1*3 ft -H LO
3 -i rø rø rø w rø rø rø rø rø w w rø rø rø rø w w rø rø w rø w w rø rø rø rø
O O O O O O O O n ro ro ro ro ro ro ro W W rø
Figure imgf000098_0001
cfer
ts ts w ts o o o o rø ro rø rø o o o o » rø rø rø o o o o rø w w 1 I* O3s
ts £ ro ro -iJ rø W ro tn ffl ro 2? rø ro t ϋn.
3 t ts
3 3 s -ι 3 3 » -? w PS,
rø rø rø rø rø rø w w rø w rø w rø w rø rø rø rø rø rø rø ro rø rø rø rø rø
rø rø rø rø Ht rø Ht ω HH ω rø HH -H - - - --, -H -H θ o o o o o o o τj ffl ffl
Figure imgf000098_0002
rø rø rø rø o o o o rø rø w rø o o o o rø rø rø rø o o o o w rø rø |*3
rø ro S
G -I rø £ ffl ώ roro ffl21 £^ rø ro 2, ^ rø ro r ffl |*3
3 H^ ^ t c -ϊ" co c ø ω c ro -? S -*- ^ rt rø c ro H-H 2-^? >c^t rø ro ^ 2 -l ' t
ro rø rø rø rø rø rø rø rø rø rø rø
tO LQ LQO LQO
Figure imgf000098_0003
rø ω ω ω o o o o rø rø rø w o o o o rø rø w rø o o o o rø rø w |*3
cj CJ ffl eQ
J CJ
Figure imgf000099_0001
S 'S
Figure imgf000099_0002
^ --3 33 θ CJ CQ m 53 X cj CJ CQ eQ 53 53 cj CJ m ffl S3 3l Q CJ cQ eQ
U 2 CJ S U 2 CJ 2 CJ 2 Q S U S C-J S CJ
^ ^ ^ ^ ^ ω w w w w w S S S S
Figure imgf000099_0003
rø ro rø w TI £ ør J flf £ rø TJ m £ rø TJ ffl £ ,
T) lf ffl β -i 3 3 3 r rt rø f £ rt rø TJ £
3 3 3 c
O O O O o O O o O O o o O o o o o o o o O o o o o o
33 33 33 33 53 33 33 33 S3 33 33 33 33 33 S3 33 33 33 33 33 33 33 S3 33
-o to to t to t to to to to to to to to p 1i co
T j j j 33 S! 33 S3 33 S3 S3 S3 33 33 S3 33 S3 33 33 33 S3 33 S3 S3 33 S3 S3 S3
1 PI cr o o n o o rø rø rø rø rø rø rø rø O O o O o O o ffl fl O |*3
Figure imgf000100_0001
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o [ 1 co rø rø rø rø rø ts rø ω rø rø ω rø
Figure imgf000100_0002
Figure imgf000100_0003
o rø rø rø w o o o o w rø rø rø O O O o ω ω rø ω o o O o ω rø rø ω |*3 1 Os
R3 R4a R4b R5 R6 R3 R4a R4b R5 R6 R3 R4a R4b R5 R6
Et CH3 F CF3 Br Et CH3 Cl CF3 Br Et Cl Br Cl
/-Pr CH3 F CF3 Br /-Pr CF_3 Cl CF3 Br /-Pr Cl Br Cl t-Bu CH3 F CF3 Br t-Bu CH3 Cl CF3 Br t-Bu Cl Br Cl
Me CH3 F Cl Cl Me CH3 Cl Cl Cl Me Cl Br Br
Et CH3 F Cl Cl Et CH3 Cl Cl Cl Et Cl Br Br
/-Pr CH3 F Cl Cl /-Pr CH3 Cl Cl Cl /-Pr Cl Br Br t-Bu CH3 F Cl Cl t-Bu CH3 Cl Cl Cl t-Bu Cl Br Br
Me CH3 F Cl Br Me CH3 Cl Cl Br Me Cl CF3 CF3 Cl
Et CH3 F Cl Br Et CH3 Cl Cl Br Et Cl CF3 CF3 Cl
/'-Pr CH3 F Cl Br -Pr CH3 Cl Cl Br /-Pr Cl CF3 CF3 Cl r-Bu CH3 F Cl Br t-Bu CH3 Cl Cl Br t-Bu Cl CF3 CF3 Cl
Me CH3 F Br Cl Me CH3 Cl Br Cl Me Cl CF3 CF3 Br
Et CH3 F Br Cl Et CH3 Cl Br Cl Et Cl CF3 CF3 Br
/-Pr CH3 F Br Cl /-Pr CH3 Cl Br Cl /-Pr Cl CF3 CF3 Br t-Bu CH3 F Br Cl t-Bu CH3 Cl Br Cl t-Bu Cl CF3 CF3 Br
Me CH3 F Br Br Me CH3 Cl Br Br Me Cl CF3 Cl Cl
Et CH3 F Br Br Et CH3 Cl Br Br Et Cl CF3 Cl Cl
/-Pr CH3 F Br Br /-Pr CH3 Cl Br Br /-Pr Cl CF3 Cl Cl r-Bu CH3 F Br Br t-Bu CH3 Cl Br Br t-Bu Cl CF3 Cl Cl
Me CH3 Br CF3 Cl Me Cl F CF3 Cl Me Cl CF3 Cl Br
Et CH3 Br CF3 Cl Et Cl F CF3 Cl Et Cl CF3 Cl Br -Pr CH3 Br CF3 Cl /-Pr Cl F CF3 Cl -Pr Cl CF3 Cl Br
/-Bu CH3 Br CF3 Cl t-Bu Cl F CF3 Cl /-Bu Cl CF3 Cl Br
Me CH3 Br CF3 Br Me Cl F CF3 Br Me Cl CF3 Br Cl
Et CH3 Br CF3 Br Et Cl F CF3 Br Et Cl CF3 Br Cl
/-Pr CH3 Br CF3 Br /-Pr Cl F CF3 Br /-Pr Cl CF3 Br Cl t-Bu CH3 Br CF3 Br t-Bu Cl F CF3 Br /-Bu Cl CF3 Br Cl
Me CH3 Br Cl Cl Me Cl F Cl Cl Me Cl CF3 Br Br
Et CH3 Br Cl Cl Et Cl F Cl Cl Et Cl CF3 Br Br
/-Pr CH3 Br Cl Cl /-Pr Cl F Cl Cl /-Pr Cl CF3 Br Br t-Bu CH3 Br Cl Cl t-Bu Cl F Cl Cl .-Bu Cl CF3 Br Br
Me CH3 Br Cl Br Me Cl F Cl Br n-Pτ Cl Cl Cl Cl
Et CH3 Br Cl Br Et Cl F Cl Br ti-Bu Cl Cl Cl Cl
/-Pr CH3 Br Cl Br -Pr Cl F Cl Br s-Bu Cl Cl Cl Cl
/-Bu CH3 Br Cl Br t-Bu Cl F Cl Br /-Bu Cl Cl Cl Cl
Me CH3 Br Br Cl Me Cl F Br Cl Me Br F CF3 Cl
Et CH3 Br Br Cl Et Cl F Br Cl Et Br F CF3 Cl --i ffl £ ro ro ? S ώ ro -3
O O O O O O O O O O
►--C ffi K ffi ffi ffi ffi ffi ffi ffi
LO LO ' J LO LO LO LO LO LO LO
Figure imgf000102_0001
Q Q Q o o o o ; : _ M, , » rø rø w rø w fl
Q Q Q Q Q Q Q ω rø w rø rø rø rø rø Q o o o o o o o Q Q ffl ffl ffl ffl ffl Q ro ω w rø ω rø iro
LO LO LO LO LO LO LO ^ ^ ^ ^ ^ ** ^ ^ ~ ~ ~ -^ ~ ~ ~ ~ LO LO t tO LO LO ^ ^ ^ ^ -I I LΛ rø ω w o o o o rø w rø rø o o o o ω ω rø w o o o o rø rø ω rø o o o o ω rø rø ω o o |*3
ro 2J ^ ct ώ __ ro 2? !'c ro -y ^rø c' grø' H.jr' Ηrø- £ct ώ c -roϊ' rø-'- 2fD rø ro rø S ro ro -r " ft -? "" CO ___ c H- i O rø rø ω w rø ω w rø ω rø rø ω ω rø ω o o o o o o o o o o o o o o o o o o o o o o l
Figure imgf000102_0002
Ω Ω Ω Ω Ω Ω Ω ro Q Q Q Q Q Q Q θ o o o o o o Q Q Q Q Q Q Q Q ω rø ω ω rø w |*3
rø rø rø o o o o rø rø ω w o o o o ω ω rø ω o o o o ω rø rø rø o o o o rø rø rø rø o o |*3
ro HH -^S ^ft rø Ϊ -H rt1 ic- rø c ro πT ^? ^t rø c ro -y 2 <-*J• ^ o> ώ j- ro H-r rø^ St rø g' ro-^ 2'-^1 -rtl' ώ c Ϊ H- 2Η-? rt> rø g* ro -y 2ϊ o' rø c H-r ^ ft g' -y i '-o rø rø rø rø ro rø w rø rø rø rø rø ro rø rø rø rø rø rø rø rø rø rø rø rø rø rø w rø rø w rø rø rø w rø rø Pi
Figure imgf000102_0003
Figure imgf000102_0004
Ω ^ Ω Ω Ω Ω Ω ro ro ro ro ro ro ro Q rø rø w rø w rø rø rø o o o o o o o o Q Q Q Q Q Q iro
rø ts ω o o o o w rø rø rø o o o o rø rø rø rø o o o o rø rø rø rø o o o o ω rø ω rø o o |*3
ro HH O
Figure imgf000103_0001
Q Q Q Q Q Q Q rø rø ω ω rø rø rø rø o o o rø rø rø ro ω rø rø ω o o o o o o o o Q 1*3
I LΛ ro rø ts o o o o rø rø rø rø o o o o o o o o rø ω ω rø o o o o ω ω ω ω o o o o ω |*3 I s
- H? ffl ~ £ ro ^ ro H? w ~ S rt ro ^ ro-? S^ Sf ro ^ ro -? ~| S 1* rt ro -? m ~ - fl^) ro £- roH? 2~| 2Ct ro ft ro g' ro-? S^ 20) ro ^ roTJ SHH ^O, W W ro ^ S -, S „ ro W t3o o o o rø rø ør rø rø rø rø rø rø rø w rø rø rø rø rø rø rø w rø rø w rø rø rø rø w rø rø w w rø w |*3 I -o
— HH — o o o o o o o o
-T Hr H? M -^ -^ --ι - - M -| -, --' --l w " --| " M M M " --l " --' " " ro ro ro ro ro ffl ffl ro ro
"- "- "- tO to tO LO LO LO LO LO LO P IIr o o o o rø ω rø rø rø ω rø ω o o o o o o o o Q Q Q Q Q Q Q Q ω w rø rø rø rø ω rø o |*3 I tr, o o o rø rø rø rø o o o o rø rø ω w o o o o rø rø rø rø o o o o ω rø rø rø o o o o w 1*3 I 5h ώ ώ ώ ro 21 ^ rø ro 21 ' rø ro 2- ^ rø ro , ^ rø ro 1 > rø ro 2? ^ rø ro 2- ' ro ro 1 ^ ro 1*3 I to o o rø rø rø rø rø w rø w rø rø rø rø rø rø rø rø rø rø rø rø w rø rø rø rø rø rø rø rø rø rø rø ts II rø rø rø ro ts w rø w rø rø w rø rø rø w ts rø rø rø rø rø rø rø rø rø rø o o o o o o o o o
I rt cr o Q rø rø w rø rø w rø rø o o o o o o o o Q Q Q Q Q Q Q Q w ro ro ro ro rø rø ro o |*3
I fl o rø rø rø rø rø o o o o rø w rø rø o o o o rø rø rø rø o o o o rø rø w rø o o o o rø |*3
I o,
Figure imgf000104_0001
o o o o o o o o o o o o O O O O o o o o o o O O o o o O o ffi UZ K K K ffi 33 S3 33 33 33 33 53 33 53 S3 53 S3 53 53 o to PI τj ffl ffl τ] τj --3 --3 --3 33 33 33 33 33 33 33 33 33 33 33 53 33 33 33 S3 33 S3 33 S3 S3 P II cr
Figure imgf000104_0002
o o o o o o o o o o o o o O o O o o O O O o o o o O O O O
Figure imgf000104_0003
rø rø ts ts rø |*3
X 33 33 53 53 33 33 33 33 53 33 X 53 S3 33 33 33 33 33 S3 S3 33 33 33
1 cr
Figure imgf000104_0004
o rø rø rø rø o O O ro rø ffl ω o o o o rø rø rø rø o o o o ω ω rø rø |*3
ffl rø ro 2? rø tn rø ro rømrø
3 -i 3 ro-i 2? rø ro wffl £ rø tn o ϋfflJ o > |*3 I
3 -i ir rø r w 3 ro-i 2? W r LO o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
Figure imgf000105_0001
o o o o o o o o o o o o o o o o o o Tj ffl TJ ro ro ffl ffl ffl TJ
Figure imgf000105_0002
Figure imgf000105_0003
o o rø rø w w o o o o rø rø rø rø o o o O rø W w rø o o o o rø rø rø rø o o o o rø rø rø 1*3 I Os ffl rø ffl £t rø ro W £
3 r t rø
3 r 21 ' W ro 21 ^ ro ro t-? S w ro ) ^ W ro w S ro ^ 2, ' W ro w 1 I* t3o rø rø rø rø rø rø O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O
IIo rø ts ts ω ro ro rø rø rø rø rø rø rø ω rø w rø rø o o o o o o o o o o o o o o o o o o o I f cr
4-
-? -? -? -? -? -? Ω Ω ° Ω ffl ffl ffl ffl ffl ffl ro ro ;ω --u uω -r ω ~ rø H, rø H, ω HH HωH ω H, o — o — o — o — o — o — o — o — ΩI ΩJ JΩI 1*3 I i-n w rø o o o o o o o o w rø rø rø o o o o rø w rø rø o o o o ω rø rø rø o o o o rø rø ω |*3 I os ffl £ ro ro rø ^ ώ ro 2? ^ rø ro 2) ^ rø ro 21 ^ rø ro rø |' ώ ro w S rt rø ^ S l rø J -S ^ rø ro rø |*3
I LO
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O PI
Figure imgf000105_0004
Figure imgf000105_0005
rø rø o o o o rø ω ro ro o o o o ω ω rø rø o o o o ω rø rø w o o o o ω rø rø w o o o
Figure imgf000105_0006
or 21
Figure imgf000106_0001
o o o o o o o o o O O O O o o o o o o o o o o o o o o o o o o o o o o o o
33 53 53 53 S3 S3 33 F
IS rø rø rø rø rø rø rø ts rø w rø ts rø rø w rø rø rø rø rø rø rø W O O O o o o p I cr
0 0 0 0 0 0 0 — — rø rø rø W w ts o o o o o o o o o O O O ffl ro o O
TJ ro TJ Tj ffl Tj w ts ts t rø rø 1*3
LO to to to to to LO |-t I tn ω ts rø o o o o rø rø ro ro o o o o rø rø rø rø o o o o rø ro rø rø o o o o w ts rø w o o 1*3 I Ch ro ra ro rø ffl £ rø rø rø ro tn o m rø ø
3 3 3 -■ rø ro 2* £ f rø r β -ι 3 ro S rø ro tn r r |
3 3 ro 2- ω *3
3 o -i I to rø rø rø rø ts rø w ts rø rø rø rø rø ts rø rø w rø w rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø W rø W
Figure imgf000106_0002
oro oro oro o o o 3
Figure imgf000106_0003
^ ^ O O O O O O O O Q Q Q TJ TJ TJ TJ TJ TJ TJ TJ ffl O CO -? H? H? H? H? Ω Ω Ω Ω Ω ° Ω Ω ro ro τ] Q τ τj τl Q rø ω 1*3
o o o ω rø rø ω o o o o rø rø w rø o o o o rø rø rø rø o o o o w rø rø rø o o o o rø w |*3 I Ch
-.. -. -- -- ro ϋ rø £ ts ro -5 £ rø ro t mn £ ts ro 2? % § § § $ ® % § % ® % § i? ® % § t? & % V ffl ffl ffl CO CO CO ffl ffl CO CO ffl ffl ffl ffl -? Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 1 - cfeo-
Tj j j j j Tj j j Tj j j j j Tj ^ oi rh2 Qi ni roI Oτι Oro τOj Oro Offl fO O 1*3 ffl L fl ffl Offl roO Oro Oro Oτj Oτj Offl OTj Oτi Offl 1 cfer-
Figure imgf000106_0004
rø ts ts o o o o rø rø rø rø o o o o o o o o rø ω rø rø o o o o w ω rø rø o o o o rø rø |*3
1 Ch
ro tn
Figure imgf000107_0001
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o fe fe fe fe fe fe fe fe fe 33 53 fe UZ fe fe fe fe fe fe fe fe fe fe fe l-O to fe fe fe fe fe fe fe fe fe fe fe fe P
Figure imgf000107_0002
ω ts rø o o o o o o o o o TJ o TJ o TJ o TJ o TJ o n o TJ o ro rø rø rø rø rø ro rø ω o o o o o o o o Ω 1*3 I rø ro rø rø rø rø rø o o o o w rø ω rø o o o o ω rø ω rø o o o o rø rø ω rø o o o o ω |*3 I CΛ
Figure imgf000107_0003
O O O O O O O fe fe fe fe fe fe fe rø rø ffl rø ro w ro w rø w rø ts rø ts rø cd rø ro rø ts rø rø rø ro rø ro rø rø w |*3 I • Pfe-
Figure imgf000107_0004
o o o rø rø ω rø o o o o o o o o o o o ro o TJ o o o ro o TJ ts. CO ffl CO CO CO ffl ffl O O O |*3
I tn o o O o o o o ts rø rø rø Ω Ω Ω Ω H? H? H? H? Ω Ω Ω Ω !-? ω ω ω o o o o rø rø rø rø o 1*3 I Ch ώ rø rø TI m £ ts ffl ffl £ o ro rø ro ? & ro r ro w
3 r o ro 2 S rø ro w S* t ω- ø ro ffl? £ 0 rø ro w £ rø |*3
3 3 ro 21 1 r I to
3 o o
53 S3 rø rø w rø w rø rø CO ro w ro rø rø ts rø ts rø ro rø rø ts rø ro rø w rø rø w rø w rø rø w PI o Q o o o o Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω rø rø ffl ffl rø ffl Tj Tj Tj
Figure imgf000107_0005
o rø rø ts rø rø H roH Hrø, t Hs, rø H, o - o — o — o — o _ o — o _ o - JΩl JQJ ΩTI QTI ΩJ Q jΩJ
Figure imgf000107_0006
o rø rø ro rø rø o n o o ffl co ffl ffl o n o o ffl co co ffl o n n o td ffl ffl co o o o o oo Pi
I Ch
Figure imgf000108_0001
CJ ffl eQ
υ _s o
Figure imgf000109_0001
Figure imgf000109_0002
ω ro 21 rø o ? rø rø f |*3
3 r 3 ro 21 ffl
3 rt ffl r ffl £ f 3 ro 2* ø l
3 ro 21 I to
3 o 33 o33 offi offi oHH oHH o--H oK offi o-- o-H oHH ofif o- oK oK o-H o--H oW o- oK oH oK o-]H o- oH o-C o-M PI *3 tn
Figure imgf000110_0001
o o o o rø w ω rø o o o o rø ω rø rø o o o o ω rø ω rø o o o o |*3
rø ro 2 ffl1 ro ro W ro J 2 m1 rø rø w T) ω ro ro 21 rø W Ht c rø r s tt-nnv ro ro i wϋ £ |*3
3 ~ r ts ffl
3 o 3 I LO
- - _ ,-, - _ ,_ _ - Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω
O O O O TJ TJ ro
Figure imgf000111_0001
o o o o rø ω rø rø o o o o o o o o rø ro rø w o o o o rø rø ω rø o o o o ω rø rø ts |*3 I Os
rø r ts ro 21 ro r 21 rø r ro w rø ro - ffliJ rø ? |*3
3 o 21 3 3 o 3 ro 21 rt ø o y m. r
3 3 3 r ø T. ffl ro ro 2
3 "« 3 I LO
Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 33 33 S3 33 33 33 53 53 5H 53 33 33 33 33 53 33 33 S3 S3 S3
O O O O O O O O τj τj τj τj τj ro τj ffl Q Q τ τι Q τj τι Q ω HH ro -I w HI rø _
Figure imgf000111_0002
o o o o rø w w rø o o o o rø rø rø rø rø w rø rø o o o o rø rø rø rø o o o o rø w rø rø |*3
ώ ro rø ^ rø ro rø ^ ro j rø ^ rø τj rø S rø τj rø S rø j rø 2 rø 21 S
o n n n o n o o n n o o o n n o o o o o i^ *3 Ln
Ω Ω Q Ω Q Ω Q Ω Ω Ω Ω Ω Ω Q Ω Ω ffi ffi HH H^ Iro
Ito
H -H3 ---3 EHH H-H3 ffiHH —X - HH3 —-3 Oifl iOj Oi7i O>ιi Oiτ) Oiτi 'O7j ιOι « H H H ιro O
HH rø W rø rø j-. 53 ffl Ito o o o o rø rø rø rø o o o o rø ω ro ω rø rø rø rø o o o o ω rø rø rø o o o o rø rø rø w |*3
Figure imgf000112_0001
rø rø rø rø o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o rl 1* L3n
Tj Tj _J oTJ oTJ oTj oTJ oTj oj oTj oj t to t to to LO tO LO rø rø rø W W rø rø rø 33 33 33 33 33 33 3; 33 Ito
o o o o o o o o rø ω rø w o o o o rø rø ω rø o o o o ω rø rø rø o o o o ω rø ω rø l*!
δ g rø ώ rø ώ j rø ζ m ώ j w ώ j m ^ ό ώ rø 5? rø ro w w S ts J rø ^ ω ro w £
3 -i rt I 15? w
ro ro rø rø o o
— n —ro —ro —ro ,Q~, ,O--ι
Figure imgf000112_0002
ώ ro rø -? ώ 5 rø S ώ ζ S ' -? ffl H? S rø 3 ro -ι -? 2 ro ro ™ 2 ro 3 -i
*3 rø w ra ω ra ω rø ω rø ro rø rø ω ra w w ω rø ra rø o o o o o o o o o o o o o o o o pl tn
P
Ito ro -^ -J W Ω Ω Ω Ω Ω Ω Ω Ω ro ro ro n ro ro ro Tj Q Q Q Q Q Q Q Q H^ H-H Hfl Hfl H- HrH Hfl H^ I^ o 33
^ LO LO LO LO LO LO LO O I CJ* , Ito rø o o o o w ω rø rø o o o o w rø rø ω o o o o o o o o ω rø rø rø o o o o rø rø rø ω l*3
W TJ w £ ts o 2? rt ro I LO 3 -* 3 r 3 ro » rø
3 ro w rø ro ϋ tnJ rø 3 -* 3 ro 2? rø
3 ro 2? |*3
Figure imgf000113_0001
ts rø ω w o o o o rø w rø rø o o o o rø rø rø rø o o o o rø rø rø rø 1*3 I Os
** *—- •—. ts ffl ω ro tn1 rø ro ro tn rø ro 2 m ffl1 £ rø ro S
3 3 -i 3 -i 2 m1 ^ rø ro 2, ^ rø ro l ^ rt I PS to,
*3 rø w rø w rø M w w rø rø w w rø rø w w rø rø rø rø rø rø rø rø rø rø rø rø |^ tn
O
S3 r: ro rø rø rø rø rø rø rø O O O O O O O τj τj τj T 5. |Q to 1 ° |OJ
ώ '-d rø S ώώβ roζ H-H 2røΉ-l S.' tώ jr> ζ -y w <-••
Figure imgf000113_0002
*3 π π π Ω Q Q π π rø ro rø ω ω ffl rø ω ω ro rø ω rø rø rø w ro rø rø ω l5! tn
P
Ito Iffl
, Q-. ,n-. ,G-. ,ϋ-. , —-. , H---, ,-2, ,Q-, 0τj 0τj 0ro 0ro 0τj 0τj 0τj 0ro ιι ι— ' HH — — — HH rø rø rø W I*. o
33 . Ito ro o o o o ffl rø ω rø rø ω ω rø o o o o ω ω rø ω o o o o rø rø ω ω i*3
Figure imgf000114_0001
o o o o O O O O O O O O O O O O
33 t 3o3 t 3o3 L 3 HH HH t O3 LO tO l-O l-O LO LO l- tO l- l-O l-O l-
ro ts rø w -? Ω Ω Ω Ω Ω Ω Ω Ω ro ro τj
Figure imgf000114_0002
rø o o o o ω ω rø ω o o o o rø rø ω ω o o o o rø w ω ω o o o o |*3
w rø 2 w $ l w 5 w rø ro -? $ l: ^
o o o o o o o o o o o o *3 tn tOS tOS l-SO tOS tSO LOS l-SO tSO l-SO tOS LSO tSO LSO I-SO l-SO LOS LSO LSO LSO LSO tSO tOS LSO β I B o
33
33 θ —O O — O — τj n ffl ffl ffl ffl ro ro —Q O O θ LOQ LOQ LOQ I-OQ LOQ LOQ LOQ LOQ -H - -- -H -H - -H -H ^rø ω ^ rø ^ | |?l ro
-— CJ* Ito
rø o o o o rø rø w rø o o o o o o o o rø w rø ω o o o o rø rø rø rø o o o o rø ω ω |*3
S t ζ rø £ t ζ 21 ^ rø τj rø 2 ro τ 2' £ rø τj rø S rø τj rø 2 rø τj rø ^ rø τ^
Ω Ω Ω Ω
S3 Ω Ω
Figure imgf000115_0001
w o o o o rø rø rø rø o o o o rø w rø rø w w rø ω o o o o rø rø rø rø o o o o rø w rø |*3
S CD 3ro ^-? rø--*- Srt ro g- τ -?j S £ O ro -y τ-y w-H- Srt ^ro ro -? 2 ~? S rt ro 3 τ-? ^Η* 2rt ^ro τj ~| £ rt ώ g^ ro -? rø -* S CD cro τ -? -w• S CD ro ^ τ-?j 2"-1 |l'r?t,
Figure imgf000115_0002
ω o o o o rø ω rø rø o o o o rø rø ω rø rø w rø ω o o o o w rø ω rø o o o o ω ω w |*3
rø ro 2 tn? ffl ro 2? rø ts t ø
3 3 SI r wi ts tn
3 ω ro m ω TJ m £ rø
3 -* 3 -I 3 3 ro 21 r
3 ro 21 |*3 I to
ω rø rø w ω o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o P *3
II tn
O
— — — — — O O O O O O O O ι n ffl ffl ffl Tj Tj Tj '-rj Tj '-ri Tj Tj Tj rø rø W rø rø ro rø W τj i ; ' !n 3 3' f3 σ* Itofl
w o o o o o o o o ω w rø rø o o o o rø rø rø rø o o o o rø w rø w o o o o rø rø rø |*3
S rø ζ w £ ro rø ro τ rø ro rø ^ ώ ro rø ^ ώ ro w 2 ώ τ rø S ro τ rø S ώ τj
Figure imgf000116_0001
w o o o o o o o o ω rø rø rø o o o o ω ω ω rø o o o o rø ω ω rø o o o o ω rø rø |*3
2D t cs τ H?j rø -^ S to rø c τ -irj rø - 2t ώ £ τ H?j rø " 2t ro ^ τ-yj 2-H?- £a. rø ^ τ-?j rø-H- Srt ro g' τ-y. -H-| Srt ro c τ -? *? £ ni ώ ^ ro -? «rø £» ώ g* -y « ι w
ts rø rø ro ro w rø rø rø rø w rø rø ør rø rø ør ts w w rø
ro -? -? -? -? Ω Ω Ω Ω Ω Ω Ω ffl ffl ffl ro ffl ffl ffl ffl
Figure imgf000116_0002
rø o o o o rø w rø rø o o o o rø rø ro rø o o o o o o o o rø rø rø w o o o o w HI roHI røHH lIffl O.
rø ffl rø ro 21 rø ro 2 ffl1 rø ro w £ ro T ww ffl ro ff ffl ffl ro 2 tn? |*3
3 -i I to
ro w rø rø w w w rø w ro rø rø ro rø rø ffl rø rø w ro rø w ro rø rø rø rø 1*3 *3
V, o w ro rø rø W rø rø ω o o o o o o 1 33 o o -rj Tj Tj * -3fe f *- [tfl σ o
ts rø rø ε? Ω o o rø rø ro rø o o o o rø rø ts rø o o o o rø w rø 1*3
I o,
Figure imgf000117_0001
'*3 rø rø rø rø rø w rø rø w rø rø rø rø rø rø rø rø rø w rø rø rø rø rø w rø rø *j?c. ι-n
P 53 Ito rø ro ro ffl ts ts ts ts o o o o o o o o Tj Tj Tj 1* *3 t *•
ro rø ts rø o o o o rø rø ω w o o o o ω rø ro ts o o o o ω rø rø |*3
ώ 3 ro -, rø ^ rt rø j- ro -*f/ <-*) ^ <π> ώ c ro HH 2^1 rt' rø c ro -H 2rt? rt' crø ro -y 2 •"■■? C.« rø JJ ro H* W o' ώ c ro 2l lJS-
1*3 o o o o o o o o w rø w rø rø rø rø rø rø rø rø w rø rø w rø w rø w II ι-n
P
Ito Iro o o o o o o o o Q rø rø rø o
LOQ LOQ LQO LOQ LQO LOQ LO LOQ f Il σ* 33 ffl Ito o o o o ro w ω ω ω rø rø ω o o o o ω rø ω rø o o o o ω rø ω |*3
ro w
Figure imgf000118_0001
Figure imgf000118_0002
O O o 33 to S3 to 33
O O
Figure imgf000118_0003
o o o o ro ts rø w o o o o ω ω rø rø o o o o rø rø rø rø o o o o |*3
Figure imgf000119_0001
Figure imgf000119_0002
rø ro rø ts o o o o rø rø rø rø o o o o rø ω rø ω o o o o ω rø w rø o o o o rø ω rø rø 1*3
tS TJ g ffl> rt — ro ro -^ ™ ffl rø ro ffli £ ts ro ϋ ffl' rø ro S ffl
3 -i 3 *-* rø 3 ro ø -ι - ω7 r
3 -i s H - ? ? s pw
_ _ _ ^ Λ - _ ^ Λ _ Λ _ _ - - ^ o o o o o o o o o o o o o o o o o θ ιro *3
Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω S3 53 S3 33 33 S3 33 33 33 33 33 S3 53 33 S3 33 53 33 33 3J H-*- tn
Ω Ω Ω Ω Ω Ω Ω Ω S3 ffi ffi 33 -i3 !-C --3 S3 ro ro ro Q n n Q τj tO tO tO LO LO LO LO to o -* o " o -* o "" p Ii σ- I "tfto
o o o o rø ω rø rø o o o o ω ω ω ω ω ω rø ω o o o o ω ω ω rø o o o o rø rø rø rø |*3
C ro ►τ?j 2 "1■ ^ « rø C ro rø -l § <^1) trø Cs - ffl^ - £^ CD ^ όM τ-?. --3*- ^rt rø g* τ -?j 2 w? ^ C £O rø ^ ro roH? ffl"-l ^rt £ rø c τ ►? rø - m* ^ £t rø C ro - wH-? £^ CO rø c rn τ ► S?j rø « w £ ct V I? to i*3 tn
Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 33 33 33 33 33 33 33 53 S3 33 33 33 33 33 33 33 3; 3; 33 S; pl
P
I ,to rø o
Ω Ω Ω Ω Ω Ω Ω Ω ro τj τj ro ro ro τj τj 33 33 33 33 53 33 33 33 θ O O O ro 33
Ito o o o o rø rø w ω o o o o ω w rø rø rø rø rø ω o o o o rø rø rø rø o o o o ω ω rø rø |*3
ω ro fl o ffl IS ro 2? rø ro w 1*3 I to
3 ? ω
3 ro 2? ω r
3 ro 21 o r 2? ro miJ f r c o 3 ro - 3 ro -? 3 3 3 rø w rø w o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o ,*3 tn
O
33
- i-?' --?' -'-?' --?' ro ro ro ro Q — O — O H- O— j n ro ro rø -' rø-' -rø' rø-' -rø' ro-' -ro' ω-' Lon tQo tQo LQo LQo tQo LQo i-τo 33 53 3 33 | I^ o" Ito ro
o o o o o o o o o o o o w rø rø w o o o o ω rø rø rø o o o o rø w rø rø o o o o |*^
rø ro g ffl? £ rt ro t IS ffl rø r ω o ffl -i.J rø ffl r
3 3 ro ø m r ffl ro ffl -V £ ø
3 3 3 3 3 rt 3 ro « £ rt rø
3 ro 2? |*3 I to
3 3
Figure imgf000120_0001
o o o o o o o o rø rø rø rø o o o o rø ω w rø o o o o ω rø rø w o o o o rø rø rø rø |*3
rø ro rø |* r ro rø £ rø ro ffl £ w ro 21 -! rø ro rø ϊ ro - rø !' rø ro rø
3 -i 21 ø S rt £ 3 -I 3 -I rt I to
Figure imgf000120_0002
o o o o rø rø rø ω o o o o o o o o rø rø rø rø o o o o ω ω rø rø o o o o ω rø rø rø |*3
ro T. tn £ ro TJ t 2n? ts ro 21 ro ro 21 rø rø ro 21 ro TJ w |*3
I LO
ts rø ts ts rø ro rø rø rø rø w rø ts rø rø rø w rø rø rø rø rø rø rø rø ts rø rø
O O O O O O O O τj iτj ffl τj τj τj τj τj tS ffl rø rø
Figure imgf000121_0001
ω rø rø rø o o o o rø w rø rø o o o o rø rø w rø o o o o rø rø w rø 1*3
I Λ
rø ro 21 rø TJ 2 m m? ra rø -zr m ts rø ts rø rø ro 21 rø ro ffl M |*3
3 -i 3 ". 3 I-* I LO
ts ffl ts ts ts ro rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø w rø rø rø rø rø
Figure imgf000121_0002
rø rø ts rø ts ro ts rø O — O — O — O — O — O — O — O — τj Tj ffl τj | I:l σ*
Figure imgf000121_0003
ffl ro rø rø o o o o rø ω rø rø o o o o rø rø ω rø o o o o ω rø ω rø |*3
ro ?T HH^? ffl-*- rt ro ^ τ-pj rø--* Srt ro " τ -yj rø — S o ro ^ τ-? 2Η-| Srt rø "r -? rø-H- Srt ro ϊr τ-pj -| St ro ? τ H?j rø " ^ <»< l i';:',
ro rø rø rø rø rø ts rø ts
ro
Figure imgf000121_0004
ts ω rø rø o o o o rø rø rø rø o o o o rø w w rø o o o o rø w rø rø l*3
Figure imgf000122_0001
Figure imgf000122_0002
HH H^ αo
Figure imgf000122_0003
u u cj u u o u u u o c o O <-> HH -r* 5 u ππ Η 3 ω 3 I- 3 -H 3 W °- m tq °H ffl >g 2 ro CQ *-> — - 3 5 ω PH ffl w ffl m it Di S ω fV °?
~. *» a a -H. rø zr o _ r 21 5? ω ro S rø ro 2 tn1 rø rø rø TJ rø ro 2 ro? ts ro 2 tn1 ffl r ion ffl rø ro 2 tn ra ? rø ro 2 tn? 1*3 to
C S S 3 -i
o o o o o o o o o o o o o
Figure imgf000123_0001
o rø rø rø rø o o o o ro rø w rø o o o o w rø rø rø o o o o rø rø ro w o o o o rø rø ω
Figure imgf000123_0002
rø T) . ffl \ CO TJ 21 S rø ό TJ ffl £ rø 3 ro -ι S ffl £ ro ^ w £ ro - w £ ffl S rø 2 *s ^ rø ? t 3 I. S |':5-
*3
Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 33 33 S3 53 S3 53 S3 33 S! 33 33 33 33 33 33 33 31 S3 53 l tn
P |33 t ro Ω Ω Ω Ω Ω Ω Ω Ω S3 33 33 33 33 33 S3 3-; ro ro ro ro Q τι Q Q p _. _. p-, i rro n |oHfi t I σ* iL
rø o o o o rø rø rø rø o o o o rø rø rø rø ω ω ω rø o o o o rø ω ω ω 'o o o o rø w rø |*3
§■ « 5 w §■ rø TJ ffl £ d rø τj rø -f' rø ro ? l' rø ro rø |' rø ro 2, l' rø ro s ^ S 3 - -S* s ^ -p -s E pS.
Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω
O — O — O — O — O — — O — O —
Figure imgf000123_0003
rø o o o o rø rø rø rø o o o o w rø ω ω rø rø rø rø o o o o rø rø w w o o o o rø ω rø |*3
ts ro 2- ω ro w rø ro 21 £t rø ΓH ro 21 £t W ro 2* ro ro flf rø n o
3 - T HHiJ 2 "* rt £ ro ro 21 ^ r ro ffl 1*3
3 -i 3 -! I to
rø rø rø rø rø o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o 1*3 i o
33 ro ro w CD rø CO rø CO H-j -- --j o o o o TJ Tj f te rø rø rø ts rø rø rø 0 0 0 0 0 0 0 0 - H- HH |*3 τj Tj τj τι τ] τj ffl τι S3 33 33 4-.
LO LO L LO LO LO LO LO | cj* , Ito rø
rø o o o o o o o o o o o o rø rø rø ω o o o o rø rø rø ffl o o o o rø rø rø rø Ω Ω Ω p
Figure imgf000124_0001
w o o o o o o o o w rø rø ω o o o o ω rø rø ω o o o o rø rø rø rø o o o o rø rø ω |*3
ro ro j 2 ra. £ rn W Tj. 2211 ?s, W ro 2' , 2s* ώro τroj rø2! 2s* ώro HroH ffl21 £ l " f c£t ro g H jH -ι 3 -< 3 -i ro or f ? ffl ~ £ r
3 a gt' oH-' '-' Srt ffl g* -r "l il':!w:',
rø ra rø rø ω w rø rø w w w ω ω
Figure imgf000124_0002
rø o o o o rø w rø rø o o o o o o o o w rø ω ω o o o o rø ω w rø o o o o ω ω rø |*3
rø ro 2 ffl? r &n t z ro - ffli.J ffl ffl - ffl5 -ς ffl TJ ffl ffl rø ro ffl? ffl ro 5 w* I? LO.
rø w rø rø w rø rø w rø rø rø rø rø rø w rø rø rø rø w rø rø rø w rø rø *3
-1 rø -I i * g tn
O O O O O O O O n ro ro ro ro ro ro ro ro W ro : Ito
ts ts rø rø o o o o rø rø rø rø o o o o rø ω ω ro O o o O rø ■-i ffl ffl |*3 1 Os
ts TJ w w ro w rø ^ΓJ n rø ro - tniJ ts ffl £ or l £ 3
3 3 3 3 t rø ff
3 ffl ffl 1*
3 1 t
Figure imgf000125_0001
w ro ro ffl o o o o ro ω rø w o o o o w rø ω rø o o o o ω rø ω |*3
rø G ro -H1 ^ ωG ro ™ ^^ røG ro 2? -^F w ro 2? ^ rø ro , ? rø ro l -f' ω ro w P9. ^ G ^ G '-I
*3 rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø Pϊ <-n o It fflo ro Q LQO LQO LQO LOQ tQo tQo w ^ ω ^ w -* -rø* ω rø ω o
LO LO ^ ω -• o p Il CJ* ffl
Ito rø rø ts rø o o o o rø rø rø rø o o o o rø rø rø rø o o o o ω rø ω |*3
£ ct ffl ro ffl £ rø TI ffl £ rø M £ ώ TJ ffl £ ro flf £ T) ffl rt 3 rt £t ro ffl £
3 3 rt 3 3 rt ffl
3 r 3 rt
Figure imgf000126_0001
O O O ro ro O O rø rø ffl rø rø rø ffl rø O O O O O O O O O O O O O O O TJ TJ TJ Tj Tj TJ TJ TJ J 1*3 o to to 1 tn
Figure imgf000126_0002
O o o o O o o O O o o o O o o o o o o O o O o O o o o O f 1l a rø rø ro rø ts rø ffl IS ro ro ffl ffl 1 σ*
Figure imgf000126_0003
o ffl rø TO ts o o O o rø ts rø ør o O O W rø ω rø o o o o ffl ffl ro ts |*3
Figure imgf000127_0001
o o o o O o o o O o o o O o o O o o o o o o o o o o o o o O O O O O O O O 1*3
33 53 S3 33 33 53 S3 S3 33 33 S3 S3 33 33 33 33 33 33 33 33 to to to to to •fe- ffl ro •-i ffl ffl ffl ro ffl ro ffl ffl ffl ω ro ro ω rø ffl •-i ro ffl ro ro ro ro
Figure imgf000127_0002
rø ω •-i o o o o o o o o o o ro o O
Tj fl to ro o TJ f ro rø rø ω rø ω o o o o o o o Q Q ζj |*3 to to ro o to t ro o o to •-i ffl o 1 Ln
O o rø ro ffl rø o o o o ro ro ω ffl O o O O rø ts rø rø o o o o rø rø ro rø o o o o rø rø rø
Figure imgf000127_0003
Figure imgf000127_0004
o o ro ro w ro o o o o rø rø ro ffl o o O ro w ro ffl o o o o ro ro ro w o o o o ro w ffl 1 1* o3
Figure imgf000127_0005
ω rø o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o F+
TJ Tj O
Figure imgf000127_0006
Figure imgf000127_0007
o o o o o o ω rø ω rø o o o o rø rø rø ω o o o o ω rø rø ω o o o o rø ω m rø o o o V I O3s
-^ ffl £ ro -rt ffl £ ro τj -S ^ ro τj 2' 2 ro j rø S rø τ rø^ £! ώ τj 2? S rø ro I'?,
O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O Q O O ITJ
toAJ? ,.? ι-7 ι-7 ij? 1 H, H, H, H, H, H, | *:
Q Q Q Q Q Q Q rø rø rø rø ω w rø rø Q Q θ o o o o Q Q Q Q Q Q Q Q ω rø rø w ω ω |*3
rø ro ro o o o o rø rø rø ω o o o o rø ω rø rø o o o o rø ω rø rø o o o o rø ω ω rø o o |*3
τj rø ^ ώ τj rø ^ rø τj ffl ^ rø ro W ^ ώ ro rø ^ ώ τj rø ^ rø ro rø S ώ % ffl rø rø rø w ω w ω ra rø rø ts w rø ts rø o o o o o o o o o o o o o o o o o o o o o o pl
O Tj OTj OTj OTj OTj On Qffl Offl Oro Oro Oro Oro Oor Oro rOo Q. ^Q oQ oQ Q oQ oQ rQ-, ^Q oQ oQ Q--. Q--, Q--. oQ ^Q, ^Tj _Tj Tjj Tjj _Tj, „Tj | r*j3., to - .
Ω Ω Ω Ω Ω Ω Ω ro ro Q Q Q Q Q Q Q θ o o o o o o Q Q Q Q Q Q ro ro -? » H? -? -? -? l^ ω ro rø o o o o rø rø ω rø o o o o rø ω rø rø o o o o rø w rø rø o o o o ω ω ω ω o o |*3
ro HH 2rt? lC? rø g* -roy 2 •"►5 l CD? rø _. ro -? 2"? l(,? rø c ro -? ~rø | rt? rø £* ' --yd 2 **♦? l CD" rø £ ^ " CD JJ <-, T ^ rt 3 -1 ** <t> g -r l w rø rø rø rø rø ts rø ro ro ro ro ro ro ro rø w w rø rø ts rø rø rø rø w rø rø rø rø w rø rø w w rø rø rø
O O — O — O — O — O — O — O — O — O — O — O — O — O — O fl ffl ro ro ro ro Tj ffl Tj Tj Tj ffl ffl Tj Tj Tj Tj Tj Tj Tj T] Iffl
— — n f | \σt_,
Ω Ω Ω Ω ° Ω Ω ffl Q n Q Q Q Q Q rø ω ω ω rø rø rø ω o o o o o o o o Q ro ro Q Q Q |^ ω ω rø o o o o ω ω ω ω o o o o ω ω ω rø o o o o ω ω rø rø o o o o rø rø rø ω o o |*3
|*3
I !-0 - - - - - - - - - - - - - O O O O O O O O O O O O O O O O O O O O O
Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω 33 S3 S3 53 33 33 S3 S3 31 33 33 33 S3 53 S1 S3 S3 53 53 S3 S3 pi
- ^? -^? -^? -^? -^? -^? -^? ° o o— o o o— o— o— o o~ LQO LOQ l-Q LOro l-roO LQO LOQ LQO LOQ LOQ LnO LQO LOQ LQO LQO LO LQO F I÷ σ*
Q Q Q Q Q Q Q rø rø rø rø rø rø rø ør Q o o o rø w ω rø rø w ω rø o o o o o o o o Q |*3
I tn
Figure imgf000129_0001
P Ω Ω -? H? H? H? H? H? H? H? Ω ^ o o o o o o Q Q Q Q Q Q Q Q ffl ω ffl ro w ro w ffl o |*3 I tn o o o ro ro rø rø o o o o rø rø rø w o o o o rø rø w rø o o o o w rø rø rø o o o o rø 1*3 I s
Figure imgf000129_0002
o o w rø rø rø rø rø rø rø rø rø rø rø rø w rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø rø ts Fl
Figure imgf000129_0003
o w rø rø rø rø o o o o w rø rø rø o o o o rø rø rø rø o o o o rø rø rø w o o o o rø 1*3 I Os
rø ro 2 W- £ ts ro W rø ro w r? ro ro ffl
S* rV ro i wi' ro ro iw-v ts TJ W |*3 t o o o o o o o o o o O O O
►--H UZ UZ HH ffi ffi ffl ffl ffl ffl fflo o ffl o ffl o ffl o ffl o ffl o ffl o ffl o ffl o ffl o o o o o
LO S3 L3O3 L 3O3 L 3o3 t33 LO 33 l- 3O3 LO S3 L3O3 I
TJ TJ TJ TJ TJ 53 53 33 33 53 53 S3 33 3! 33 3; 33 3; 33 33 3; 33 33 33 S3 33 33 5 —3 5HH3
Figure imgf000130_0002
Figure imgf000130_0001
o o o o o o o o o o o o o o o o o o o o o o o o o o o Ω Ω P
-? -? -? -? -? 53 53 33 33 33 S3 S3 S3 S3 33 33 33 S; 53 S3 S; 33 33 3; 33 33
Figure imgf000130_0004
rø O O O O O Ω Ω Ω ffl ro ffl ffl Q Q Q Q rø rø w w rø ro ts w o o Ω Ω 5. o rø ro rø ts o o o o rø rø w rø o o o o rø rø w rø o o o o rø rø ω ω 1*3
ffl ro ro 2? rø in ro ro ffl ϋJ ffl ro - tn ts J - fflV ro w ϋj ro ro m
3 ro Ml 3 3 3 3 ro rt ro ffl
3 ro t ro |*3 I to
3 3 -l MI £
3 ro 21
O O O O O O O O O O O O O O O O O O O O ff ff ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl o ffl o o o o l ffl ffl ffl ffl ffl ffl l ffl olff o ffl o ffl o ffl o ffl o ffl o ffl o ffl o ffl o ffl o ffl o ffl t 3o3 L 3O3 LO 33 PI
O O O O O O O O O O O O O O O O O O TJ TJ TJ TJ TJ TJ TJ TI TI Tj ffl ffl ffl ffl
I pi CJ*
— — -. - - - - .-. - - O O O O O O O O ffl rø ro ro ro ro ro w o o o o o o o o Q Q ζj |*3 I tn
O O ffl ffl ffl ffl O O O O W W ffl ffl O O O O ffl rø rø S? Ω o o o rø ffl ffl ffl o o o o ts ts ro |*3 I Os ffl ffl ro M ffll £ ffl ro 2 W? £ ώ J W rø ro 2 W? ω rø M fflI ffl ffl ffl ffl ro ffl 2? i rø ro 2 ffl? W J ffl |*3 3 -i to ts w ts ts ts ts o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o pi rø ω rø rø ts ffl ts ro ts ts ts ts ts ts ro ro ω ts o o o o o o o o o o o o o o o o o o o F Il σ* t rø rø rø rø rø rø n o o o Q Q Q Q Q Q Q Q ω rø rø ω rø rø rø rø o o o Q Q n Q o Q Tj Q Tj Q Tj |*3 ) L*0 J I tn rø rø o o o o o o o o rø rø rø rø o o o o rø rø rø rø o o o o rø rø rø w o o o o rø rø rø |*3
I O rø £ ό w -? s rø £ ό rø ro rø 21 £ rø ro ør £ a ro ro - 23? 2 ώ J -3 ? d W ro ffl 2- £
Figure imgf000131_0001
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o F Il ta o Tj o Tj o Tj o Tj oj o Tj rø rø rø rø rø rø rø 1*3 J ) C J L*J CoJ I cfer-
Q Q Q Q Q Q rø rø rø rø rø rø rø w o o o o o o o
Figure imgf000131_0002
rø rø o o o o ω ω ro ro o o o o ro rø ω rø o o o o rø ω rø rø o o o o ω ω ω w o o o |*3 I Os
ro M tnl rø tn ffl lff £ ffl ffl r w c fl.
3? ro tn ø ro 2 m? ω w
3 3 o r - fJ -i 21 rø o r
3 -■ ffl 3 ro
3 -i o o o o o o o o o O O O O O O O O 33 33 ffl ffl ffl ffl ffl ffl ffl ffl Έo oS oHH oS oΈ Έo oΈ oΈ oS oΈ oS oHH oHH o
33 HH oHH HoH HoH oHH oHH oHH f 1t>
IS ffl ro ts rø rø w rø rø w rø rø IS rø rø ts rø rø rø rø ro is ffl ffl o o o o o o |*3
1 σ*
Ofl o ffl o TJ o TJ o ffl o TJ o ro ro W rø rø rø rø rø o o o O o o o o o O
TJ o ro o Tj to to ffl ffl o Tj o TJ o o f ffl o TJ ffl ro w ts w ffl |*3 ) to t to to 1 n ro ro ts o o o o ro ffl W ffl O O O O ffl ffl ro ro o o o o w ro ro ω o o o o ffl ffl ro ω o o |*3
1 Os rn £ ro ffl ω or m f ro M tnl ffl ffl IS ffl ffl ro M tnl ffl
3 3fl 3 3 ffl ro 2? ffl ro 2 tn? fe ro ffl ffl ffl ffl ffl ts ro ro ro ro ro ro rø rø ts ro ffl ro ro ro ts rø ts ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl ffl ro ro |*3
I 0 -fe)- o Tj o TJ o O O O O O Tj o Tj o o TJ TJ TJ TJ Tj Tj ro w to LO LO to t LO LO I cr
O O O O O O O O O O O
TJ TJ TJ TJ TJ TJ TJ TJ ts w ro ro ro ro rø ω o o o o o o o o Q Q Q Q Q Q Q Q W rø |*3 I tn o o o ω w ω rø o o o o w w rø ro o o o o w rø rø rø o o o o rø rø rø rø o o o o rø rø |*3 I ON
ro M ffll £ ffl ctl ffl ro l ^ ώ ro w S w ro rø S rø Tj ffl ^ ώ ro rø ^ ro
S - roi 2? r 30 -i 5 -? I - w S S i ff ro 1*3
3 -1 -1 rt »o e ι-ι <*"> e ι-ι ct C Ht I to rø ts rø rø rø rø rø rø rø rø rø w rø w rø o o o o o o o o o o o o o o o o o o o o o o pi j Tj Tj j j j j j Tj Tj j j j Tj Tj (j π
Figure imgf000132_0001
o o o o o o
Figure imgf000132_0002
ffl ts ffl o o o o ffl ro ro ro o o o o o o o o w ro ro ro o o o o ffl ffl ffl ffl o o o o ffl ffl 1*3
I ON
ffl rø ro 2? rø o t Mnl rø ro w <-? rø ro ffl ffl r 2? ro t & ffl ffl tn ffl Pi
3 3 r 3 3 -I 3 o
3 or 2 -n~? rt 3 ro Ml rt ro l
3 ro M tnl ff
3 t o o o o o o O o o o o o O O O O o o o o o o o o o n o o o o o o o o o
HH UZ UZ Z I--H uz 33 UZ UZ UZ HH UZ HH HH HH Z UZ UZ ffi Z Z UZ * z t t 3O3 L SO3 L SO3 L SO3 S3 33 33 33 LO 33 L 3O3 t 3o3 t 5o3 PI o o O O O O O |*3
Tj Toj Toj Toj Toj oj Tj Toj oj T n) Toj oJ Tn O j Tj Tj j Tj Tj Tj > ) ) U-> I cr
O ffl ffl ffl O O O O O O O O O O O O O j TJ TJ TJ TJ TJ o TJ o TJ ffl ffl ts ro ffl ro LO LO LO LO LO LO LO ts ω o o o o o o o o Q |*3 I tn ffl ts ts ts ts ts rø o o o o rø rø rø rø o o o o ro ffl ffl ro o o o o w w ro ro o o o o w |*3 I ON
Figure imgf000133_0001
ro ro
3f 3 ffl
Figure imgf000133_0002
<-. ,-. O O O
P P p j ro rø rø rø rø ro ω ω rø rø rø rø rø M ro rø Q Q o TJ o TJ o Tj o Tj o ffl o Tj o Tj oJ oJ o Tj o Tj t τOι t roO L roO to p Ii cr to t o o o rø rø ro rø o o o o o o o o o O O ro T oJ T oj T oj o o rø rø rø rø rø rø rø rø o o o o o 1*3 to to I tn o o o o o o o ts ω rø ts o o o o ω ω rø ts o o o o ω w ro ro o o o o ω w ffl ffl o |*3 I ffl ffl IS r TJ rø m ø fl ro ro ffl £ 3 3 3 ro 2? o r o f wf - £ rø f f ro 2 j? δ ro « S ό ro o l
3 r 3 3 -i fl r ff1 £ & ώ w |*3 I t
O O HH — — ø ts to S3 l- S r rø rø rø rø rø rø rø O3 H? H? H? ffl ts ø rø ts ω rø rø rø W rø rø -d rø w rø ro rø ts rø rø r Fl o P o ro o o o Ω G Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω Ω rø ffl ffl ffl rø rø rø ffl ffl
Figure imgf000133_0003
Figure imgf000133_0004
o ro ro rø rø rø o o o o rø w rø rø o o o o rø rø rø ro o o o o ω ω rø rø o o o o rø 1*3 I ON
Table 30
Figure imgf000134_0001
F
F
F
F
Br
Br
Br
Br
Br
Br
Br
Br
Br
Br
Br
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
OMe
CF3
Figure imgf000135_0001
CF3 2-OCF3 CF3 3-OCF3 CF3 4-OCF3
CF3 2-OCF2H CF3 3-OCF2H CF3 4-OCF2H
CF3 2-OCF2CF2H CF3 3-OCF2CF2H CF3 4-OCF2CF2H
CF3 2-OCH7CF3 CF3 3-OCH2CF3 CF3 4-OCH2CF3
CF3 2-SCF3 CF3 3-SCF3 CF3 4-SCF3
CF3 2-SOCF3 CF3 3-SOCF3 CF3 4-SOCF3
CF3 2-S02CF3 CF3 3-SO7CF3 CF3 4-S02CF3
CF3 2-SCF2H CF3 3-SCF2H CF3 4-SCF2H
CF3 2-SOCF2H CF3 3-SOCF2H CF3 4-SOCF2H
CF3 2-S02CF2H CF3 3-S02CF2H CF3 4-S02CF2H
OCF2H 2-CF3 OCF2H 3-CF3 OCF2H 4-CF3
OCF2H 2-OCF3 OCF2H 3-OCF3 OCF2H 4-OCF3
OCF2H 2-OCF2H OCF2H 3-OCF2H OCF2H 4-OCF2H
OCF2H 2-OCF2CF2H OCF2H 3-OCF2CF2H OCF2H 4-OCF2CF2H
OCF2H 2-OCH7CF3 OCF2H 3-OCH2CF3 OCF7H 4-OCH7CF3
OCF2H 2-SCF3 OCF2H 3-SCF3 OCF2H 4-SCF3
OCF2H 2-SOCF3 OCF2H 3-SOCF3 OCF2H 4-SOCF3
OCF2H 2-SO7CF3 OCF2H 3-S02CF3 OCF2H 4-S02CF3
OCF2H 2-SCF2H OCF2H 3-SCF2H OCF2H 4-SCF2H
OCF2H 2-SOCF2H OCF7H 3-SOCF2H OCF2H 4-S0CF2H
OCF2H 2-S02CF2H OCF2H 3-S02CF2H OCF2H 4-S02CF2H
Me 2-Me-4-CF3 F 2-Me-4-CF3 Cl 2-Me-4-CF3
Me 2-Me-4-OCF3 F 2-Me-4-OCF3 Cl 2-Me-4-OCF3
Me 2-Me-4-OCF2H F 2-Me-4-OCF2H Cl 2-Me-4-OCF2H
Me 2-Me-4-OCH2CF3 F 2-Me-4-OCH2CF3 Cl 2-Me-4-OCH2CF3
Me 2-Me-4-SCF3 F 2-Me-4-SCF3 Cl 2-Me-4-SCF3
Me 2-Me-4-SOCF3 F 2-Me-4-SOCF3 Cl 2-Me-4-SOCF3
Me 2-Me-4-S02CF3 F 2-Me-4-S02CF3 Cl 2-Me-4-S02CF3
Me 2-Me-4-SCF2H F 2-Me-4-SCF2H Cl 2-Me-4-SCF2H
Me 2_Me-4-SOCF2H F 2-Me-4-SOCF2H Cl 2-Me-4-SOCF2H
Me 2-Me-4-S02CF2H F 2-Me-4-S02CF2H Cl 2-Me-4-S02CF2H
Br 2-Me-4-CF3 2-Me-4-CF3 OMe 2-Me-4-CF3
Br 2-Me-4-OCF3 2-Me-4-OCF3 OMe 2-Me-4-OCF3
Br 2-Me-4-OCF2H 2-Me-4-OCF2H OMe 2-Me-4-OCF2H
Br 2-Me-4-OCH2CF3 2-Me-4-OCH2CF3 OMe 2-Me-4-OCH2CF3
Br 2-Me-4-SCF3 2-Me-4-SCF3 OMe 2-Me-4-SCF3
Br 2-Me-4-SOCF3 2-Me-4-SOCF3 OMe 2-Me-4-SOCF3
Br 2-Me-4-S02CF3 2-Me-4-S02CF3 OMe 2-Me-4-S02CF3 o o o o o £ o rt £ rt £ rt rt rt Fl ro o Tj o Tj o o O Tj o Tj Tj o TJ o O
TJ TJ TJ rø w w J J J t J J to to
CΛ CΛ O O O O O — O — £ rt £ rt £ £ rt £ £ £ £ rt Fl £ £ £ £ £ £ £ £ ? rt c ClD S rt £ rt £ rt
Figure imgf000137_0002
Figure imgf000138_0001
Figure imgf000139_0001
Figure imgf000139_0002
O O O O O O O O O O O
Tj o O O O O O O O ro ro o ro o TJ ro o TJ o Tj oTj oj oTj oTj oTj o Tj o TJ oj o ffl oJ Tj Tj j Tj Tj Tj Tj to K> t tO to tJ ) J ) t J C-J 0- f J £ ffl lff ffl flf 53 rt
Figure imgf000139_0003
o O O
O o O O O O o o o O O O O
O r LOff T O O O o o
TJ Oro t toro o o TJ oJ O O toro TJ J or to IO to to to tro l O TJ O O O O o O o too to LOro LOffl J
L ιflf j Tj TJ -o LO LO LO LOro LOffl £
33 33 S3 33 33 S3 33 S3 33 33 33
Figure imgf000139_0004
£ 1*3 o rt Tj oj o O Tj o Tj oj o TJ o o ro ro rø rø rø rø ts ts ts rø £ £ £ £ £ £ ) ) i_ J ffl ffl ffl Tj
Figure imgf000140_0001
Figure imgf000141_0001
o O o l fl fl o ffl O o T o O O ff f O O o o o o l f j oj T oj T oj Tj o o O o o o ffl O O to ff £ £ £ £ £ πι £ £
53 53
Figure imgf000142_0001
Figure imgf000142_0002
Figure imgf000143_0001
O O
Z Z Z JZ JZ JZ JZ J 'Z o o O O O O O o o o o
O O O O O O O O O ro TJ Tj TJ ffl J j ff o J o ffl o ff o O o to to to to to t to to to ffl tol ffl ffl l t to to to to to ffl to ffl ffl 33 33 S3 33 ffl 53 33 S3
Figure imgf000143_0002
GO GO CΛ O O O o o o o o o O O O O O O
£ O O ,
£ £ £ £ £ £ Ω O O O O O O O O O o O O
O O O O O ffl ro o O ffl ffl o Tj ffl Tj rt £ £ £ £ £ £ to ffl ffl to t to t to t t to
33 33 33 ffl 53 53 33 33 33
Figure imgf000143_0003
CF3 2-Me-4-S02CF2H N02 2-Me-4-S02CF2H | SMe 2-Me-4-S02CF2H
Table 33
Figure imgf000144_0001
o o o o O O O O O O O £ CD £CD £CD £CD £ £ £ £ £ £ £
Figure imgf000145_0001
o o o o o o o o o o o £ rt £rt £rt £rt £CD £CD £rt £rt £rt £rt £ rø ro w ro ro rø rt
Figure imgf000145_0002
O O O O O O O O O O O £ rt £rt £rt £rt £rt £rt £CD £rt £rt £rt £ ts ts ro ts ro ro rt
Figure imgf000145_0003
Figure imgf000146_0001
o o o O O O O O O O O j j Tj j Tj Tj Tj Tj j j o flf o Tj o o o o to to t flf to ffl ffl Tj o o o o o o o ffl ff ffl Tj ffl TJ o O toffl o O l O O l to t to to ffl t ffl to ffl to ffl to ff ffl ffl L fflO ffl
S3 S3 53 33 33 33 S3 S3 33 S3 S3
Figure imgf000146_0002
Br 2-Me-4-S02CF3 I 2-Me-4-S02CF3 OMe 2-Me-4-S02CF3
Br 2-Me-4-SCF2H I 2-Me-4-SCF2H OMe 2-Me-4-SCF2H
Br 2-Me-4-SOCF2H I 2-Me-4-SOCF2H OMe 2-Me-4-S0CF2H
Br 2-Me-4-S02CF2H I 2-Me-4-S02CF2H OMe 2-Me-4-S02CF2H
CF3 2-Me-4-CF3 N02 2-Me-4-CF3 SMe 2-Me-4-CF3
CF3 2-Me-4-OCF3 N02 2-Me-4-OCF3 SMe 2-Me-4-OCF3
CF3 2-Me-4-OCF2H N02 2-Me-4-OCF2H SMe 2-Me-4-OCF2H
CF3 2-Me-4-OCH2CF3 N02 2-Me-4-OCH2CF3 SMe 2-Me-4-OCH2CF3
CF3 2-Me-4-SCF3 N02 2-Me-4-SCF3 SMe 2-Me-4-SCF3
CF3 2-Me-4-SOCF3 N02 2-Me-4-SOCF3 SMe 2-Me-4-SOCF3
CF3 2-Me-4-S02CF3 N02 2-Me-4-S02CF3 SMe 2-Me-4-S02CF3
CF3 2-Me-4-SCF2H N02 2-Me-4-SCF2H SMe 2-Me-4-SCF2H
CF3 2-Me-4-SOCF2H N02 2-Me-4-SOCF2H SMe 2-Me-4-SOCF2H
CF3 2-Me-4-S02CF2H N02 2-Me-4-S02CF2H SMe 2-Me-4-S02CF2H
Formulation/Utility
Compounds of this invention will generally be used as a formulation or composition with an agriculturally suitable carrier comprising at least one of a liquid diluent, a solid diluent or a surfactant. The foπnulation or composition ingredients are selected to be consistent with the physical properties of the active ingredient, mode of application and environmental factors such as soil type, moisture and temperature. Useful formulations include liquids such as solutions (including emulsifiable concentrates), suspensions, emulsions (including microemulsions and/or suspoemulsions) and the like which optionally can be thickened into gels. Useful formulations further include solids such as dusts, powders, granules, pellets, tablets, films, and the like which can be water-dispersible ("wettable") or water-soluble. Active ingredient can be (micro)encapsulated and further formed into a suspension or solid formulation; alternatively the entire formulation of active ingredient can be encapsulated (or "overcoated"). Encapsulation can control or delay release of the active ingredient. Sprayable formulations can be extended in suitable media and used at spray volumes from about one to several hundred liters per hectare. High-strength compositions are primarily used as intermediates for further formulation.
The formulations will typically contain effective amounts of active ingredient, diluent and surfactant within the following approximate ranges that add up to 100 percent by weight. Weight Percent
Active
Ingredient Diluent Surfactant
Water-Dispersible and Water-soluble 5-90 0-94 1-15
Granules, Tablets and Powders.
Suspensions, Emulsions, Solutions 5-50 40-95 0-15
(including Emulsifiable
Concentrates)
Dusts 1-25 70-99 0-5
Granules and Pellets 0.01-99 5-99.99 0-15
High Strength Compositions 90-99 0-10 0-2
Typical solid diluents are described in Watkins, et al., Handbook of Insecticide Dust Diluents and Carriers, 2nd Ed., Dorland Books, Caldwell, New Jersey. Typical liquid diluents are described in Marsden, Solvents Guide, 2nd Ed., Interscience, New York, 1950. McCutcheon 's Detergents and Emulsifiers Annual, Allured Publ. Corp., Ridgewood, New Jersey, as well as Sisely and Wood, Encyclopedia of Surface Active Agents, Chemical Publ. Co., Inc., New York, 1964, list surfactants and recommended uses. All formulations can contain minor amounts of additives to reduce foam, caking, corrosion, microbiological growth and the like, or thickeners to increase viscosity.
Surfactants include, for example, polyethoxylated alcohols, polyethoxylated alkylphenols, polyethoxylated sorbitan fatty acid esters, dialkyl sulfosuccinates, alkyl sulfates, alkylbenzene sulfonates, organosilicones, NN-dialkyltaurates, lignin sulfonates, naphthalene sulfonate formaldehyde condensates, polycarboxylates, and polyoxyethylene/polyoxypropylene block copolymers. Solid diluents include, for example, clays such as bentonite, montmorillonite, attapulgite and kaolin, starch, sugar, silica, talc, diatomaceous earth, urea, calcium carbonate, sodium carbonate and bicarbonate, and sodium sulfate. Liquid diluents include, for example, water, N,N-dimethylformamide, dimethyl sulfoxide, N-alkylpyrrolidone, ethylene glycol, polypropylene glycol, paraffins, alkylbenzenes, alkylnaphthalenes, oils of olive, castor, linseed, tung, sesame, corn, peanut, cotton-seed, soybean, rape-seed and coconut, fatty acid esters, ketones such as cyclohexanone, 2-heptanone, isophorone and 4-hydroxy-4-methyl-2-pentanone, and alcohols such as methanol, cyclohexanol, decanol and tetrahydrofurfuryl alcohol.
Solutions, including emulsifiable concentrates, can be prepared by simply mixing the ingredients. Dusts and powders can be prepared by blending and, usually, grinding as in a hammer mill or fluid-energy mill. Suspensions are usually prepared by wet-milling; see, for example, U.S. 3,060,084. Granules and pellets can be prepared by spraying the active material upon preformed granular carriers or by agglomeration techniques. See Browning, "Agglomeration", Chemical Engineering, December 4, 1967, pp 147-48, Penγ 's Chemical Engineer's Handbook, 4th Ed., McGraw-Hill, New York, 1963, pages 8-57 and following, and PCT Publication WO 91/13546. Pellets can be prepared as described in U.S. 4,172,714. Water-dispersible and water-soluble granules can be prepared as taught in U.S. 4,144,050, U.S. 3,920,442 and DE 3,246,493. Tablets can be prepared as taught in U.S. 5,180,587, U.S. 5,232,701 and U.S. 5,208,030. Films can be prepared as taught in GB 2,095,558 and U.S. 3,299,566.
For further information regarding the art of formulation, see T. S. Woods, "The Formulator's Toolbox - Product Forms for Modern Agriculture" in Pesticide Chemistiγ and Bioscience, The Food-Environment Challenge, T. Brooks and T. R. Roberts, Eds., Proceedings of the 9th International Congress on Pesticide Chemistry, The Royal Society of Chemistry, Cambridge, 1999, pp. 120-133. See also U.S. 3,235,361, Col. 6, line 16 through Col. 7, line 19 and Examples 10-41; U.S. 3,309,192, Col. 5, line 43 through Col. 7, line 62 and Examples 8, 12, 15, 39, 41, 52, 53, 58, 132, 138-140, 162-164, 166, 167 and 169-182; U.S. 2,891,855, Col. 3, line 66 through Col. 5, line 17 and Examples 1-4; Klingman, Weed Control as a Science, John Wiley and Sons, Inc., New York, 1961, pp 81-96; and Hance et al., Weed Control Handbook, 8th Ed., Blackwell Scientific Publications, Oxford, 1989. hi the following Examples, all percentages are by weight and all formulations are prepared in conventional ways. Compound numbers refer to compounds in Index Tables A-D. Example A
Wettable Powder
Compound 7 65.0% dodecylphenol polyethylene glycol ether 2.0% sodium ligninsulfonate 4.0% sodium silicoaluminate 6.0% montmorillonite (calcined) 23.0%.
Example B
Granule
Compound 7 10.0% attapulgite granules (low volatile matter,
0.71/0.30 mm; U.S.S. No. 25-50 sieves) 90.0%. Example C Extruded Pellet
Compound 7 25.0% anhydrous sodium sulfate 10.0% crude calcium ligninsulfonate 5.0% sodium alkylnaphthalenesulfonate 1.0% calcium/magnesium bentonite 59.0%.
Example D Emulsifiable Concentrate Compound 7 20.0% blend of oil soluble sulfonates and polyoxyethylene ethers 10.0% isophorone 70.0%.
Example E Granule
Compound 7 0.5% cellulose 2.5% lactose 4.0% cornmeal 93.0%. Compounds of this invention are characterized by favorable metabolic and/or soil residual patterns and exhibit activity controlling a spectrum of agronomic and non- agronomic invertebrate pests. (In the context of this disclosure "invertebrate pest control" means inhibition of invertebrate pest development (including mortality) that causes significant reduction in feeding or other injury or damage caused by the pest; related expressions are defined analogously.) As referred to in this disclosure, the term
"invertebrate pest" includes arthropods, gastropods and nematodes of economic importance as pests. The term "arthropod" includes insects, mites, spiders, scorpions, centipedes, millipedes, pill bugs and symphylans. The term "gastropod" includes snails, slugs and other Stylommatophora. The tenn "nematode" includes all of the helminths, such as: roundworms, heartworms, and phytophagous nematodes (Nematoda), flukes (Tematoda), Acanthocephala, and tapeworms (Cestoda). Those skilled in the art will recognize that not all compounds are equally effective against all pests. Compounds of this invention display activity against economically important agronomic, forest, greenhouse, nursery, ornamentals, food and fiber, public and animal health, domestic and commercial structure, household, and stored product pests. These include larvae of the order Lepidoptera, such as armyworms, cutworms, loopers, and heliothines in the family Noctuidae (e.g., fall armyworm (Spodoptera fugiperda J. E. Smith), beet armyworm (Spodoptera exigua Hiibner), black cutworm (Agrotis ipsilon Hufhagel), cabbage looper (Trichoplusia ni Hϋbner), tobacco budworm (Heliothis virescens Fabricius)); borers, casebearers, webworms, coneworms, cabbageworms and skeletonizers from the family Pyralidae (e.g., European corn borer (Ostrinia nubilalis Hϋbner), navel orangeworm (Amyelois transitella Walker), corn root webworm (Crambus caliginosellus Clemens), sod webwomi (Herpetogramma licarsisalis Walker)); leafrollers, budworms, seed worms, and fruit worms in the family Tortricidae (e.g., codling moth (Cydia pomonella Linnaeus), grape berry moth (Endopiza viteana Clemens), oriental fruit moth (Grapholita molesta Busck)); and many other economically important lepidoptera (e.g., diamondback moth (Plutella xylostella Linnaeus), pink bollworm (Pectinophora gossypiella Saunders), gypsy moth (Lymantria dispar Linnaeus)); nymphs and adults of the order Blattodea including cockroaches from the families Blattellidae and Blattidae (e.g., oriental cockroach (Blatta orientalis Linnaeus), Asian cockroach (Blatella asahinai Mizukubo), German cockroach (Blattella germanica Linnaeus), brownbanded cockroach (Supella longipalpa Fabricius), American cockroach (Periplaneta americana Linnaeus), brown cockroach (Periplaneta bninnea Burmeister),
Madeira cockroach (Leucophaea maderae Fabricius)); foliar feeding larvae and adults of the order Coleoptera including weevils from the families Anthribidae, Bruchidae, and Curculionidae (e.g., boll weevil (Anthonomus grandis Boheman), rice water weevil (Lissorhoptrus oiγzophilas Kuschel), granary weevil (Sitophilus granarius Linnaeus), rice weevil (Sitophilus oiγzae Linnaeus)); flea beetles, cucumber beetles, rootworms, leaf beetles, potato beetles, and leafminers in the family Chrysomelidae (e.g., Colorado potato beetle (Leptinotarsa decemlineata Say), western corn rootworm (Diabrotica virgifera virgifera LeConte)); chafers and other beetles from the family Scaribaeidae (e.g., Japanese beetle (Popilliajaponica Newman) and European chafer (Rhizotrogus majalis Razoumowsky)); carpet beetles from the family Dermestidae; wireworms from the family Elateridae; bark beetles from the family Scolytidae and flour beetles from the family Tenebrionidae. In addition it includes: adults and larvae of the order Deπnaptera including earwigs from the family Forficulidae (e.g., European earwig (Forficula auricularia Linnaeus), black earwig (Chelisoches morio Fabricius)); adults and nymphs of the orders Hemiptera and Homoptera such as, plant bugs from the family Miridae, cicadas from the family Cicadidae, leaflioppers (e.g. Empoasca spp.) from the family Cicadellidae, planthoppers from the families Fulgoroidae and Delphacidae, treehoppers from the family Membracidae, psyllids from the family Psyllidae, whiteflies from the family Aleyrodidae, aphids from the family Aphididae, phylloxera from the family Phylloxeridae, mealybugs from the family Pseudococcidae, scales from the families Coccidae, Diaspididae and
Margarodidae, lace bugs from the family Tingidae, stink bugs from the family Pentatomidae, cinch bugs (e.g., Blissus spp.) and other seed bugs from the family Lygaeidae, spittlebugs from the family Cercopidae squash bugs from the family Coreidae, and red bugs and cotton stainers from the family Pyrrhocoridae. Also included are adults and larvae of the order Acari (mites) such as spider mites and red mites in the family Tetranychidae (e.g., European red mite (Panonychus ulmi Koch), two spotted spider mite (Tetranychus urticae Koch), McDaniel mite (Tetranγchus mcdanieli McGregor)), flat mites in the family Tenuipalpidae (e.g., citrus flat mite (Brevipalpus lewisi McGregor)), rust and bud mites in the family
Eriophyidae and other foliar feeding mites and mites important in human and animal health, i.e. dust mites in the family Epidermoptidae, follicle mites in the family Demodicidae, grain mites in the family Glycyphagidae, ticks in the order Ixodidae (e.g., deer tick (Ixodes scapidaris Say), Australian paralysis tick (Ixodes holocyclus Neumann), American dog tick (Dermacentor variabilis Say), lone star tick (Amblyomma americanum Linnaeus) and scab and itch mites in the families Psoroptidae, Pyemotidae, and Sarcoptidae; adults and immatures of the order Orthoptera including grasshoppers, locusts and crickets (e.g., migratory grasshoppers (e.g., Melanoplus sanguinipes Fabricius, M. differentialis Thomas), American grasshoppers (e.g., Schistocerca americana Drury), desert locust (Schistocerca gregaria Forskal), migratory locust (Locitsta migratoria Linnaeus), house cricket (Acheta domesticus Linnaeus), mole crickets (G γllotalpa spp.)); adults and immatures of the order Diptera including leafminers, midges, fruit flies (Tephritidae), frit flies (e.g., Oscinella frit Linnaeus), soil maggots, house flies (e.g., Musca domestica Linnaeus), lesser house flies (e.g., Fannia canicularis Linnaeus, F.femoralis Stein), stable flies (e.g., Stomoxys calcitrans Linnaeus), face flies, horn flies, blow flies (e.g., Chiγsomya spp., Phormia spp.), and other muscoid fly pests, horse flies (e.g., Tabanus spp.), bot flies (e.g., Gastrophilus spp., Oestrus spp.), cattle grubs (e.g., Hypoderma spp.), deer flies (e.g., Clvγsops spp.), keds (e.g., Melophagus ovinus Linnaeus) and other Brachycera, mosquitoes (e.g., Aedes spp., Anopheles spp., Culex spp.), black flies (e.g., Prosimidium spp., Simulium spp.), biting midges, sand flies, sciarids, and other Nematocera; adults and immatures of the order Thysanoptera including onion thrips (Thrips tabaci Lindeman) and other foliar feeding thrips; insect pests of the order Hymenoptera including ants (e.g., red carpenter ant (Camponotus ferrugineus Fabricius), black carpenter ant (Camponotus pennsylvanicus De Geer), Pharaoh ant (Monomorium pharaonis Linnaeus), little fire ant (Wasmannia auropimctata Roger), fire ant (Solenopsis geminata Fabricius), red imported fire ant (Solenopsis invicta Buren), Argentine ant (Iridomyrmex humilis Mayr), crazy ant (Paratrechina longicornis Latreille), pavement ant (Tetramorium caespitum Linnaeus), cornfield ant (Lasius alienus Fόrster), odorous house ant (Tapinoma sessile Say)), bees (including carpenter bees), hornets, yellow jackets and wasps; insect pests of the order Isoptera including the eastern subterranean termite (Reticulitermes flavipes Kollar), western subterranean termite (Reticulitermes hesperus Banks), Formosan subterranean termite (Coptotermes formosanus Shiraki), West Indian drywood termite (Incisitermes immigrans Snyder) and other termites of economic importance; insect pests of the order Thysanura such as silverfish (Lepisma saccharina Linnaeus) and firebrat (Thermobia domestica Packard); insect pests of the order Mallophaga and including the head louse (Pediculus humanus capitis De Geer), body louse (Pediculus humanus humanus Linnaeus), chicken body louse (Menacanthus stramineus Nitszch), dog biting louse (Trichodectes canis De Geer), fluff louse (Goniocotes gallinae De Geer), sheep body louse (Bovicola ovis Schrank), short-nosed cattle louse (Haematopinus einγsternus Nitzsch), long-nosed cattle louse (Linognathus vituli Linnaeus) and other sucking and chewing parasitic lice that attack man and animals; insect pests of the order Siphonoptera including the oriental rat flea (Xenopsylla cheopis Rothschild), cat flea (Ctenocephalides felis Bouche), dog flea (Ctenocephalides canis Curtis), hen flea (Ceratophylhis gallinae Schrank), sticktight flea (Echidnophaga gallinacea Westwood), human flea (Pulex irritans Linnaeus) and other fleas afflicting mammals and birds. Additional arthropod pests covered include: spiders in the order Araneae such as the brown recluse spider (Loxosceles reclusa Gertsch & Mulaik) and the black widow spider (Latrodectus mactans Fabricius), and centipedes in the order Scutigeromorpha such as the house centipede (Scutigera coleoptrata Linnaeus). Activity also includes members of the Classes Nematoda, Cestoda, Trematoda, and Acanthocephala including economically important members of the orders Strongylida, Ascaridida, Oxyurida, Rhabditida, Spirurida, and Enoplida such as but not limited to economically important agricultural pests (i.e. root knot nematodes in the genus Meloidogyne, lesion nematodes in the genus Pratylenchus, stubby root nematodes in the genus Trichodorus, etc.) and animal and human health pests (i.e. all economically important flukes, tapeworms, and roundworms, such as Strongylus vulgaris in horses, Toxocara canis in dogs, Haemonchus contortus in sheep, Dirofύaria immitis Leidy in dogs, Anoplocephala perfoliata in horses, Fasciola hepatica Linnaeus in ruminants, etc.). Compounds of the invention show particularly high activity against pests in the order
Lepidoptera (e.g., Alabama argillacea Hϋbner (cotton leaf worm), Archips argyrospila Walker (fruit tree leaf roller), A. rosana Linnaeus (European leaf roller) and other Archips species, Chilo suppressalis Walker (rice stem borer), Cnaphalocrosis medinalis Guenee (rice leaf roller), Crambus caliginosellus Clemens (corn root webworm), Crambus teterrellus Zincken (bluegrass webworm), Cydia pomonella Linnaeus (codling moth), Earias insulana Boisduval (spiny bollworm), Earias vittella Fabricius (spotted bollworm), Helicoverpa armigera Hϋbner (American bollworm), Helicoverpa zea Boddie (corn earworm), Heliothis virescens Fabricius (tobacco budworm), Herpetogramma licarsisalis Walker (sod webworm), Lobesia botrana Denis & Schiffermϋller (grape berry moth), Pectinophora gossypiella Saunders (pink bollworm), Phyllocnistis citrella Stainton (citrus leafminer), Pieris brassicae Linnaeus (large white butterfly), Pieris rapae Linnaeus (small white butterfly), Plntella xylostella Linnaeus (diamondback moth), Spodoptera exigua Hϋbner (beet armyworm), Spodoptera litura Fabricius (tobacco cutworm, cluster caterpillar), Spodoptera frugiperda J. E. Smith (fall armyworm), Trichoplnsia ni Hϋbner (cabbage looper) and Tula absoluta Meyrick (tomato leafrniner)). Compounds of the invention also have commercially significant activity on members from the order Homoptera including: Acyrthisiphon pisum Harris (pea aphid), Aphis craccivora Koch (cowpea aphid), Aphis fabae Scopoli (black bean aphid), Aphis gossypii Glover (cotton aphid, melon aphid), Aphis pomi De Geer (apple aphid), Aphis spiraecola Patch (spirea aphid), Aulacorthum solani Kaltenbach (foxglove aphid), Chaetosiphon fragaefolii Cockerell (strawberry aphid), Diuraphis noxia Kurdjumov/Mordvilko (Russian wheat aphid), Dysaphis plantaginea Paaserini (rosy apple aphid), Eriosoma lanigerum Hausmann (woolly apple aphid), Hyalopterus pruni Geoffroy (mealy plum aphid), Lipaphis eiγsimi Kaltenbach (turnip aphid), Metopolophium dirrhodum Walker (cereal aphid), Macrosipum euphorbiae Thomas (potato aphid), Myzus persicae Sulzer (peach-potato aphid, green peach aphid), Nasonovia ribis igri Mosley (lettuce aphid), Pemphigus spp. (root aphids and gall aphids), Rhopalosiphum maidis Fitch (corn leaf aphid), Rhopalosiphum padi Linnaeus (bird cherry- oat aphid), Schi∑aphis graminum Rondani (greenbug), Sitobion avenae Fabricius (English grain aphid), Therioaphis maculata Buckton (spotted alfalfa aphid), Toxoptera aurantii Boyer de Fonscolombe (black citrus aphid), and Toxoptera citricida Kirkaldy (brown citrus aphid); Adelges spp. (adelgids); Phylloxera devastatrix Pergande (pecan phylloxera); Bemisia tabaci Gennadius (tobacco whitefly, sweetpotato whitefly), Bemisia argentifolii Bellows & Perring (silverleaf whitefly), Dialeurodes citri Ashmead (citrus whitefly) and Trialeurodes vaporariorum Westwood (greenhouse whitefly); Empoasca fabae Harris (potato leafhopper), Laodelphax striatellus Fallen (smaller brown planthopper), Macrolestes quadrilineatus Forbes (aster leafhopper), Nephotettix cinticeps Uhler (green leafhopper), Nephotettix nigropictus Stal (rice leafhopper), Nilapamata lugens Stal (brown planthopper), Peregrinus maidis Ashmead (corn planthopper), Sogatella furcifera Horvath (white-backed planthopper), Sogatodes orizicola Muir (rice delphacid), Typhlocyba pomaria McAtee white apple leafhopper, Eiγthroneoura spp. (grape leafhoppers); Magicidada septendecim Linnaeus (periodical cicada); Iceiγa purchasi Maskell (cottony cushion scale), Quadraspidiotus perniciosas Comstock (San Jose scale); Planococcus citri Risso (citrus mealybug); Pseudococcus spp. (other mealybug complex); Cacopsylla pyricola Foerster (pear psylla), Trioza diospyri Ashmead (persimmon psylla). These compounds also have activity on members from the order Hemiptera including: Acrosternum hilare Say (green stink bug), Anasa tristis De Geer (squash bug), Blissus leucopterus leucopterus Say (chinch bug), Coiγthuca gossγpii Fabricius (cotton lace bug), Cγrtopeltis modesta Distant (tomato bug), Dysdercus suturellus Herri ch-Schaffer (cotton stainer), Euchistus servus Say (brown stink bug), Euchistus variolarius Palisot de Beauvois (one-spotted stink bug), Graptosthetus spp. (complex of seed bugs), Leptoglossus corculus Say (leaf- footed pine seed bug), Lygus lineolaris Palisot de Beauvois (tarnished plant bug), Nezara viridula Linnaeus (southern green stink bug), Oebalus pugnax Fabricius (rice stink bug), Oncopeltus fasciatus Dallas (large milkweed bug), Pseudatomoscelis seriatus Reuter (cotton fleahopper). Other insect orders controlled by compounds of the invention include Thysanoptera (e.g., Frankliniella occidentalis Pergande (western flower thrip), Scirthothrips citri Moulton (citrus thrip), Sericothrips variabilis Beach (soybean thrip), and Thrips tabaci Lindeman (onion thrip); and the order Coleoptera (e.g., Leptinotarsa decemlineata Say (Colorado potato beetle), Epilachna varivestis Mulsant (Mexican bean beetle) and wireworms of the genera Agriotes, Athous or Limonius).
Compounds of Formula I can also be mixed with one or more other biologically active compounds or agents including insecticides, fungicides, nematocides, bactericides, acaricides, growth regulators such as rooting stimulants, chemosterilants, semiochemicals, repellents, attractants, pheromones, feeding stimulants, other biologically active compounds or entomopathogenic bacteria, virus or fungi to form a multi-component pesticide giving an even broader spectrum of agricultural utility. Thus the present invention also relates to a method wherein the invertebrate pest or its environment is contacted with a biologically effective amount of a compound of Formula I or a composition comprising a compound of Formula I and a biologically effective amount of at least one additional compound or agent for controlling invertebrate pests. Likewise compositions of the present invention comprising a compound of Formula la can further comprise a biologically effective amount of at least one additional biologically active compound or agent. Examples of such biologically active compounds or agents with which compounds of this invention can be formulated are: insecticides such as abamectin, acephate, acetamiprid, avermectin, azadirachtin, azinphos-methyl, bifenthrin, binfenazate, buprofezin, carbofuran, chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clothianidin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, diflubenzuron, dimethoate, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, fenothicarb, fenoxycarb, fenpropathrin, fenproximate, fenvalerate, fipronil, flonicamid, flucythrinate, tau-fluvalinate, flufenoxuron, fonophos, halofenozide, hexaflumuron, imidacloprid, indoxacarb, isofenphos, lufenuron, malathion, metaldehyde, methamidophos, methidathion, methomyl. methoprene, methoxychlor, monocrotophos, methoxyfenozide, nithiazin, novaluron, oxamyl, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, pymetrozine, pyridalyl, pyriproxyfen, rotenone, spinosad, sulprofos, tebufenozide, teflubenzuron, tefluthrin, terbufos, tetrachlorvinphos, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tralomethrin, trichlorfon and triflumuron; fungicides such as acibenzolar, azoxystrobin, benomyl, blasticidin-S, Bordeaux mixture (tribasic copper sulfate), bromuconazole, carpropamid, captafol, captan, carbendazim, chloroneb, chlorothalonil, copper oxychloride, copper salts, cyflufenamid, cymoxanil, cyproconazole, cyprodinil, (S)-3,5-dichloro-N-(3- chloro- 1 -ethyl- l-methyl-2-oxopropyl)-4-methylbenzamide (RH 7281), diclocymet (S-2900), diclomezine, dicloran, difenoconazole, (S)-3,5-dihydro-5-methyl-2-(methylthio)-5-phenyl-3- (phenylamino)-4H-imidazol-4-one (RP 407213), dimethomorph, dimoxystrobin, diniconazole, diniconazole-M, dodine, edifenphos, epoxiconazole, famoxadone, fenamidone, fenarimol, fenbuconazole, fencaramid (SZX0722), fenpiclonil, fenpropidin, fenpropimorph, fentin acetate, fentin hydroxide, fluazinam, fludioxonil, flumetover (RPA 403397), fluquinconazole, flusilazole, flutolanil, flutriafol, folpet, fosetyl-aluminum, furalaxyl, furametapyr (S-82658), hexaconazole, ipconazole, iprobenfos, iprodione, isoprothiolane, kasugamycin, kresoxim-methyl, mancozeb, maneb, mefenoxam, mepronil, metalaxyl, metconazole, metominostrobin/fenominostrobin (SSF-126), myclobutanil, neo-asozin (ferric methanearsonate), oxadixyl, penconazole, pencycuron, probenazole, prochloraz, propamocarb, propiconazole, pyrifenox, pyraclostrobin, pyrimethanil, pyroquilon, quinoxyfen, spiroxamine, sulfur, tebuconazole, tetraconazole, thiabendazole, thifluzamide, thiophanate-methyl, thiram, tiadinil, triadimefon, triadimenol, tricyclazole, trifloxystrobin, triticonazole, validamycin and vinclozolin; nematocides such as aldicarb, oxamyl and fenamiphos; bactericides such as streptomycin; acaricides such as amitraz, chinomethionat, chlorobenzilate, cyhexatin, dicofol, dienochlor, etoxazole, fenazaquin, fenbutatin oxide, fenpropathrin, fenpyroximate, hexythiazox, propargite, pyridaben and tebufenpyrad; and biological agents such as Bacillus thiiringiensis including ssp. aizawai and kurstaki, Bacillus thiiringiensis delta endotoxin, baculovirus, and entomopathogenic bacteria, virus and fungi. A general reference for these agricultural protectants is EΛe Pesticide Manual, 12th Edition, C. D. S. Tomlin, Εd., British Crop Protection Council, Farnham, Surrey, U.K., 2000.
Preferred insecticides and acaricides for mixing with compounds of Fomiula I or la include pyrethroids such as cypermethrin, cyhalothrin, cyfluthrin, beta-cyfluthrin, esfenvalerate, fenvalerate and tralomethrin; carbamates such as fenothicarb, methomyl, oxamyl and thiodicarb; neonicotinoids such as clothianidin, iniidacloprid and thiacloprid; neuronal sodium channel blockers such as indoxacarb; insecticidal macrocyclic lactones such as spinosad, abamectin, avermectin and emamectin; γ-aminobutyric acid (GABA) antagonists such as endosulfan, ethiprole and fipronil; insecticidal ureas such as flufenoxuron and triflumuron; juvenile hormone mimics such as diofenolan and pyriproxyfen; pymetrozine; and amitraz. Preferred biological agents for mixing with compounds of Formula I or la include Bacillus thiiringiensis and Bacillus thiiringiensis delta endotoxin as well as naturally occurring and genetically modified viral insecticides including members of the family Baculoviridae as well as entomophagous fungi.
Most preferred mixtures include a mixture of a compound of Formula I or la with cyhalothrin; a mixture of a compound of Formula I or la with beta-cyfluthrin; a mixture of a compound of Fomiula I or la with esfenvalerate; a mixture of a compound of Formula I or la with methomyl; a mixture of a compound of Fomiula I or la with imidacloprid; a mixture of a compound of Fomiula I or la with thiacloprid; a mixture of a compound of Formula I or la with indoxacarb; a mixture of a compound of Fomiula I or la with abamectin; a mixture of a compound of Fomiula I or la with endosulfan; a mixture of a compound of Fomiula I or la with ethiprole; a mixture of a compound of Formula I or la with fϊpronil; a mixture of a compound of Formula I or la with flufenoxuron; a mixture of a compound of Fomiula I or la with pyriproxyfen; a mixture of a compound of Formula I or la with pymetrozine; a mixture of a compound of Formula I or la with amitraz; a mixture of a compound of Formula I or la with Bacillus thiiringiensis and a mixture of a compound of Formula I or la with Bacillus thiiringiensis delta endotoxin.
In certain instances, combinations with other invertebrate pest control compounds or agents having a similar spectrum of control but a different mode of action will be particularly advantageous for resistance management. Thus, compositions of the present invention comprising a compound of Formula la can further comprise a biologically effective amount of at least one additional invertebrate pest control compound or agent having a similar spectrum of control but a different mode of action, and the methods of the present invention can utilize compositions compromising a compound of Formula I and a biologically effective amount of at least one additional invertebrate pest control compound or agent having a similar spectrum of control but a different mode of action. Contacting a plant genetically modified to express a plant protection compound (e.g., protein) or the locus of the plant with a biologically effective amount of a compound of Formula I or la can also provide a broader spectrum of plant protection and be advantageous for resistance management.
Invertebrate pests are controlled and protection of agronomic, horticultural and specialty crops, animal and human health is achieved by applying one or more of the compounds of Formula I or la, in an effective amount, to the environment of the pests including the agronomic and/or nonagronomic locus of infestation, to the area to be protected, or directly on the pests to be controlled. Thus, the present invention comprises a method for the control of foliar- and soil-inhabiting invertebrates and protection of agronomic and/or nonagronomic crops, comprising contacting the invertebrates or their environment with a biologically effective amount of one or more of the compounds of Formula I, or with a composition comprising at least one such compound or a composition comprising at least one such compound and an effective amount of at least one additional biologically active compound or agent. A preferred method of contact is by spraying. Alternatively, a granular composition comprising a compound of Formula I or la can be applied to the plant foliage or the soil. Compounds of Formula I or la are effective in delivery through plant uptake by contacting the plant with a composition comprising a compound of Formula I or la applied as a soil drench of a liquid formulation, a granular formulation to the soil, a nursery box treatment or a dip of transplants. Other methods of contact include application of a compound of Fomiula I or la or a composition comprising of Formula I or la of the invention by direct and residual sprays, aerial sprays, seed coats, microencapsulations, systemic uptake, baits, eartags, boluses, foggers, fumigants, aerosols, dusts and many others.
The compounds of Fomiula I or la can be incorporated into baits that are consumed by the invertebrates or within devices such as traps and the like. Granules or baits comprising between 0.01-5 % active ingredient, 0.05-10% moisture retaining agent(s) and 40-99% vegetable flour are effective in controlling soil insects at very low application rates, particularly at doses of active ingredient that are lethal by ingestion rather than by direct contact.
The compounds of Fomiula I or la can be applied in their pure state, but most often application will be of a formulation comprising one or more compounds with suitable carriers, diluents, and surfactants and possibly in combination with a food depending on the contemplated end use. A preferred method of application involves spraying a water dispersion or refined oil solution of the compounds. Combinations with spray oils, spray oil concentrations, spreader stickers, adjuvants, other solvents, and synergists such as piperonyl butoxide often enhance compound efficacy.
The rate of application required for effective control (i.e. "biologically effective amount") will depend on such factors as the species of invertebrate to be controlled, the pest's life cycle, life stage, its size, location, time of year, host crop or animal, feeding behavior, mating behavior, ambient moisture, temperature, and the like. Under normal circumstances, application rates of about 0.01 to 2 kg of active ingredient per hectare are sufficient to control pests in agronomic ecosystems, but as little as 0.0001 kg/hectare may be sufficient or as much as 8 kg/hectare may be required. For nonagronomic applications, effective use rates will range from about 1.0 to 50 mg/square meter but as little as 0.1 mg/square meter may be sufficient or as much as 150 mg/square meter may be required. One skilled in the art can easily determine the biologically effective amount necessary for the desired level of invertebrate pest control. The following Tests in the Biological Examples of the Invention demonstrate the efficacy of methods of the invention for protecting plants from specific arthropod pests. "Control efficacy" represents inhibition of arthropod development (including mortality) that causes significantly reduced feeding. The pest control protection afforded by the compounds is not limited, however, to these species. See Index Tables A-D for compound descriptions. The following abbreviations are used in the Index Tables which follows: t is tertiary, n is normal, i is iso, s is secondary, c is cyclo, Me is methyl, Et is ethyl, Pr is propyl and Bu is butyl; accordingly /-Pr is isopropyl, s-Bu is secondary butyl, etc. The abbreviation "Ex." stands for "Example" and is followed by a number indicating in which example the compound is prepared.
Index Table A
Figure imgf000159_0001
Compound RJ R4 R 5a R 5b mp °C
1 ;-Pr 2-Me H 4-OCF3 oil
2 /-Pr 2-Me H 4-CF3 oil
3 (Ex. 1) -Pr 2-Me 2-Me 4-CF3 100-103 Index Table B
Figure imgf000159_0002
Compound R3 R4 X mp °C
/-Pr Cl NPh N CH CCF3 155-159
Index Table C
Figure imgf000160_0001
Compound R3 R4 W X Y R5 m.p. °C
5 /-Pr Me C-Me N CH CH CF3 132-135
6 /-Pr Me C-Et N CH CH Cl 127-131 Index Table D
Figure imgf000160_0002
Compound R3 R4a R4b R6 R7 V mp cC
7 (Ex. 3) Me Cl H Cl CF3 N 155-159
8 /-Pr Me H H CF3 CH
9 CH2CHC1CH3 Me H Cl CF3 CH 178-180
10 (Ex. 2) Me Me Cl Cl CF3 N solid
11 /-Pr Me Cl Cl Br N 190-193
Index Table E
Figure imgf000161_0001
Compound R3 R 4a R6 R7 V mp °C
12 CH2C≡CH Me Cl Br CH
Figure imgf000161_0002
BIOLOGICAL EXAMPLES OF THE INVENTION
TEST For evaluating control of diamondback moth (Plutella xylostella) the test unit consisted of a small open container with a 12-14-day-old radish plant inside. This was pre-infested with 10-15 neonate larvae on a piece of insect diet by use of a core sampler to remove a plug from a sheet of hardened insect diet having many larvae growing on it and transfer the plug containing larvae and diet to the test unit. The larvae moved onto the test plant as the diet plug dried out. Test compounds were formulated using a solution containing 10% acetone, 90% water and 300 ppm X-77® Spreader Lo-Foam Formula non-ionic surfactant containing alkylarylpolyoxyethylene, free fatty acids, glycols and isopropanol (Loveland Industries, Inc.), unless otherwise indicated. The formulated compounds were applied in 1 mL of liquid through a SUJ2 atomizer nozzle with 1/8 JJ custom body (Spraying Systems Co.) positioned 1.27 cm (0.5 inches) above the top of each test unit. All experimental compounds in this screen were sprayed at 250 ppm and replicated three times. After spraying of the formulated test compound, each test unit was allowed to dry for 1 hour and then a black, screened cap was placed on top. The test units were held for 6 days in a growth chamber at 25 °C and 70% relative humidity. Plant feeding damage was then visually assessed. Of the compounds tested, the following provided very good levels of plant protection
(20% or less feeding damage): 3, 4, 5, 6, 8 and 10.

Claims

CLAIMSWhat is claimed is:
1. A method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Fomiula I, its N-oxide or an agriculturally suitable salt of the compound
Figure imgf000162_0001
wherein
B is O or S;
J is a phenyl ring substituted with 1 to 4 R5, or a naphthyl ring system, a 5- or
6-membered heteroaromatic ring or an aromatic 8-, 9- or 10-membered fused heterobicyclic ring system wherein each ring or ring system is optionally substituted with 1 to 4 R5; K is, together with the two contiguous linking carbon atoms, a fused phenyl or a fused pyridinyl ring selected from the group consisting of K-l, K-2, K-3, K-4 and K-5, each optionally substituted with 1 to 4 R4
Figure imgf000162_0002
R3 is G; CrC6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, each optionally substituted with one or more substituents selected from the group consisting of halogen, G, CΝ, ΝO2, hydroxy, C--C alkoxy, Cj-C4 haloalkoxy, CrC4 alkylthio, CrC4 alkylsulfinyl, CrC4 alkylsulfonyl, C2-C6 alkoxycarbonyl, C2-Cg alkylcarbonyl, C3-C6 trialkylsilyl, or a phenoxy ring optionally substituted with one to three substituents independently selected from R6; hydroxy; Cj-C4 alkoxy; C--C4 alkylamino; C2-C8 dialkylamino; C3-C6 cycloalkylamino; C -C6 alkoxycarbonyl or C2-Cg alkylcarbonyl; G is a phenyl ring or 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6; a 5- or 6-membered nonaromatic carbocyclic or heterocyclic ring, optionally including one or two ring members selected from the group consisting of C(=O), SO or S(O)2 and optionally substituted with 1 to 4 substituents selected from R12; each R4 is independently H, CrC6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, Cj-Cg haloalkyl, C2-Cg haloalkenyl, C -Cg haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, hydroxy, C--C4 alkoxy, Cj-C4 haloalkoxy, C--C alkylthio, C--C4 alkylsulfinyl, C--C4 alkylsulfonyl, C--C4 haloalkylthio, C C4 haloalkylsulfinyl, C*-C4 haloalkylsulfonyl, CrC4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, C--C4 alkoxyalkyl, Cj-C4 hydroxyalkyl,
C(O)R10, CO2R10, C(O)N lθRll, NR^Rl l, N(RH)COR10, N(RH)CO2R10 or C3-C6 trialkylsilyl; or each R4 is independently a phenyl, benzyl, phenoxy or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with one to three substituents independently selected from R6; each R5 is independently H, Cj-Cg alkyl, C2-Cg alkenyl, C7-C6 alkynyl, C3-C6 cycloalkyl, C Cg haloalkyl, C2-Cg haloalkenyl, C2-Cg haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, CO2H, CONH2, NO2, hydroxy, CrC4 alkoxy, Cj-C4 haloalkoxy, C C4 alkylthio, C--C alkylsulfinyl, Cj-C4 alkylsulfonyl, C!-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, C1-C4 haloalkylsulfonyl, CrC4 alkylamino, C2-Cg dialkylamino, C3-C6 cycloalkylamino, C7-C6 alkylcarbonyl, C2-C6 alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl, C3-Cg trialkylsilyl; or each R5 is independently a phenyl, benzyl, benzoyl, phenoxy, 5- or 6-membered heteroaromatic ring or an aromatic S-, 9- or 10-membered fused heterobicyclic ring system, each ring optionally substituted with one to three substituents independently selected from R6; or (R5)2 when attached to adjacent carbon atoms can be taken together as -OCF2O-, -CF2CF2O-, or -OCF2CF2O-; each R6 is independently CrC4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, C C4 haloalkyl, C2-C4 haloalkenyl, C2-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, CrC4 alkoxy, CrC4 haloalkoxy, C C4 alkylthio, -C4 alkylsulfinyl, CrC4 alkylsulfonyl, C]-C alkylamino, C2-C8 dialkylamino, C3-C6 cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C2-Cg alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl or C3-C6 trialkylsilyl;
R10 is H or C C4 alkyl or C C4 haloalkyl; R" is H or Cι-C4 alkyl; each R12 is independently CJ-CT alkyl, halogen, CN, NO and C*-C2 alkoxy; and n is 1 to 4.
2. The method of Claim 1 wherein B is O and R3 is Cj-Cg alkyl, -Cg alkenyl, C2-Cg alkynyl or C3-C6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, C--C2 alkoxy, C--C alkylthio, Cj-C2 alkylsulfinyl and C--C alkylsulfonyl.
3. The method of Claim 2 wherein J is a phenyl group substituted with 1 to 4 R5.
4. The method of Claim 3 wherein n is 1 to 2; one R4 group is attached to the K-ring at the 2-position or 5-position, and said R4 is
CrC4 alkyl, CrC4 haloalkyl, halogen, CN, NO2, CrC4 alkoxy, CrC4 haloalkoxy, Cj-C alkylthio, C- -C4 alkylsulfinyl, C--C4 alkylsulfonyl, C--C4 haloalkylthio, C--C haloalkylsulfinyl or Cj-C4 haloalkylsulfonyl; and each R5 is independently H, halogen, C--C4 alkyl, C--C2 alkoxy, C--C4 haloalkyl, CN, NO2, C - -C4 haloalkoxy, C - -C4 alkylthio, C - -C4 alkylsulfinyl, C j -C4 alkylsulfonyl, C1-C4 haloalkylthio, C1-C4 haloalkylsulfinyl, Cj-C4 haloalkylsulfonyl or C7-C4 alkoxycarbonyl; or each R5 is independently a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with R6; or ( 5)2 when attached to adjacent carbon atoms can be taken together as -OCF7O-,
-CF2CF2O- or -OCF2CF2O-.
5. The method of Claim 4 wherein
R3 is Cj-C alkyl optionally substituted with halogen, CN, OCH3 or
S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3,
CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; each R5 is independently H, halogen, methyl, CF3, OCF3, OCHF2, S(O)pCF3,
S(O)pCHF2, OCH7CF3, OCF2CHF2, S(O)pCH2CF3 or S(O)pCF2CHF2; or a phenyl, pyrazole, imidazole, triazole, pyridine or pyrimidine ring, each ring optionally substituted with -C4 alkyl, C1-C4 haloalkyl, halogen or CN; and p is 0, 1 or 2.
6. The method of Claim 5 wherein R3 is /-propyl or t-butyl.
7. The method of Claim 2 wherein J is a 5- or 6-membered heteroaromatic ring optionally substituted with 1 to 4 R5.
8. The method of Claim 7 wherein
J is a 5- or 6-membered heteroaromatic ring selected from the group consisting of J-l, J-2, J-3, J-4 and J-5, each J optionally substituted with 1 to 3 R5
Figure imgf000165_0001
J-l J-2 J-3 J-4 J.
Q is O, S or NR5; and
W, X, Y and Z are independently N or CR5, provided that in J-4 and J-5 at least one of W, X, Y or Z is N.
9. The method of Claim 8 wherein n is 1 to 2; one R4 group is attached to the K-ring at the 2-position or 5-position, and said R4 is CrC4 alkyl, CrC4 haloalkyl, halogen, CN, NO2, CrC4 alkoxy, CrC4 haloalkoxy, C--C4 alkylthio, C--C4 alkylsulfinyl, Cj-C4 alkylsulfonyl, C--C4 haloalkylthio, C1-C4 haloalkylsulfinyl, or C]-C4 haloalkylsulfonyl; and each R5 is independently H, C C4 alkyl, C--C haloalkyl, halogen, CN, NO , C--C4 haloalkoxy, Cj-C4 alkylthio, C C4 alkylsulfinyl, C C4 alkylsulfonyl, C1-C4 haloalkylthio, C--C4 haloalkylsulfinyl, Cγ-C4 haloalkylsulfonyl or C -C4 alkoxycarbonyl; or a phenyl or a 5- or 6-membered heteroaromatic ring, each ring optionally substituted with R6.
10. The method of Claim 9 wherein J substituted with 1 to 3 R5 is selected from the group consisting of J-6, J-7, J-8, J-9, J-10, J-l l, J-12 and J-13
Figure imgf000165_0002
Figure imgf000166_0001
R5 IS
Figure imgf000166_0002
V is N, CH, CF, CC1, CBr or CI; each R7 is independently H, Cj-C6 alkyl, Cj-Cg haloalkyl, halogen, CN, C C4 alkoxy,
C--C4 haloalkoxy or C C4 haloalkylthio; R9 is H, C2-C6 alkyl, CrC6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl or C3-C6 haloalkynyl, provided that R7 and R9 are not both H; and n is 0, 1 or 2.
11. The method of Claim 10 wherein J substituted with 1 to 3 R5 is J-6;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3,
OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is CH3, CF3, OCHF2 or halogen; and p is 0, 1 or 2.
12. The method of Claim 11 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R7 is halogen or CF3.
13. The method of Claim 10 wherein J substituted with 1 to 3 R5 is J-7;
R3 is C C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3,
OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, 1 or 2.
14. The method of Claim 13 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3 ;
R6 is Cl or Br; and R9 is CF3, CHF2, CBrF2) CC1F2, CH2CF3, or CF2CHF2.
15. The method of Claim 10 wherein J substituted with 1 to 3 R5 is J-8; R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN R6 is CH3, CF3 or halogen; R7 is CH3, CF3 or halogen; and p is 0, 1 or 2.
16. The method of Claim 15 wherein R3 is C--C4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and R7 is halogen or CF3.
17. The method of Claim 10 wherein J substituted with 1 to 3 R5 is J-9; R is C--C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is CH3, CF3 or halogen; and p is 0, 1 or 2.
18. The method of Claim 17 wherein R3 is C--C4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and
R7 is CF3.
19. The method of Claim 10 wherein
J substituted with 1 to 3 R5 is J-10;
R3 is C1-C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is C1-C4 alkyl, CrC4 haloalkyl, halogen or CN;
R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, lor 2.
20. The method of Claim 19 wherein R3 is C--C4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and
R9 is CF3. CHF2, CBrF2, CC1F2, CH7CF3, or CF2CHF2.
21. The method of Claim 10 wherein
J substituted with 1 to 3 R5 is J-l 1 ;
R3 is C--C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3 ;
R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN;
R7 is CH3, CF3, OCHF2 or halogen; and p is 0, 1 or 2.
22. The method of Claim 21 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and
R7 is halogen or CF3.
23. The method of Claim 10 wherein
J substituted with 1 to 3 R5 is J-l 2;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3,
OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, 1 or 2.
24. The method of Claim 23 wherein R3 is C--C4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and R9 is CF3, CHF2, CBrF2; CC1F2, CH2CF3, or CF2CHF2.
25. The method of Claim 10 wherein J substituted with 1 to 3 R5 is J-l 3; R3 is C - -C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3 ; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2) S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is CrC4 alkyl, C--C4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, 1 or 2.
26. The method of Claim 25 wherein R3 is C--C4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and R9 is CF3, CHF2, CBrF2, CC1F2, CH7CF3, or CF2CHF2.
27. The method of Claim 1 wherein the compound of Formula I is selected from the group consisting of: 8-methyl-3-(l-methylethyl)-2-[2-methyl-6-(trifluoromethyl)-3-pyridinyl]-4(3H)- quinazolinone,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3,8-dimethyl-
4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3-ethyl-8-methyl- 4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-8-methyl-3-
( 1 -methylethyl)-4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3-
(l,l-dimethylethyl)-8-methyl-4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3,8-dimethyl-
4(3H)-quinazoline, 6-chloro-2-[3-chloro-l-(3-chloiO-2-pyridinyl)-lH-pyrazol-5-yl]-3-ethyl-8-methyl-
4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-8-methyl-3-
( 1 -methyl ethyl)-4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3- (l,l-dimethylethyl)-S-methyl-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3,8- dimethyl-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-ethyl-
8-methyl-4(3H)-quinazoline, 6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-8- methyl-3-(l-methylethyl)-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-
(l,l-dimethylethyl)-8-methyl-4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-8-methyl-3-(l-methylethyl)- 4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-(l,l-dimethylethyl)-8- methyl-4(3H)-quinazoline,
2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-8-methyl-3-
( 1 -methyl ethyl)-4(3H)-quinazo line, 2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-
(1,1 -dimethyl ethyl)-8-methyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- methyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-p">τazol-5-yl]-3- ethyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-(l- methylethyl)-4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3-methyl-
4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3-ethyl-4(3H)- quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3-
(l-methylethyl)-4(3H)-quinazoline, 6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-methyl- 4(3H)-quinazoline,
6,S-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-ethyl-4(3H)- quinazoline, and 6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-
(l-methylethyl)-4(3H)-quinazoline.
28. The method of Claim 1 wherein the compound of Formula I is comprised in a composition, said composition optionally further comprising an effective amount of at least one additional biologically active compound or agent.
29. The method of Claim 28 wherein at least one additional biologically active compound or agent is selected from arthropodicides of the group consisting of pyrethroids, carbamates, neonicotinoids, neuronal sodium channel blockers, insecticidal macrocyclic lactones, γ-aminobutyric acid (GABA) antagonists, insecticidal ureas and juvenile hormone mimics.
30. The method of Claim 28 wherein at least one additional biologically active compound or agent is selected from insecticide, nematocide, acaricide or biological agents in the group consisting of abamectin, acephate, acetamiprid, avermectin, azadirachtin, azinphos-methyl, bifenthrin, binfenazate, buprofezin, carbofuran, chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, cliromafenozide, clothianidin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, diflubenzuron, dimethoate, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, fenothicarb, fenoxycarb, fenpropathrin, fenproximate, fenvalerate, fipronil, flonicamid, flucythrinate, tau-fluvalinate, flufenoxuron, fonophos, halofenozide, hexaflumuron, imidacloprid, indoxacarb, isofenphos, lufenuron, malathion, metaldehyde, methamidophos, methidathion, methomyl, methoprene, methoxychlor, monocrotophos, methoxyfenozide, nithiazin, novaluron, oxamyl, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, pymetrozine, pyridalyl, pyriproxyfen, rotenone, spinosad, sulprofos, tebufenozide, teflubenzuron, teflutl rin, terbufos, tetrachlorvinphos, thiacloprid, thiamethoxam, tliiodicarb, thiosultap-sodium, tralomethrin, trichlorfon and triflumuron, aldicarb, oxamyl, fenamiphos, amitraz, chinomethionat, chlorobenzilate, cyhexatin, dicofol, dienochlor, etoxazole, fenazaquin, fenbutatin oxide, fenpropathrin, fenpyroximate, hexythiazox, propargite, pyridaben, tebufenpyrad, Bacillus thiiringiensis, Bacillus thiiringiensis delta endotoxin, baculovirus, and entomopathogenic bacteria, vims and fungi.
31. The method of Claim 30 wherein at least one additional biologically active compound or agent is selected from insecticide, nematocide, acaricide or biological agents in the group consisting of cypermethrin, cyhalothrin, cyfluthrin and beta-cyfluthrin, esfenvalerate, fenvalerate, tralomethrin, fenothicarb, methomyl, oxamyl, thiodicarb, clothianidin, imidacloprid, thiacloprid, indoxacarb, spinosad, abamectin, aveπnectin, emamectin, endosulfan, ethiprole, fipronil, flufenoxuron, triflumuron, diofenolan, pyriproxyfen, pymetrozine, amitraz, Bacillus thiiringiensis, Bacillus thiiringiensis delta endotoxin and entomophagous fungi.
32. The method of Claim 1 wherein at least one insect pest controlled is selected from the group consisting oi Alabama argillacea Hϋbner (cotton leaf worm), Archips argyrospila Walker (fruit tree leaf roller), A. rosana Linnaeus (European leaf roller) and other Archips species, Chilo suppressalis Walker (rice stem borer), Cnaphalocrosis medinalis Guenee (rice leaf roller), Crambus caliginosellus Clemens (co root webworm), Crambus teterrellus Zincken (bluegrass webworm), Cydia pomonella Linnaeus (codling moth), Earias insulana Boisduval (spiny bollworm), Earias vittella Fabricius (spotted bollworm), Helicoverpa armigera Hϋbner (American bollworm), Helicoverpa zea Boddie (com earworm), Heliothis virescens Fabricius (tobacco budworm), Herpetogramma licarsisalis Walker (sod webworm), Lobesia botrana Denis & Schiffermϋller (grape berry moth), Pectinophora gossypiella Saunders (pink bollworm), Phyllocnistis citrella Stainton (citrus leafminer), Pieris brassicae Linnaeus (large white butterfly), Pieris rapae Linnaeus (small white butterfly), Plutella xylostella Linnaeus (diamondback moth), Spodoptera exigua Hϋbner (beet armyworm), Spodoptera litura Fabricius (tobacco cutworm, cluster caterpillar), Spodoptera frugiperda J. E. Smith (fall armyworm), Trichoplusia ni Hϋbner (cabbage looper) and Tuta absoluta Meyrick (tomato leafminer), Acyrthisiphon pisum Harris (pea ■ aphid), Aphis craccivora Koch (cowpea aphid), Aphis fabae Scopoli (black bean aphid), Aphis gossypii Glover (cotton aphid, melon aphid), Aphis pomi De Geer (apple aphid), Aphis spiraecola Patch (spirea aphid), Aiilacorthum solani Kaltenbach (foxglove aphid), Chaetosiphon fragaefolii Cockerell (strawberry aphid), Diuraphis noxia Kurdjumov/Mordvilko (Russian wheat aphid), Dysaphis plantaginea Paaserini (rosy apple aphid), Eriosoma lanigerum Hausmann (woolly apple aphid), Hyalopterus pruni Geoffroy (mealy plum aphid), Lipaphis e ysimi Kaltenbach (turnip aphid), Metopolophium dirrhodum Walker (cereal aphid), Macrosipum euphorbiae Thomas (potato aphid), Myzus persicae Sulzer (peach-potato aphid, green peach aphid), Nasonovia ribisnigri Mosley (lettuce aphid), Pemphigus spp. (root aphids and gall aphids), Rhopalosiphum maidis Fitch (com leaf aphid), Rhopalosiphum padi Limiaeus (bird cherry-oat aphid), Schizaphis gramimtm Rondani (greenbug), Sitobion avenae Fabricius (English grain aphid), Therioaphis maculata Buckton (spotted alfalfa aphid), Toxoptera aurantii Boyer de Fonscolombe (black citrus aphid), and Toxoptera citricida Kirkaldy (brown citms aphid); Adelges spp. (adelgids); Phylloxera devastatrix Pergande (pecan phylloxera); Bemisia tabaci Gennadius (tobacco whitefly, sweetpotato whitefly), Bemisia argentifolii Bellows & Perring (silverleaf whitefly), Dialeurodes citri Ashmead (cit s whitefly) and Trialeurodes vaporariorum Westwood (greenhouse whitefly); Empoasca fabae Harris (potato leafhopper), Laodelphax striatellus Fallen (smaller brown planthopper), Macrolestes quadrilineatus Forbes (aster leafhopper), Nephotettix cinticeps Uhler (green leafhopper), Nephotettix nigropictus Stal (rice leafhopper), Nilapa -vata lugens Stal (brown planthopper), Peregrinus maidis Ashmead (com planthopper), Sogatella furcifera Horvath (white-backed planthopper), Sogatodes orizicola Muir (rice delphacid), Typhlocyba pomaria McAtee white apple leafhopper, Eiγthroneoura spp. (grape leafhoppers); Magicidada septendecim Linnaeus (periodical cicada); Iceiγa purchasi Maskell (cottony cushion scale), Quadraspidiotus perniciosas Comstock (San Jose scale); Planococcus citri Risso (citms mealybug); Pseitdococcus spp. (other mealybug complex); Cacopsγlla pyricola Foerster (pear psylla), Trioza diospyri Ashmead (persimmon psylla), Acrosternum hilare Say (green stink bug), Anasa tristis De Geer (squash bug), Blissus leucopterus leucopterus Say (chinch bug), Coiγthuca gossypii Fabricius (cotton lace bug), Cyrtopeltis modesta Distant (tomato bug), Dysdercus suturellus Herrich-Schaffer (cotton stainer), Euchistus servus Say (brown stink bug), Euchistus variolarius Palisot de Beauvois (one-spotted stink bug), Graptosthetus spp. (complex of seed bugs), Leptoglossus corculus Say (leaf- footed pine seed bug), Lygus lineolaris Palisot de Beauvois (tarnished plant bug), Nezara viridula Linnaeus (southern green stink bug), Oebalus pugnax Fabricius (rice stink bug), Oncopeltus fasciatus Dallas (large milkweed bug), Pseudatomoscelis seriatus Reuter (cotton fleahopper), Frankliniella occidentalis Pergande (western flower thrip), Scirthothrips citri Moulton (citms thrip), Sericothrips variabilis Beach (soybean thrip), and Thrips tabaci Lindeman (onion thrip), Leptinotarsa decemlineata Say (Colorado potato beetle), Epilachna varivestis Mulsant (Mexican bean beetle) and wireworms of the genera Agriotes, Athous or Limonius).
33. A compound of Formula la, its N-oxide or an agriculturally suitable salt of the compound
Figure imgf000173_0001
la
wherein
K is, together with the two contiguous linking carbon atoms, a fused phenyl or a fused pyridinyl ring selected from the group consisting of K-l, K-2, K-3, K-4 and K-5, each optionally substituted with 1 to 4 R4
Figure imgf000174_0001
J substituted with 1 to 3 R5 is selected from the group consisting of J-6, J-7, J-8, J-9, J-10, J-l l, J-12 and J-13
Figure imgf000174_0002
Figure imgf000174_0003
R3 is Cj-Cg alkyl, C2-C6 alkenyl, C2-Cg alkynyl or C3-C6 cycloalkyl each optionally substituted with one or more substituents selected from the group consisting of halogen, CN, CrC2 alkoxy, CrC2 alkylthio, CrC2 alkylsulfinyl and CrC2 alkylsulfonyl; one R4 group is attached to the K-ring at the 2-position or 5-position, and said R4 is CrC alkyl, CrC4 haloalkyl, halogen, CN, NO2, CrC4 alkoxy, CrC4 haloalkoxy, -C4 alkylthio, -C4 alkylsulfinyl, -C4 alkylsulfonyl, C-A4 haloalkylthio, -C4 haloalkylsulfinyl, or CJ-C4 haloalkylsulfonyl; and an optional second R4 is H, CrC6 alkyl, C2-C6 alkenyl, C2-Cg alkynyl, C3-C6 cycloalkyl, C--C6 haloalkyl, C2-Cg haloalkenyl, C7-C6 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, hydroxy, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, Cj-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, C--C4 haloalkylthio, Cj-C4 haloalkylsulfinyl, C C4 haloalkylsulfonyl, CrC4 alkylamino, C2-C8 dialkylamino, C3-C6 cycloalkylamino, Ct-C4 alkoxyalkyl, C--C hydroxyalkyl, C(O)R10, CO2R10, C^NR^ 1 NR10RJ *, N(R* ^COR-O, N(R* ^CO^10 or C3-C6 trialkylsilyl; R5 is
Figure imgf000175_0001
V is N, CH, CF, CC1, CBr or CI; each R6 is independently Cj-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C3-C6 cycloalkyl, C]-C4 haloalkyl, C7-C4 haloalkenyl, C7-C4 haloalkynyl, C3-C6 halocycloalkyl, halogen, CN, NO2, C1-C4 alkoxy, C1-C4 haloalkoxy, C1-C4 alkylthio, C1-C4 alkylsulfinyl, C1-C4 alkylsulfonyl, CrC4 alkylamino, C2-Cg dialkylamino, C3- Cg cycloalkylamino, C3-C6 (alkyl)cycloalkylamino, C2-C4 alkylcarbonyl, C2-Cg alkoxycarbonyl, C2-Cg alkylaminocarbonyl, C3-C8 dialkylaminocarbonyl or C3- C6 trialkylsilyl; each R7 is independently H, Cj-Cg alkyl, C Cg haloalkyl, halogen, CN, C--C4 alkoxy, C1-C4 haloalkoxy or C1-C4 haloalkylthio;
R9 is H, C2-C6 alkyl, CrC6 haloalkyl, C3-C6 alkenyl, C3-C6 haloalkenyl, C3-C6 alkynyl or C3-C6 haloalkynyl, provided that R7 and R9 are not both H; R10 is H or C--C4 alkyl or C*-C4 haloalkyl;
R11 is H or C!-C4 alkyl; and n is 0, 1 or 2.
34. The compound of Claim 33 wherein J substituted with 1 to 3 R5 is J-6; R3 is C-J-C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R7 is CH3, CF3, OCHF2 or halogen; and p is 0, 1 or 2.
35. The compound of Claim 34 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R7 is halogen or CF3.
36. The compound of Claim 33 wherein J substituted with 1 to 3 R5 is J-7;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3,
OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is C - -C4 alkyl, C - -C4 haloalkyl, halogen or CN;
R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, 1 or 2.
37. The compound of Claim 36 wherein R3 is C--C4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2.
38. The compound of Claim 33 wherein J substituted with 1 to 3 R5 is J-8;
R3 is C--C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3,
OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is C--C4 alkyl, CrC4 haloalkyl, halogen or CN R6 is CH3, CF3 or halogen;
R7 is CH3, CF3 or halogen; and p is 0, 1 or 2.
39. The compound of Claim 38 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R7 is halogen or CF3.
40. The compound of Claim 33 wherein J substituted with 1 to 3 R5 is J-9;
R3 is C--C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is C--C4 alkyl, CrC4 haloalkyl, halogen or CN;
R7 is CH3, CF3 or halogen; and p is 0, 1 or 2.
41. The compound of Claim 40 wherein
R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and R7 is CF3.
42. The compound of Claim 33 wherein
J substituted with 1 to 3 R5 is J-10;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is C--C4 alkyl, CrC4 haloalkyl, halogen or CN;
R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, 1 or 2.
43. The compound of Claim 42 wherein
R3 is C--C4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and R9 is CF3, CHF2, CBrF2, CC1F2, CH7CF3, or CF2CHF2.
44. The compound of Claim 33 wherein
J substituted with 1 to 3 R5 is J-l 1;
R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN;
R7 is CH3, CF3, OCHF2 or halogen; and p is 0, 1 or 2.
45. The compound of Claim 44 wherein
R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3; R6 is Cl or Br; and R7 is halogen or CF3.
46. The compound of Claim 33 wherein J substituted with 1 to 3 R5 is J-l 2; R3 is C--C4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3,
OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3; R6 is CrC4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, 1 or 2.
47. The compound of Claim 46 wherein R3 is C--C4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3 ;
R6 is Cl or Br; and R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2.
48. The compound of Claim 33 wherein J substituted with 1 to 3 R5 is J-l 3; R3 is CrC4 alkyl optionally substituted with halogen, CN, OCH3, S(O)pCH3; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, CF3, OCF3, OCHF2, S(O)pCF3, S(O)pCHF2, CN or halogen; a second R4 is H, F, Cl, Br, I or CF3;
R6 is C--C4 alkyl, CrC4 haloalkyl, halogen or CN; R9 is C2-C6 alkyl or CrC6 haloalkyl; and p is 0, 1 or 2.
49. The compound of Claim 48 wherein R3 is CrC4 alkyl; one R4 group is attached to the K-ring at the 2-position and said R4 is CH3, Cl or Br; a second R4 is H, F, Cl, Br, I or CF3;
R6 is Cl or Br; and R9 is CF3, CHF2, CBrF2, CC1F2, CH2CF3, or CF2CHF2.
50. The compound of Claim 33 selected from the group consisting of: 8-methyl-3-(l-methylethyl)-2-[2-methyl-6-(trifluoromethyl)-3-pyridinyl]-4(3H)- quinazolinone,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3,8-dimethyl- 4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3-ethyl-8-methyl-
4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2 -pyridinyl)- lH-pyrazol-5-yl]-6-chloro-8-methyl-3-
( 1 -methylethyl)-4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6-chloro-3-
(l,l-dimethylethyl)-8-methyl-4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2 -pyridinyl)- lH-pyrazol-5-yl]-3,8-dimethyl-
4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-ethyl-8-methyl- 4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-8-methyl-3-
( 1 -methylethyl)-4(3H)-quinazoline,
6-chloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-
(1,1 -dimethyl ethyl)-8-methyl-4(3H)-quinazoline, 6-chloro-2-[ 1 -(3 -chloro-2-pyridinyl)-3 -(trifluoromethyl)- 1 H-pyrazol-5-yl] -3 , 8- dimethyl-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-ethyl-
S-methyl-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-8- methyl-3-(l -methyl ethyl)-4(3H)-quinazoline,
6-chloro-2-[l-(3-chloiO-2-pyridinyl)-3-(trifluoroniethyl)-lH-pyrazol-5-yl]-3-
(1,1 -dimethylethyl)-8-methyl-4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-S-methyl-3-(l-methylethyl)-
4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-(l,l-dimethylethyl)-8- methyl-4(3H)-quinazoline,
2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-8-methyl-3-
( 1 -methylethyl)-4(3H)-quinazoline,
2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- (l,l-dimethylethyl)-8-methyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- methyl-4(3H)-quinazoline,
6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3- ethyl-4(3H)-quinazoline, 6,8-dichloro-2-[l-(3-chloro-2-pyridinyl)-3-(trifluoromethyl)-lH-pyrazol-5-yl]-3-(l- methylethyl)-4(3H)-quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,S-dichloiO-3-methyl-
4(3H)-quinazoline, 2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3-ethyl-4(3H)- quinazoline,
2-[3-bromo-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-6,8-dichloro-3- ( 1 -methyl ethyl)-4(3H)-quinazoline, 6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-methyl-
4(3H)-quinazoline,
6,8-dichloro-2-[3-chloro-l-(3-chloro-2-pyridinyl)-lH-pyrazol-5-yl]-3-ethyl-4(3H)- quinazoline, and
6, 8-dichloro-2- [3-chloro- 1 -(3 -chloro-2-pyridinyl)- 1 H-pyrazol-5 -yl] -3- (1 -methylethyl)-4(3H)-quinazoline.
51. A composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Fomiula la of Claim 33 and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.
52. A composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Fomiula la of Claim 33 and an effective amount of at least one additional biologically active compound or agent.
PCT/US2001/046629 2000-12-11 2001-12-03 Quinazolinones and pyridinopyrimidinones for controlling invertebrate pests WO2002048115A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US10/433,368 US20040110777A1 (en) 2001-12-03 2001-12-03 Quinazolinones and pyridinylpyrimidinones for controlling invertebrate pests
AU2002227243A AU2002227243A1 (en) 2000-12-11 2001-12-03 Quinazolinones and pyridinopyrimidinones for controlling invertebrate pests
JP2002549646A JP2004515543A (en) 2000-12-11 2001-12-03 Quinazolinones and pyridinyl pyrimidinones for controlling pest invertebrates
EP01996125A EP1341772A2 (en) 2000-12-11 2001-12-03 Quinazolinones and pyridinylpyrimidinones for controlling invertebrate pests

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25461400P 2000-12-11 2000-12-11
US60/254,614 2000-12-11

Publications (2)

Publication Number Publication Date
WO2002048115A2 true WO2002048115A2 (en) 2002-06-20
WO2002048115A3 WO2002048115A3 (en) 2002-09-06

Family

ID=22964948

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/046629 WO2002048115A2 (en) 2000-12-11 2001-12-03 Quinazolinones and pyridinopyrimidinones for controlling invertebrate pests

Country Status (4)

Country Link
EP (1) EP1341772A2 (en)
JP (1) JP2004515543A (en)
AU (1) AU2002227243A1 (en)
WO (1) WO2002048115A2 (en)

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003016300A1 (en) * 2001-08-15 2003-02-27 E. I. Du Pont De Nemours And Company Ortho-substituted aryl amides for controlling invertebrate pests
WO2003015518A1 (en) * 2001-08-13 2003-02-27 E.I. Du Pont De Nemours And Company Method for controlling particular insect pests by applying anthranilamide compounds
WO2003015519A1 (en) * 2001-08-13 2003-02-27 E.I. Du Pont De Nemours And Company Arthropodicidal anthranilamides
JP2006501203A (en) * 2002-07-31 2006-01-12 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー Process for the preparation of condensed oxazinones from ortho-aminoaromatic carboxylic acids and carboxylic acids in the presence of sulfonyl chloride and pyridine
US7038057B2 (en) 2001-08-13 2006-05-02 E.I. Du Pont De Nemours And Company Substituted 1H-dihydropyrazoles, their preparation and use
JP2006514650A (en) * 2002-12-27 2006-05-11 テイボテク・ビーブイビーエイ Fluorescent enzyme substrate and preparation method
JP2006517592A (en) * 2003-02-12 2006-07-27 バイオジェン・アイデック・エムエイ・インコーポレイテッド Pyrazole and methods of making and using them
US7087598B2 (en) * 2001-05-21 2006-08-08 E. I. Du Pont De Nemours And Company Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring
EP1944304A1 (en) * 2001-08-13 2008-07-16 E.I.Du pont de nemours and company Novel sustituted 1H-dihydropyrazoles, their preparation and use
DE102007061764A1 (en) 2007-12-20 2009-06-25 Bayer Healthcare Ag Anellated cyanopyridines and their use
US7696232B2 (en) 2001-09-21 2010-04-13 E. I. Du Pont De Nemours And Company Anthranilamide arthropodicide treatment
EP2213167A1 (en) 2006-01-16 2010-08-04 Syngenta Participations AG Anthranilamide derivatives and their use for the control of insects and acari
EP2266962A1 (en) * 2008-03-13 2010-12-29 Guangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences The compounds as the estrogen related receptors modulators and the uses thereof
CN102260245A (en) * 2011-06-02 2011-11-30 南开大学 2,3-dihydro-quinazolinone derivative, and preparation method and application thereof
CN102285971A (en) * 2010-06-21 2011-12-21 中国中化股份有限公司 Pyrazolyl quinazolinone compound and application thereof
US8084459B2 (en) 2004-04-02 2011-12-27 Prana Biotechnology Ltd Substituted quinazolinones for treating neurological conditions
WO2012020780A1 (en) * 2010-08-10 2012-02-16 武田薬品工業株式会社 Heterocyclic compound and use thereof
US8242281B2 (en) 2001-03-07 2012-08-14 Bayer Intellectual Property Gmbh Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands
US8304412B2 (en) 2006-12-01 2012-11-06 Bayer Intellectual Property Gmbh Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof
CN101380020B (en) * 2008-07-17 2012-11-07 张少武 Acaricide composition containing fenpyroximate with synergistic action
US8420825B2 (en) 2009-01-29 2013-04-16 Bayer Intellectual Property Gmbh Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs
US8426602B2 (en) 2008-03-11 2013-04-23 Bayer Intellectual Property Gmbh Heteroaryl-substituted dicyanopyridines and their use
US8440700B2 (en) 2007-07-27 2013-05-14 Bayer Intellectual Property Gmbh Substituted aryloxazoles and their use
CN103355340A (en) * 2012-03-31 2013-10-23 陕西韦尔奇作物保护有限公司 Insecticidal composition containing pyridalyl
US8609686B2 (en) 2007-12-20 2013-12-17 Bayer Intellectual Property Gmbh Substituted azabicyclic compounds and the use thereof
US8653109B2 (en) 2006-09-08 2014-02-18 Bayer Intellectual Property Gmbh Substituted bipyridine derivatives and their use as adenosine receptor ligands
US8691850B2 (en) 2004-09-03 2014-04-08 Bayer Intellectual Property Gmbh Substituted phenylaminothiazoles and use thereof
US8703934B2 (en) 2006-12-01 2014-04-22 Bayer Intellectual Property Gmbh Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof
US8703696B2 (en) 2007-08-01 2014-04-22 Bayer Intellectual Property Gmbh Dipeptoid prodrugs and the use thereof
US8741834B2 (en) 2008-12-16 2014-06-03 Bayer Intellectual Property Gmbh Dipeptoid prodrugs and the use thereof
US8791146B2 (en) 2008-05-29 2014-07-29 Bayer Intellectual Property Gmbh 2-alkoxy-substituted dicyanopyridines and their use
US8853221B2 (en) 2008-07-18 2014-10-07 Guangzhou Institute Of Biomedicine & Health, Chinese Academy Of Sciences Compounds of estrogen-related receptor modulators and the uses thereof
US8993483B2 (en) 2003-11-14 2015-03-31 Bayer Intellectual Property Gmbh Combination of active substances with insecticidal properties
CN104542691A (en) * 2011-05-04 2015-04-29 陕西韦尔奇作物保护有限公司 Pesticide composition containing etoxazole
US9040566B2 (en) 2010-09-02 2015-05-26 Bayer Intellectual Property Gmbh Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
US9187428B2 (en) 2010-06-30 2015-11-17 Bayer Intellectual Property Gmbh Substituted dicyanopyridines and use thereof
EP2865671A4 (en) * 2012-06-22 2015-11-25 Sumitomo Chemical Co Fused heterocyclic compound
CN105418590A (en) * 2014-09-18 2016-03-23 沈阳中化农药化工研发有限公司 6-substituted pyrazolyl quinazolinone compound and use thereof
CN105532711A (en) * 2016-01-15 2016-05-04 陕西上格之路生物科学有限公司 Insecticidal composition containing clothianidin and cyromazine and application of composition
US11957759B1 (en) 2022-09-07 2024-04-16 Arvinas Operations, Inc. Rapidly accelerated fibrosarcoma (RAF) degrading compounds and associated methods of use

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI363756B (en) * 2004-12-07 2012-05-11 Du Pont Method for preparing n-phenylpyrazole-1-carboxamides

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0579424A1 (en) * 1992-07-17 1994-01-19 Rohm And Haas Company 2-substituted pyrimidines and herbicidal use thereof
US5378678A (en) * 1992-07-17 1995-01-03 Rohm And Haas Company 2-aryl-5,6-ring-fused pyrimidines and herbicidal use
WO1999014202A2 (en) * 1997-09-12 1999-03-25 Novartis Ag Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide
US5998455A (en) * 1995-06-16 1999-12-07 Novarits Crop Protection, Inc. Crop protection compositions
US6114340A (en) * 1996-06-28 2000-09-05 Agrevo Uk Limited Fungicidal compositions

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0579424A1 (en) * 1992-07-17 1994-01-19 Rohm And Haas Company 2-substituted pyrimidines and herbicidal use thereof
US5378678A (en) * 1992-07-17 1995-01-03 Rohm And Haas Company 2-aryl-5,6-ring-fused pyrimidines and herbicidal use
EP0696588A1 (en) * 1992-07-17 1996-02-14 Rohm And Haas Company 2-Arylpyrimidines and herbicidal use thereof
US5998455A (en) * 1995-06-16 1999-12-07 Novarits Crop Protection, Inc. Crop protection compositions
US6114340A (en) * 1996-06-28 2000-09-05 Agrevo Uk Limited Fungicidal compositions
WO1999014202A2 (en) * 1997-09-12 1999-03-25 Novartis Ag Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE CHEMABS [Online] CHEMICAL ABSRACTS SERVICE,COLUMBUS OHIO; CHAURASIA M.R.ETAL: "SYNTHESIS OF SOME NEW 4 (3H) QUINAZOLINONES AS POTENTIAL FUNGICIDES" XP002198896 & J.NEPAL CHEM.SOC., vol. 1, no. 1, 1981, pages 11-17, *
DATABASE CHEMABS [Online] CHEMICAL ABSTRACTS SERVICE,COLUMBUS OHIO; GUPTA,ANIL K. SEN ET AL: "SYNTHESIS AND PESTICIDAL ACTIVITY OF SOME QUINAZOLIN-4(3H)-ONE DERIVATIVES" XP002198895 & PESTIC.SCI., vol. 26, no. 1, 1989, page 41-9 *

Cited By (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8242281B2 (en) 2001-03-07 2012-08-14 Bayer Intellectual Property Gmbh Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands
US7087598B2 (en) * 2001-05-21 2006-08-08 E. I. Du Pont De Nemours And Company Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring
US9029365B2 (en) 2001-08-13 2015-05-12 E I Du Pont De Nemours And Company Arthropodicidal anthranilamides
WO2003015518A1 (en) * 2001-08-13 2003-02-27 E.I. Du Pont De Nemours And Company Method for controlling particular insect pests by applying anthranilamide compounds
US9084422B2 (en) 2001-08-13 2015-07-21 E I Du Pont De Nemours And Company Anthranilamides compositions
US9078437B2 (en) 2001-08-13 2015-07-14 E I Du Pont De Nemours And Company Arthropodicidal anthranilamides
US8148521B2 (en) 2001-08-13 2012-04-03 E.I. Du Pont De Nemours And Company Arthropodicidal anthranilamides
WO2003015519A1 (en) * 2001-08-13 2003-02-27 E.I. Du Pont De Nemours And Company Arthropodicidal anthranilamides
US7232836B2 (en) 2001-08-13 2007-06-19 E. I. Du Pont De Nemours And Company Arthropodicidal anthranilamides
US8697734B2 (en) 2001-08-13 2014-04-15 E I Du Pont De Nemours And Company Method for controlling particular insect pests by applying anthranilamide compounds
EP1944304A1 (en) * 2001-08-13 2008-07-16 E.I.Du pont de nemours and company Novel sustituted 1H-dihydropyrazoles, their preparation and use
US9445593B1 (en) 2001-08-13 2016-09-20 E I Du Pont De Nemours And Company Arthropodicidal anthranilamides
US7622595B2 (en) 2001-08-13 2009-11-24 E.I. Du Pont De Nemours And Company Substituted 1H-dihydropyrazoles, their preparation and use
US7696233B2 (en) 2001-08-13 2010-04-13 E. I. Du Pont De Nemours And Company Method for controlling particular insect pests by applying anthranilamide compounds
US8158802B2 (en) 2001-08-13 2012-04-17 E.I. Du Pont De Nemours And Company Arthropodicidal anthranilamides
US7038057B2 (en) 2001-08-13 2006-05-02 E.I. Du Pont De Nemours And Company Substituted 1H-dihydropyrazoles, their preparation and use
US8921400B2 (en) 2001-08-13 2014-12-30 E I Du Pont De Nemours And Company Arthropodicidal anthranilamides
US7902231B2 (en) 2001-08-13 2011-03-08 E.I. Du Pont De Nemours And Company Anthropodicidal anthranilamides
US7932395B2 (en) 2001-08-13 2011-04-26 E. I. Du Pont De Nemours And Company Substituted 1H-dihydropyrazoles, their preparation and use
US9049862B2 (en) 2001-08-13 2015-06-09 E I Du Pont De Nemours And Company Arthropodicidal anthranilamides
US9049861B2 (en) 2001-08-13 2015-06-09 E I Du Pont De Nemours And Company Arthropodicidal anthranilamides
WO2003016300A1 (en) * 2001-08-15 2003-02-27 E. I. Du Pont De Nemours And Company Ortho-substituted aryl amides for controlling invertebrate pests
US7288554B2 (en) 2001-08-15 2007-10-30 E.I. Du Pont De Nemours And Company Ortho-substituted aryl amides for controlling invertebrate pests
US8637552B2 (en) 2001-09-21 2014-01-28 E I Du Pont De Nemours And Company Anthranilamide arthropodicide treatment
US7696232B2 (en) 2001-09-21 2010-04-13 E. I. Du Pont De Nemours And Company Anthranilamide arthropodicide treatment
JP2006501203A (en) * 2002-07-31 2006-01-12 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー Process for the preparation of condensed oxazinones from ortho-aminoaromatic carboxylic acids and carboxylic acids in the presence of sulfonyl chloride and pyridine
JP2006514650A (en) * 2002-12-27 2006-05-11 テイボテク・ビーブイビーエイ Fluorescent enzyme substrate and preparation method
JP2006517592A (en) * 2003-02-12 2006-07-27 バイオジェン・アイデック・エムエイ・インコーポレイテッド Pyrazole and methods of making and using them
US8993483B2 (en) 2003-11-14 2015-03-31 Bayer Intellectual Property Gmbh Combination of active substances with insecticidal properties
US8084459B2 (en) 2004-04-02 2011-12-27 Prana Biotechnology Ltd Substituted quinazolinones for treating neurological conditions
US8691850B2 (en) 2004-09-03 2014-04-08 Bayer Intellectual Property Gmbh Substituted phenylaminothiazoles and use thereof
EP2213167A1 (en) 2006-01-16 2010-08-04 Syngenta Participations AG Anthranilamide derivatives and their use for the control of insects and acari
US8653109B2 (en) 2006-09-08 2014-02-18 Bayer Intellectual Property Gmbh Substituted bipyridine derivatives and their use as adenosine receptor ligands
US8304412B2 (en) 2006-12-01 2012-11-06 Bayer Intellectual Property Gmbh Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof
US8703934B2 (en) 2006-12-01 2014-04-22 Bayer Intellectual Property Gmbh Substituted 4-amino-3,5-dicyano-2-thiopyridines and use thereof
US9095582B2 (en) 2007-07-27 2015-08-04 Bayer Intellectual Property Gmbh Substituted aryloxazoles and their use
US8440700B2 (en) 2007-07-27 2013-05-14 Bayer Intellectual Property Gmbh Substituted aryloxazoles and their use
US8703696B2 (en) 2007-08-01 2014-04-22 Bayer Intellectual Property Gmbh Dipeptoid prodrugs and the use thereof
US8618119B2 (en) 2007-12-20 2013-12-31 Bayer Intellectual Property Gmbh Fused cyanopyridines and the use thereof
DE102007061764A1 (en) 2007-12-20 2009-06-25 Bayer Healthcare Ag Anellated cyanopyridines and their use
US8609686B2 (en) 2007-12-20 2013-12-17 Bayer Intellectual Property Gmbh Substituted azabicyclic compounds and the use thereof
EP2556831A1 (en) 2007-12-20 2013-02-13 Bayer Intellectual Property GmbH 3,4-Dihydro-4-oxo-5-aryl-pyrido[2,3-d]pyrimidine-6-carbonitriles as Adenosin Receptor Ligands for Treatment of Cardiovascular Diseases
EP2556856A1 (en) 2007-12-20 2013-02-13 Bayer Intellectual Property GmbH 6-Cyano-substituted Pyrido[2,3-d]pyrimidines as Adenosin Rezeptor Ligands for the Treatment of Cardiovascular Diseases
US8426602B2 (en) 2008-03-11 2013-04-23 Bayer Intellectual Property Gmbh Heteroaryl-substituted dicyanopyridines and their use
EP2266962A4 (en) * 2008-03-13 2011-12-07 Guangzhou Inst Biomed & Health The compounds as the estrogen related receptors modulators and the uses thereof
EP2266962A1 (en) * 2008-03-13 2010-12-29 Guangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences The compounds as the estrogen related receptors modulators and the uses thereof
JP2011513441A (en) * 2008-03-13 2011-04-28 グアンジョウ インスティテュート オブ バイオメディスン アンド ヘルス,チャイニーズ アカデミー オブ サイエンスィズ Estrogen-related receptor modulator compounds and uses thereof
JP2014141522A (en) * 2008-03-13 2014-08-07 Guangzhou Institute Of Biomedicine And Health Chinese Academy Of Sciences Estrogen related receptor modulator compound and use thereof
US8791146B2 (en) 2008-05-29 2014-07-29 Bayer Intellectual Property Gmbh 2-alkoxy-substituted dicyanopyridines and their use
CN101380020B (en) * 2008-07-17 2012-11-07 张少武 Acaricide composition containing fenpyroximate with synergistic action
US8853221B2 (en) 2008-07-18 2014-10-07 Guangzhou Institute Of Biomedicine & Health, Chinese Academy Of Sciences Compounds of estrogen-related receptor modulators and the uses thereof
US8741834B2 (en) 2008-12-16 2014-06-03 Bayer Intellectual Property Gmbh Dipeptoid prodrugs and the use thereof
US8420825B2 (en) 2009-01-29 2013-04-16 Bayer Intellectual Property Gmbh Alkylamino-substituted dicyanopyridines and their amino acid ester prodrugs
CN102285971A (en) * 2010-06-21 2011-12-21 中国中化股份有限公司 Pyrazolyl quinazolinone compound and application thereof
WO2011160569A1 (en) * 2010-06-21 2011-12-29 中国中化股份有限公司 Pyrazolyl quinazolone compounds and uses thereof
CN102285971B (en) * 2010-06-21 2013-12-18 中国中化股份有限公司 Pyrazolyl quinazolinone compound and application thereof
US9187428B2 (en) 2010-06-30 2015-11-17 Bayer Intellectual Property Gmbh Substituted dicyanopyridines and use thereof
US9150588B2 (en) 2010-08-10 2015-10-06 Takeda Pharmaceutical Company Limited Substituted pyridazin-4(1H)-ones as phosphodiesterase 10A inhibitors
WO2012020780A1 (en) * 2010-08-10 2012-02-16 武田薬品工業株式会社 Heterocyclic compound and use thereof
US9040566B2 (en) 2010-09-02 2015-05-26 Bayer Intellectual Property Gmbh Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension
CN104542691A (en) * 2011-05-04 2015-04-29 陕西韦尔奇作物保护有限公司 Pesticide composition containing etoxazole
CN102260245A (en) * 2011-06-02 2011-11-30 南开大学 2,3-dihydro-quinazolinone derivative, and preparation method and application thereof
CN103355340A (en) * 2012-03-31 2013-10-23 陕西韦尔奇作物保护有限公司 Insecticidal composition containing pyridalyl
CN103355340B (en) * 2012-03-31 2016-02-17 陕西韦尔奇作物保护有限公司 A kind of Pesticidal combination containing pyridalyl
EP2865671A4 (en) * 2012-06-22 2015-11-25 Sumitomo Chemical Co Fused heterocyclic compound
CN105418590A (en) * 2014-09-18 2016-03-23 沈阳中化农药化工研发有限公司 6-substituted pyrazolyl quinazolinone compound and use thereof
CN105418590B (en) * 2014-09-18 2018-06-29 沈阳中化农药化工研发有限公司 6- substituted pyrazolecarboxylic base quianzolinones and application thereof
CN105532711A (en) * 2016-01-15 2016-05-04 陕西上格之路生物科学有限公司 Insecticidal composition containing clothianidin and cyromazine and application of composition
US11957759B1 (en) 2022-09-07 2024-04-16 Arvinas Operations, Inc. Rapidly accelerated fibrosarcoma (RAF) degrading compounds and associated methods of use

Also Published As

Publication number Publication date
WO2002048115A3 (en) 2002-09-06
EP1341772A2 (en) 2003-09-10
JP2004515543A (en) 2004-05-27
AU2002227243A1 (en) 2002-06-24

Similar Documents

Publication Publication Date Title
AU2003212811B2 (en) Quinazoline(di) ones for invertebrate pest control
AU2002331706B2 (en) Ortho-substituted aryl amides for controlling invertebrate pests
AU2002254107B2 (en) Heterocyclic diamide invertebrate pest control agents
EP1341772A2 (en) Quinazolinones and pyridinylpyrimidinones for controlling invertebrate pests
AU2003295491B2 (en) Novel anthranilamide insecticides
US20040242645A1 (en) Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests
AU2002343512B2 (en) Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests
US20040110777A1 (en) Quinazolinones and pyridinylpyrimidinones for controlling invertebrate pests
AU2003212811A1 (en) Quinazoline(di) ones for invertebrate pest control
AU2002331706A1 (en) Ortho-substituted aryl amides for controlling invertebrate pests
WO2004033468A1 (en) Anthranilamide insecticides
AU2005277228A1 (en) Novel anthranilamides useful for controlling invertebrate pests
US7157475B2 (en) Diamide invertebrate pest control agents
AU2002343512A1 (en) Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests
US20040235959A1 (en) Insecticidal diamides
EP1511385A1 (en) Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
WO2002032856A2 (en) Insecticidal 1,8-naphthalenedicarboxamides
AU2003202966A1 (en) Diamide invertebrate pest control agents
AU2002334581A1 (en) Insecticidal diamides
AU2002331708A1 (en) Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2001996125

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2002549646

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2001996125

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10433368

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001996125

Country of ref document: EP